Bio-Extraction(TSX.V: V.BXI) -Nahrungsmittelunternehmen in Nischenmarkt - 500 Beiträge pro Seite

[Popeye82]

Ich hab das Unternehmen vor ein paar Tagen auch woanders vorgestellt. In meinen Augen ziemlich interessant &hab mir dazu mal ein bissl Zeit genommen, um u.a. auch ein Chance/Risiko-Profil auszuarbeiten, also keine einseitigen Jubelarien. Vor allem da das IMO eine richtig interessante Investchance, mit längerem Horizont, werden könnte, stell ich das auch mal hier rein. Musste das teilweise nochmal etwas überarbeiten, weshalb ich teilweise die alten Angaben dringelassen &aktualisierte Sachen zusätzlich angefügt habe(zum Vergleich, v.a. da die zugrundliegenden Preise sich auch etwas verschlechtert haben). Falls ein MOD hier mal reingucken sollte -bei der Threaderöffnung konnte ich das nicht unter der Eingabe der ISIN, sondern musste das mit der Forumfunktion machen. Ich vermute, daß das nicht mit der Aktie verknüpft wird -wäre in dem Fall nett, daß mal gleich zu machen.


Sharestructure(04.09): 111,49Mio O +9Mio Options(weighted average von 0,27 C$, mit Laufzeit von in Kürze –July 2013) &26Mio W(weighted average von 0,39 C$, mit Laufzeit von in Kürze –Jan 2010), FD dann 146,49Mio

akt. Bewertung(11.04) 0,44CAD/Aktie macht, ohne Optionen &Warrants, 49,06Mio CAD
Handelsvolumen:
Cash:
Debt: 4,5Mio $ für den Aufbau etc. von der Farm Credit Canada
2,5Mio $ Kreditlinie bei der Bank of Montreal um das Working Capital zu erhöhen, wenn die Anlage in Produktion ist

(beides aufgenommen in Q3 ´08)

Capitalstructure(FD, Stand: Sep 30, 2008):

Christopher Carl(CEO) 7,4%
Paul McCory(Director) 3,3%
AGF Management Ltd. 3,3%
Christopher Schnarr(CFO) 1,5%
Stone &Co. 1,4%
Ilja Troitschanski 1,4%
Will Ollerhead(Director) 1,1%
Samah Garringer(VP, BD) 0,9%
John Michael Lorenzo 0,4%
John MacDonald(Director) 0,2%
Mavrix Fund Management 0,2%
David Carbonaro 0,2%
Peter Lacey(Director) 0,1%

Total: 21,3%

(etwa 13,7Mio Aktien des Managements sind, entwicklungs- &performanceabhängig, 3Jahre “under escrow”)

WS: www.bioexx.com


Bio-Extraction Technologies(TSX-V: V.BXI) ist ein relativ junges kanadisches „agricultural technology“-Unternehmen mit Hauptquartier in Toronto, das mit einigen Patenten in der Nahrungsmittelindustrie seinen Weg gehen will. Die Geschäftsidee sieht für mich ziemlich interessant aus, vor allem, da sie es wohl auf einen Nischenmarkt absehen, der mir für einige ganz interessante Besonderheiten gut zu sein scheint. Agrar/“Cleantech“ finde ich neben Commodities &Energy langsam mit am interessantesten, auch wenn es noch vieles mehr gibt &die Branche kurzfristig wohl keine Bäume ausreissen wird. Inzwischen hab ich schon einige wenige Unternehmen gesehen, die da interessant sein könnten, bei einer genaueren Betrachtung kommen die meisten aber wohl nicht über die Kategorie „Hopefuls“ hinaus. Das könnte bei BXI anders aussehen. Versuche ab jetzt immer wieder Stärken/Schwächen nochmal separat aufzuführen. Das scheint mir doch immer wichtiger &ergibt dann erst ein abgerundetes Gesamtbild. Werden seit einiger Zeit auch von einigen Brokern gecovert(3* Strong Buy, 2* Buy, 1* Hold) und sind nicht in Deutschland handelbar.


Unternehmen/Produkte/Märkte/Ziele

BXI hat eine Technologie, mit dazugehörigen Patenten, entwickelt, die es ermöglicht aus „organischer Biomasse“ verschiedene Inhaltsstoffe zu extrahieren/gewinnen. Mit dieser „Extraction“-Technology können sie aus verschiedenen Bioausgangsstoffen Öl, Mehl &Produkte mit speziell erhaltenen Proteinen gewinnen. Möglich ist das mit mehreren Ausgangsstoffen, anfänglich wird aber nur Canola dafür verwendet. Später hätten sie dann v.a. mal Raps, Soya &Flachs im Visier. Das Besondere ist jetzt daran, dass sie im Vergleich zu ähnlichen Unternehmen nicht 2(Öl &Mehl), sondern 3(+Proteine) Endprodukte daraus herstellen können, die auch noch bessere Eigenschaften aufweisen, als die meisten anderen.

Bessere Eigenschaften deswegen, da sie bei Ihrer speziellen Vorgehensweise ein anderes Verfahren &eine niedrigere Temperatur, </= 50° C, beim Gewinnungsprozess anwenden, was dafür sorgt, dass, wie bei vielen anderen, die Proteine und der Nährgehalt nicht in diesen Massen zerstört werden/weitestgehend erhalten bleibt(was bei einer Temperatur ab etwa 65° C passiert, meist werden bei ähnlichen Verfahren Temperaturen von >100° C angewandt). In der Begründung zur Vergabe des „Frost &Sullivan Awards“ wurde dazu folgendes festgehalten: „Conventional solvent extraction processes involve the extraction of oil from oilseed by hexane, which is a highly flammable petroleum-based solvent. Hexane is used because vegetable oils dissolve easily in petroleum fractions, but not in water. The extraction process begins when oilseeds are first crushed to extract some of the oil and then hexane is introduced to extract the remaining edible oil from the oilseed. Although hexane has a boiling point of about 69 degrees C, steam is used at 100 degrees C or higher to recover the residual hexane in the oil extracted meal. During this process, much of the protein content of the oilseed will be denatured, reducing its solubility and making it more difficult and costly to concentrate and separate the protein from the cellulose content of the meal. The inherent nutritional value of the protein is substantially lost in this process, and the resulting meal has little value except as low value added animal feed.

Fortunately, BioExx’s proprietary extraction technology is capable of preventing the degradation of such heat-sensitive components. As BioExx’s technology is based on the utilization of patented non-flammable solvents with very low boiling points (minus 20 degrees C), the recovery of solvent is carried out at near ambient temperatures (35 degrees C to 45 degrees C).

These favorable operating conditions result in an oil yield of about 98% to 99% and the retention of the nutritional value and solubility of the protein in the oilseeds. This high-quality and highly soluble protein can be further refined to become protein concentrate (more than 65% protein content) and protein isolate (more than 90% protein). In comparison to conventional methods to produce protein concentrates and isolates, BioExx’s technology will allow for a considerably higher yield at a lower cost. The protein concentrate can ultimately be applied as specialty animal feeds or aquaculture feeds, whereas the protein isolate can be used as a food-grade protein supplement or protein powder, both of which are high-value compounds in the nutritional and food processing industries. The production of protein derivatives contributes toward increased crop utilization, meaning more value can be obtained from the original oilseed crop. Bioexx’s extraction technology has been tested successfully on canola, soybean, and flaxseed.

The entire extraction process operates as a closed loop process. This allows BioExx to recover the solvents efficiently and more completely without overheating the meal and denaturing the protein. Since less heat is required in the process, less energy is required to generate this heat, and therefore energy consumption requirements can be considerably lowered. The BioExx solvents are also considered much safer to work
with than hexane.

Besides extraction of edible oils, BioExx’s extraction technology can also be utilized to extract pharmaceutical and nutraceutical compounds such as Omega-3 fatty acids, paclitaxel, artemisinin, lutein, betulin, lycopene and beta carotene from plant, fish, and marine sources. The technology can also be applied in the cleansing of metal swarf from industrial lubricants, the recycling of specialty plastics and glass, as well as in the production of biofuels. „


Das dürfte für ein paar Vorteile gut sein:

1. geringerer Aufwand/Energieverbrauch

2. daraus resultierend niedrigere Kosten

3. alles was in die Produktion reingeht, kommt als Produkt wieder heraus, es gibt keinerlei Abfallstoffe

4. der gesamte Prozess verursacht voraussichtlich keine Emissionen

5. auch unter anderen Gesichtspunkten ein wesentlich umweltfreundlicheres Verfahren

6. der Ölgehalt und die Gewinnungsquoten variieren bei den verschiedenen Biostoffen sehr stark, beim Gehalt z.B. von etwa 1 - >40%. Hier wäre Canola mit >40% Ölgehalt &einer Gewinnungsquote von etwa 85% sehr weit vorne

7. durch spezielle Produkte ist ein prinzipiell breiter gefächerter Absatzmarkt gegeben


Hierbei/Proteine etc. würde es v.a. bei den „Isolaten“ am spannendsten werden. Durch den besagten Erhalt der Proteine/des Nährwertes/der Eigenschaften der Biomasse würden sich, neben anderen, v.a. ganz entscheidende Erlös- wie auch Margenvorteile ergeben. Ich versuch das mal ein bisschen aufzuschlüsseln:

Durch diesen Ansatz werden sie es wahrscheinlich schaffen, neben dem Mehl &dem Öl, Produkte herzustellen, die die Proteine in einer Spanne von je 60 - >90% erhalten können. Je höher der Prozentsatz, desto interessanter &erlösträchtiger die Produkte –mit den Isolaten potentiell an der Spitze.

In der letzten Presentation, die noch vom Nov ´08 ist, gehen sie bei den „konventionellen“ Herstellungsverfahren von einem Erlös von etwa 1,30 $/kg(momentan von 1$/kg) beim Öl &25C/kg beim Mehl aus. Bei anderen Ausgangsstoffen gehen sie von ähnlichen Erlösen aus, wobei ich nicht sagen kann, ob das wirklich für alle Alternativen, oder nur für die meisten zählen würde. Bei Ihrer Methode gehen sie beim Öl von gleichen Erlösen aus, beim Mehl auch etwa gleich, allerdings mit einem kleinen Aufschlag(siehe auch das Verkaufsagreement). Spannend wird es aber erst mit den Proteinen, den 3 zusätzlichen Produkten. Die könnten hier für das gewisse Extra und sehr interessante Aussichten sorgen. Die könnten nämlich für Erlöse von einem vielfachen des Mehls sorgen.

Die erste Stufe wären die Proteinkonzentrate, mit einer Reinheit von 60 -70%. Das Produkt nennt sich CONCENTREXX &dabei gehen sie von Erlösen von 1,50C$/kg(momentan 1$/kg) aus. Verwendung wäre hier großteils noch als Tiernahrung.

Die zweite Stufe wären Protein „Superkonzentrate“ mit einer Reinheit von 70 -85%. Das Produkt nennt sich ADVANTEXX &gibt es in 2 Ausführungen. Hier kalkulieren sie mit Erlösen von 2 -3C$/kg(momentan 2,50$/kg). Das würde dann in Backwaren, Vegetarischen Produkten und anderem verwendet werden.

Das allerbeste wären aber die Protein „Isolate“ mit einer Reinheit von >90%. Hiervon sind dann auch wieder 2 Versionen geplant, die sich ISOLEXX und VITALEXX nennen. Hier rechnen sie mit Erlösen von 5 -8C$/kg(momentan 7$/kg). Die Verwendung wäre dann noch spezieller, wie z.B. für die Kosmetik, Soft- &Energydrinks, speziell gesunder Nahrung u.ä. . Im Vergleich zu dem Mehl wären das Erlöse von 5 bis >25* soviel. Neben den Erlösen könnte das aber v.a. auch noch beträchtliche Auswirkungen auf die Margen haben –während man nämlich bei dem einfachen Konzentrat mit Margen von gut 25% rechnet, geht man davon aus, dass die sich mit den Isolaten auf mehr als 50%(!) verbessern würden. Die Umsätze würden deutlich ansteigen &die Margen zusätzlich auch noch mal. Und genau das könnte, wirtschaftlich, der Knackpunkt werden. In der neuen Präsentation(S. 16/17) ist das mal aufgeführt wie das theoretisch funktionieren soll &sich wirtschaftlich auswirken würde –wenn das aufgeht, wäre das IMO arg beeindruckend!

Sie sprechen davon sich hier in einem weltweitem 200Mrd. $/anno-Markt zu bewegen, wesentlich interessanter, innerhalb einer Branchenbetrachtung, scheint mir aber der Ansatz, à lá: „aus weniger mach mehr“. Laut eigenen Angaben hat das „Rennen begonnen“, ursprünglich vorhandenen Nährwert/Proteine zusätzlich noch aus Canola gewinnen zu können. Testversuche bis zu den „Superkonzentraten“ konnten erfolgreich abgeschlossen werden, für die „Isolate“ steht das noch aus. Inzwischen, siehe letzte Meldung, konnten auch die Testversuche mit den Isolaten erfolgreich abgeschlossen werden. Es gibt momentan wohl 2 weitere kanadische Unternehmen, die sich daran versuchen, Denen gegenüber man aber schätzt einen 2 -3Jahresvorsprung zu haben.

Eine weitere interessante, hier IMO mit ausschlaggebende, Sache hier sind die „Crush Margins“. Die sorgen nämlich dafür, dass das Unternehmen nicht so zyklisch/den Zyklen unterworfen sein dürfte. Während z.B. Rohstoff(und viele andere)unternehmen Ihre Gewinne aus der Differenz von den Rohstoffpreisen abzüglich der Förder-, allen weiteren operativen Kosten, sowie Verrechnung der CAPEX und Investitionen, rausholen müssen, hängt man hier nicht so direkt von „einer Variablen ab“, bzw. die bedingen sich vielmehr. Heisst dann in der Praxis, dass wenn die Rohstoffpreise(Ertragsseite) fallen, die Kosten für die Förderung nicht auch fallen müssen -&dass das übel ins Auge gehen kann, sieht man ja gerade sehr deutlich. Die „Crush Margin“ dagegen resultiert aus der Differenz vom Einkaufspreis des zu bearbeitenden Produktes abzüglich aller operativer Kosten. Da der In- und Output beides Agrar/Nahrungsmittel sind, fällt oder steigt meist auch der Einkaufspreis, wenn das Endprodukt im Preis steigt oder fällt. Das muss nicht zwangsläufig der Fall sein, ist es aber meist. Dadurch hat man dann eigentlich wesentlich flexiblere Margen. Auf die Punkte wird auch in der Presentation und in dem Fraser Mackenzie Research näher eingegangen, wobei die Crush Margins langfristig bisher deutlich am steigen waren –in der Präsentation wird noch angefügt, dass die Entwicklung bisher bei allen hauptsächlichen Bioausgangsstoffen für die Ölgewinnung zu beobachten ist. Hier dazu noch eine Erklärung aus der letzten MD &A(wobei die m.A. nach die kompletten operativen Kosten unterschlagen!): „Commodity Market Dynamics: BioExx is pleased to note that crush margins have remained healthy in the face of the steep general downturn in commodity prices. Conceptually, crush margins are a representation of the per metric tonne excess of output revenues (from oil and meal sales) less input costs (from seed purchases). Since these three items tend to change together, even in a declining commodity price market, margins can remain strong. The same can also hold true in strong commodity markets. BioExx believes that this provides the company with good earnings stability and insulation from the economic impact of constantly changing commodity prices by offering a long-term economic profile with less volatile margins than those of the underlying commodities. We continue to see favourable demand-driven conditions continuing in oilseed commodity markets over the longer term, driven by population growth and economic growth, in spite of the recent unwinding of speculative positions which had held prices at unsustainably high levels in the short run. All in, we believe we remain in a very healthy secular agricultural commodity market. We believe this provides a very firm foundation on which to build our Saskatoon plant and drive aggressively from that entry point to longer term capacity growth and value creation for our shareholders.“

Der mittel –längerfristige Plan geht dahin, prinzipiell weltweit gestreut, mehr und größere Anlagen zu bauen. Konkret sprechen sie selber über ein Ziel von 5 Anlagen, mit einem Gesamtvolumen von etwa 800.000Mt/anno, und einem Umsatz von >/= 1Mrd. $ in den nächsten 5 Jahren. Dabei hätten sie v.a. Nordamerika, Südamerika und die EU im Visier, wobei sie in Nordamerika (komplett)eigene Anlagen betreiben &in Südamerika &der EU Partnerschaften eingehen wollen. Ganz langfristig haben sie im Hinterkopf eventl. zu versuchen über die „oilseed industry“ hinaus zu expandieren &auch andere Industriezweige zu erschliesen. Ausserdem wird noch in Erwägung gezogen, mal auch durch Lizenzabkommen Geld zu verdienen. Ob das wirklich möglich sein wird kann man erstmal dran zweifeln, das werden sie beweisen müssen, die jetzige Situation dürfte das auch alles andere als leichter machen. Gefühlsmässig hätte ich an den Zielen ziemliche Zweifel, wenn man sich allerdings die zügigen Fortschritte in der noch jungen Unternehmensgeschichte anguckt &das sie, was ich bis jetzt gesehen habe, Ihre Ankündigungen bis jetzt weitgehend eingehalten haben, dann würde ich eher am Zeitrahmen zweifeln, dass aber durchaus ernst nehmen, dass sie Ihre Kapazitäten m.d. Zeit noch sehr stark ausbauen können.

Die im Februar erstmalig aufgenommene Produktion soll im Laufe/wahrscheinlich Mitte des Jahres, unter voller Auslastung, eine Kapazität von 40.000Mt/anno erreichen. Von Fraser Mackenzie wird angenommen, dass die nächsten Anlagen eine potentielle Kapazität 80.000, 160.000 &dann folgend 2*250.000Mt haben(was dann gesamt 780.000Mt wären). 250.000Mt pro Anlage/Jahr wird derzeit von BXI als geplante Maximumgrenze gesehen. FM kalkuliert mit einem kleinen Verlust dieses, &einem minimal größerem Gewinn nächstes Jahr, bei erstmals stark ansteigenden Umsätzen, ab 2009. Die erste bedeutende Entwicklung bei den Gewinnen könnte dann in 2011 anstehen. Die Produktionsstufen teilen sich wiederum, jetzt mit der 1sten Anlage, in 3 Phasen auf:

Phase I
Phase I involves seed preparation and pressing; taking canola seed feedstock and pressing it to remove up to 85% of the oil. This produces a crude, expeller grade oil, and a high oil content meal (or “cake”). Both of these products are saleable into BioExx markets as and when produced. Phase I is based on standard and well accepted
equipment and processes, which have been widely used globally for decades. During this phase, a limited amount of cake will be further processed to produce Protein Concentrates utilizing the BioExx Intermediate Size Plant. It is expected that Phase I will be operating at more than 80% capacity before Phase II commences.

Phase II
Phase II is the extraction of the remaining oil from the Phase I press cake, based on the patented BioExx low-temperature oil extraction technology. The output from this phase will be a high quality Super-degummed canola oil, as well as a high quality, highsolubility protein canola meal. Current market prices and expected operating costs suggest that BioExx can earn a meaningful profit at the plant level based on the sale of products derived from this phase.

Phase III
Phase III is the separation of protein from the Phase II meal, to produce high quality Protein Concentrates for sale into specialty feed markets, followed by a goal to introduce Super-Concentrates in early 2010 and then Protein Isolates in early 2011. BioExx has a patent application pending for its unique method of producing these specialty proteins, as well as the unique and high-value protein products that result.


Finanziert werden soll der Ausbau durch Schulden und die Entwicklung eigenen Cashflows, wobei man zu große Verwässerung möglichst vermeiden will. Da sich beim EPS vor 2011 wahrscheinlich nichts entscheidendes tut, dürfte das fraglich sein, wie sie das aus eigenen, nennenswertem, Cashflow finanzieren wollen –sofern sie an Ihrem, straffen, Zeitplan festhalten(wobei der hauptsächliche Teil durch Schuldenaufnahme erfolgen soll). Das wird zu beobachten und ich denke einer der Knackpunkte sein.


Extraction

The BioExx extraction technology requires less energy input in the solvent recovery process. This results in higher value meal, higher quality oil, and more nutritional proteins.

Using Canola as an example, in a typical solvent-based extraction process, the biomass is first pre-pressed to expel approximately half of the oil contained in the oilseed. The remaining oil is then removed by 'washing' the seed with a solvent that removes 95 to 97% of the remaining oil. This solvent, typically a petrochemical, must then be recovered from the oil and remaining biomass, the 'meal'. These petrochemical based solvents boil at between 65°C and 70°C and as a result the meal is heated with steam to well over 100°C to recover the solvent which in turn exposes the proteins to temperatures well above the point where they start to degrade.

In the BioExx extraction process, the biomass is pre-pressed and the remaining oil is removed using a patented refrigerant based solvent. The key difference is the BioExx solvents have a boiling temperature of approximately minus 20°C, which allows for a cost effective solvent recovery. The BioExx extraction process maintain the solvent at less than 50°C, a temperature below the point at which proteins begin to denature. These differences, although apparently simple, result in a system that produces higher quality and added value oil, meal and specialty proteins.


Umweltverträglichkeit

The BioExx process and technology is environmentally friendly and compares favorably to conventional commercial-scale extraction processes. The BioExx solvents are significantly less toxic resulting in reduced health and safety issues associated with handling solvents in our operating plants. In addition, the solvents have GRAS (Generally Regarded as Safe) standing in their use as food ingredients.

Solvent Emissions - the BioExx system is a closed -loop system whereby no solvents or other air emissions are generated from the process. The low boiling temperature of solvents allows for easier recovery and reduced emission when compared to traditional solvent extraction facilities.

GRAS standing of solvents - the BioExx process uses a mixture of solvents one of which is used as a propellant in asthma inhalers due to its ultra low toxicity. Both components have GRAS standing as well as significantly reduced toxicity over the n-hexane, predominantly used by the Canola and Soybean Industries.

Lower Heating Requirements - the BioExx process requires heating marginally above ambient temperatures whereas conventional extraction processes require heating in excess of 100°C This difference in operating temperatures results in much lower emissions.

Health and Safety - the solvents used by BioExx are significantly less flammable than conventional extraction solvents. The closed extraction and solvent recovery system, reduced flammability and significantly lower toxicity results in a safer working and operating environment for employees.


BXIs Produkte, Verwendung

Product Uses
Canola Oil Cooking oil, baked goods, processed foods

Canola Meal High grade feed for livestock(i.e. sheep, cattle, chickens)

Protein Concentrates Aquafeed, swine meal, baby livestock

Super Concentrates Baked goods, processed foods,meat products

Protein Isolates Nutritional supplements, power bars, energy drinks, vegetarian products (cheese), infant formula


für 2009 geplant:

CONCENTREXX™
a canola protein concentrate, at 60% to 70% protein by weight, for primary use in aqua feeds, swine
and pet foods. (C$1.50/kg)

ADVANTEXX™ 70
a canola protein concentrate, at 70% to 75% protein by weight, for primary use in products such as
baked goods (bread, rolls, cakes, cookies, biscuits, crackers, pancakes, pastries, donuts, pasta products, etc.), meat products (baked meat, hot dogs, sausages, bologna, ham, etc.) and vegetarian foods. (C$2.00-C$2.50/kg)

ADVANTEXX™ 80
a canola protein concentrate, at 75% to 85% protein by weight, for primary use in products such as
baked goods, meat products and miscellaneous applications (candies and confection, desserts, diet items, Asian
foods, soup mixes, gravies, etc.) (C$2.50-C$3.00/kg)


für 2010 geplant:

ISOLEXX™
a high-functional canola protein isolate, with 90% or higher protein by weight, for primary use in products
such as nutritional beverages (protein fortified soft drinks, sports drinks, fruit juices, etc.), nutritional supplements, infant formula, meat products (emulsified meats, combination meat products, etc.), dairy analogs and dried milk replacers and egg replacers. (C$5.00-C$8.00/kg)

VITALEXX™
a hydrolyzed canola protein isolate, with 90% or higher protein by weight, for primary use in products
such as nutritional beverages, cosmetic ingredients and health foods. (C$5.00-C$8.00/kg)


Oilseeds

The major oilseeds grown in Canada are soybeans, sunflowers, canola and flax. The oil content of small grains (e.g., wheat) is only 1-2%; however that of oilseeds ranges from about 20% for soybeans to over 40% for sunflowers and rapeseed (canola) thus providing excellent sources for oil extraction.


Canola

Canola is the second largest oilseed crop in the world after soybeans with global production of 47.3 million Mt in 2006-07. Of this, Canada produced 8.4 million Mt, coming second only to China with production of 13 million Mt. Nearly 70% of Canada’s canola exports are to the U.S. Canola is an altered form of the rapeseed plant, which is a member of the mustard seed family.


Canola Oil

The global market for canola oil is estimated to be worth US$29 billion based on 19 million Mt of annual production. Canola oil consumption in the U.S. alone increased by 8% in 2007, outpacing other vegetable oils. Many restaurants in the U.S. have made the switch, with 28% of restaurants changing to cooking with canola oil in the last two years. These trends are consistent with a global trend toward consumer demand for trans fat-free oils. BXI’s oil production at 17,000 Mt (plant #1) would constitute 0.0009% of total world production and therefore would simply be incorporated into the global supply chain presumably by an impending partner.


Protein Meal/ Canola Meal

Protein meal is a product derived from crushing oilseeds. From 2001-2007, annual world production of protein meal increased by 29% to 226 million Mt. Global production is expected to grow at 2.4% per annum to 2015,4 with the most common protein meals being soy meal and canola meal.

Canola meal is what remains after extraction of the oil and separation of the high quality proteins from the canola seed. Canola meal is usually sold as a low value animal feed ingredient containing high levels of fibre and soluble and insoluble protein for use in livestock diets including cattle, sheep and pigs as well as feed for aquaculture operations. The current estimated market for canola meal globally is approximately 28 million Mt per annum of production 5 worth about US$9 billion. Factors driving the demand for meal include dietary changes resulting from increased per capita income. This increase in wealth, especially in developing economies, leads to greater demands for meat products, which leads to an ever greater need for high protein animal feeds.


Uses of Canola Meal

Canola meal has several end markets most notably for livestock, as there has been a shift from animal-based proteins in animal feed, and in aquaculture, to replace fishmeal.

Events such as “mad cow disease” have resulted in bans on meat and bone meal as protein sources in animal feed in Europe and Japan. Thus, the need for high quality protein sources in fish meal and animal feeds has become more prevalent and is driving market demand for alternative high quality protein sources.

The Food and Agriculture Organization of the United Nations estimates the global aquaculture market is worth in excess of US$60 billion annually, with significant expansion expected as aquaculture accounts for almost one-third of the world’s fish supply. It is estimated that by 2010, aquaculture could exceed beef production. Global aqua feed production for the aquaculture market is estimated at 25 million Mt per year. Fishmeal for use as aqua feed is a finite resource, which will not be produced in sufficient quantities to sustain aquaculture’s future growth. Fishmeal prices in June 2008 were in the range of $1,200/Mt, as shown in Exhibit 2; prices have been steadily increasing and are expected to continue.

BXI hopes to exploit this opportunity with its plant-based canola meal, which has a superior solubility and amino acid profile compared to other available meals.


Specialty Proteins

The global protein market has experienced positive growth in large part due to scientific advances and global demand. In 2006, the world market for protein ingredients and isolates was estimated to be US$10.5 billion.7 The various protein products have a wide price range from $1.00/kg to $8.00/kg 7, depending on the precise composition. Specialty proteins, such as protein concentrates (60%-85% purity) and isolates (90% purity) are very high in soluble protein and are used in everything from fishmeal and animal feed to nutritional beverages, nutritional supplements, and infant formulas.

In a recent research report conducted by Global Industry Analysts (GIA), global sales of protein ingredients are expected to top U.S.$18 billion by 2010 with the U.S. being the fastest growing market at an annual rate of 7.6% followed by Asia-Pacific at 7.2%. The report also indicates that a wide number of plant protein ingredients (e.g. canola and soy) have been substituted for animal proteins (i.e. meat, eggs and fish) primarily because they are cheaper to produce. Animal protein ingredients currently account for 69% of the total protein ingredients market, however since the rising incidences of BSE (bovine spongiform encephalopathy) in 1995, several protein ingredient producers have been forced to formulate alternative proteins to meet changing consumer preferences.8 This along with emergence of markets such as sport nutrition and dietary supplements, the aging population, and increased concerns over health issues such as heart disease, has propelled the demand for alternative protein sources such as plant proteins.


Vergleich

Ein direkter Vergleich mit anderen Unternehmen ist hier, wie sie auch sagen, schwer zu machen, auf einer oberflächlichen Basis versuchen sie es trotzdem mal:

„Direct comparison within the canola seed processing market is difficult due to the range in size of operations,
extraction processes, end products and global presence. Relative to its competition, BXI will be a minute processor of canola seeds at 40,000 Mt annually. In comparison, BXI’s competitors process up to 137 million Mt of canola seeds (i.e. Bunge) annually with a global presence in close to 70 countries. Exhibit 6 shows a comparison between BXI and other industry participants.“

Bio-Extraction Cargill Ltd. Bunge Archer Daniels M. Burcon Nutra Science
BXI:TSXV private BG: NYSE ADM: NYSE BU: TSXV

2007 Revenues US$ n/ a 120.4 B 37 B 44 B n/ a
Global Presence Canada 67 countries 30 countries 60 countries Canada
Canola Processing 40,000 Mt* annually 1.5 mio Mt annually 137 mio Mt annually 30 mio Mt annually n/a
Canada Canada Global Global
Canola Products Canola oil, c. meal, Canola oil, c. meal Canola oil, c. meal, Canola oil, c. meal, Canola proteins
Specialty proteins byproducts biodiesel (SUPERTEIN and
PURATEIN)

*2009 expected production


Verantwortliche

Management Team

Chris Carl, President & CEO (Founder)
-has over 20 years experience in project finance, plant construction and in commercialization of new technologies. Prior to BXI, Mr. Carl spent 11 years with The CanFibre Group and was involved in the financing, construction and operation of two MDF (Medium Density Fibreboard) facilities in North America. Chris also worked at a Canadian subsidiary of Tenneco Inc. and was involved in the construction, start-up and operation of two $70 million manufacturing facilities that utilized new patented technologies.

Chris Schnarr, Chief Financial Officer
-17 years experience finance, small cap/growth, 7 years public company

Samah Garringer, Vice President, Business Development
-23 years sales, marketing and operations, domestic and international

Laurence Parslow, Director of Research & Development
-19 years extraction experience, degrees in Chemistry and Chemical Engineering

Gordon Maclennan, Plant Manager
-23 years extraction, technology, and project management experience, has spent the last 15 years with Bunge Canada at its canola processing facility in Nipawin, Saskatchewan


Science Advisory Board

Dr. Peter F. Wilde (B.Sc., Ph.D., F.R.I.C., F.L.S.)
-Original inventor of 2 BioExx patents, 50 years international experience

Dr. Tom MacMurray (B.Sc., Ph.D.)
-40 years experience, broad base in extraction, former Heinz executive

Dr. Albert G.J. Tacon (B.Sc., Ph.D.)
-30 years in the aquaculture nutrition and feed development, 193 publications


Board of Directors

Chris Carl – President & CEO

Chris Schnarr – Chief Financial Officer

Paul McClory
-Entrepreneur in alternate energy and renewable technologies, UK resident

Peter Lacey
-Seasoned ag industry executive, TSX CEO/Chair experience, corporate governance

John MacDonald
-25 years accounting/tax/audit private practice, public/growth company experience

Will Ollerhead
-Finance professional, tremendous experience in debt markets


kurzer Abriss Unternehmensentwicklung

Die Gründung des ursprünglichen Unternehmens fand im Jahr 2003 statt. In der folgenden Zeit war man hauptsächlich in der Forschung &Entwicklung aktiv.

Im März ´06, damals unter dem Namen „Life Sciences Capital Corp“ wurde die(eine andere) Gesellschaft als „Capital Pool Company“ unter den Vorgaben der TSX-V eingetragen. . Dabei wurden 800.000Aktien von Verantwortlichen zu einem Preis von 0,125$/Aktie bezogen. Das IPO fand am 1. Sep, 2006 zu einem Preis von 0,25$/Aktie statt, wobei 1,9Mio $ eingesammelt wurden. Am 10. Oktober 2006 unterzeichnete Life Sciences Capital einen LOI zur Übernahme von Bio-Extraction Ltd. . Am 9. Mai ´07 wurde die Übernahme, durch die Ausgabe von etwa 45,4Mio neuen Aktien, abgeschlossen und der Name auf „Bio-Extraction Inc.“ geändert, wobei sie dann am 16. Mai das erste Mal in dieser neuen Konstellation handelbar waren. Im 1. HJ ´08 wurde der Grund &Boden für die Fertigungsanlage übernommen, was nach dem Aufbau der Anlage, weiteren Forschungsarbeiten, abschliessen von Vertriebsabkommen &Testversuchen zur in Betriebnahme kürzlich führte.


Patente

Dr. Peter Wilde, who is now a member of the Bio-Extraction Advisory Board, developed BXI’s original technology. Dr Wilde sold his interest in the technology to MGA Holdings, which was ultimately purchased by BXI and is now a wholly owned subsidiary. BXI has complete ownership of all issued patents with no rights or royalties due to Dr. Wilde.

BXI currently has three patents granted with expiration in 2020 and beyond and has recently filed two additional
patent applications in the U.S. The issued patents cover the company’s use of solvents in the extraction process and the filed patents relate to BXI’s continuous counter-flow method for extraction and the process for the production of protein isolates and concentrates.


Partner/Abkommen/Verträge

Partner

-Feeds Innovation Institute, University of Saskatchewan
-POS Pilot Plant
-University of Alberta
-EUROFINS Scientific
-German Institute for Food Technology


Einkauf(Canola):

Viterra Inc.(Canada’s largest handler of grains and seeds, distributes grains and oilseeds globally with customers in over 50 countries and is Canada’s lead exporter of canola seeds with a grain elevator conveniently located within 10 km of the Saskatoon plant)

-40.000Mt/anno Canola Seeds über 6 Jahre +2*2 Jahre erneuerbare Option auf Verlängerung, der Kaufpreis basiert je auf den Futures Kontrakt-Preisen zu dem Zeitpunkt, zu dem die Order in Auftrag gegeben wird, die 40.000Mt/anno entsprechen etwa 0,02% von Viterra´s Kapazitäten, sollten sie theoretisch trotzdem nicht liefern können, kann BXI seinen Bedarf am offenen Markt decken


Verkauf:

Mehl

Shafer Commodities, (based in Vancouver, a subsidiary of Shafer-Haggart Ltd., founded in 1934 in Vancouver, BC. In the mid-1970’s Shafer became a leader in distributing low cost feed formulations to the livestock industry. Since 2004, Shafer has concentrated on procuring and marketing feed ingredients for dairy, beef, poultry, hogs, aquaculture feed, pet food and organic ingredients)

-12.500Mt/anno of Canola Meal über 6 Jahre +2*2 Jahre erneuerbare Option auf Verlängerung, das Abkommen beinhaltet einen Aufschlag zu normalem Canolamehl, abhängig von den Spezifika des gelieferten Canolamehls(wird von Fraser Mackenzie auf etwa +10 -15% geschätzt)

Öl

-Shafer Commodities, „10 year contract including renewals“, die Preise richten sich nach aktuellen Marktpreisen zum Zeitpunkt des Verkaufs, mit einem Aufschlag für eventuelle Spezifika des Öl´s

-Sunora Foods Ltd.(based in Calgary, Alberta, is internationally recognized for its canola oil and related canola products and is a major Canadian exporter of food oil. Operating through a base of more than 10 warehouse outlets, Sunora is a significant distributor of both expeller grade and organic food oils. Its introduction of canola oil into new specialty markets has elicited the support of both health practitioners and nutritionists. Sunora has spent around 20 years developing and servicing the specialty oil needs of a global base of customers in the retail, food service and food processing industries)

-„10 year contract including renewals“, vermute dass die Beiden gleich gestrickt sind, wie das obere 6/2/2-Konstrukt, die Preise richten sich nach aktuellen Marktpreisen zum Zeitpunkt des Verkaufs, mit einem Aufschlag für eventuelle Spezifika des Öl´s


„Specialty“ Proteins

-Helm AG(a 108 year old company with offices worldwide including Europe, Africa, Asia and North America, and 2007 sales in excess of $12 billion CDN. Helm has built its success upon working with quality producers as suppliers rather than concentrating on its own production facilities and is one of largest distributors of animal and human nutrition products worldwide. Helm’s markets include chemicals, nutrition, pharmaceuticals, polymers, crop protection, and fertilizers. Helm has a large team of scientists to maintain very strict quality control and works exclusively with suppliers who can produce products that meet strict parameters of quality and consistency)

-über 5Jahre, mit 5*der Option auf je ein Jahr Verlängerung(in der Meldung stand was von „with five automatic one year renewals.“, so „vollautomatisch“ kann das IMO ja eigentlich nicht sein –sonst hätte man ja gleich einen festen 10-Jahresvertrag abschliessen können? Das wäre vielleicht noch mal ein Punkt zum nachhaken.),umfasst alle Stufen der Proteinkonzentrate, wobei eine Minimalabnahmekapazität von 70% festgeschrieben ist. Im Gegenzug für das Abnahmeabkommen wird Helm eingeräumt der alleinige Vertreiber der „Specialty“ Proteinprodukte(von der ersten Anlage) in Europa zu sein(hier weiss ich nicht genau, ob BXI selber davon auch ausgeschlossen wäre, vermute es aber). Es wurde auch vereinbart Deren Beziehungen „auf globaler Ebene zu vertiefen“, was bei neuen Anlagen zum Tragen kommen würde. Im Zuge dessen hat man Helm eine Art Erstverhandlungsrecht für mögliche künftige, weitere Kapazitäten, durch neue Anlagen, eingeräumt. Das Unternehmen wird eigentlich als der wichtigste zukünftige Partner angesehen.

Die haben sich auch ziemlich positiv zu BXIs Proteinprodukten geäussert(noch aus Ende Nov ´08):

"Our detailed analytical testing of the BioExx proteins returned superior results and showed unique characteristics, including high protein solubility, an excellent amino acid profile, and exceptionally low anti-nutrient levels", said Thomas Arnold, Executive Director Nutrition of Helm AG. "We are very pleased to be adding the BioExx proteins to our global product family, particularly in a market characterized by very strong demand and limited high quality sources of supply. The Saskatchewan production volume is relatively small , however, we view this as an opportunity to establish a relationship which can grow as BioExx grows and expands its production capacity."


Stärken/Chancen

-laut eigenen Angaben ist Deren Technologie „the only known commercial scale, low-temperature extraction process that does not denature extracted proteins allowing for their use in higher-value applications such as food additives.“
- also ein First Mover/Alleinstellungsmerkmale, wollen sich in einem noch recht jungen Nischenmarkt positionieren
-seit kurzem mit der ersten Fertigungsanlage zum Produzenten geworden
-Canola –hoher Ölgehalt &hohe Gewinnungsquoten
-großteils längere Branchenerfahrungen der Verantwortlichen
-langfristige (Teil)Abnahmeverträge, soll noch ausgebaut werden
-partizipieren an „Crush Margins“ im Vergleich zu z.B. Rohstoffunternehmen
-emissionsfreie Anlage
-vor dem Jahresende wollen sie den Break Even schaffen(allerdings dann noch nicht annualisiert)
-meinem Eindruck nach scheinen auch die nötigen Investitionen für so eine Anlage(im Vergleich zu später möglichen Umsätzen &Gewinnen) ziemlich niedrig zu sein, will mir da aber noch mal genaue Zahlen zu raussuchen
-Kapazitäten sollen mittel- längerfristig stark ausgebaut werden(an den eigenen Zielen gemessen wäre es etwa ein Faktor20 innerhalb der nächsten 5 Jahre); horizontale &vertikale Expansion geplant
-breitere Absatzmöglichkeiten als vergleichbare „konventionelle“ Produzenten, was dann auch eine gezieltere Auswahl der Abnehmer erlauben dürfte
-wenige, aber große &international ausgerichtete Vertriebspartner(Ein- &Verkauf)
-keinerlei genetische Anwendungen dafür

Schwächen/Risiken

-v.a. die Gewinnentwicklung ist sehr schwer abzuschätzen, es könnte noch eine Weile dauern, bis es deutlich profitabel wird/müssen sie erst unter Beweis stellen
-über die nächsten Jahre größerer Finanzierungsbedarf(der großteils über Schulden realisiert werden soll)
-Agrar- &Nahrungsmittelmärkte haben sicherlich Zukunft, können sich aber der jetzigen Situation auch nicht entziehen
-es wäre möglich, dass BXI es nicht schafft, die hochwertigen Proteine(Isolate, die mit 90% Reinheit) erfolgreich zu produzieren(Versuche inzwischen aber erfolgreich)
-es ist nicht zwangsläufig selbstverständlich, dass kleinere Testversuche sich so problemlos großflächig/auf die Massenproduktion- &Vertrieb umsetzen lassen
-da das ein recht junger Markt ist, ist es nicht selbstverständlich, dass BXI auf die entsprechende Nachfrage treffen wird
-auch wenn die besagten Crush Margins eine ganz gute Absicherung in ungewissen Zeiten darstellen, können sie auch fallen, was sie auch gerade tun
-einzuhaltende Regulatorien &Standards, Denen man entsprechen muss, um bestimmte Genehmigungen zu bekommen(in Amerika z.B. den GRAS-Standard durch die FDA, Abkürzung für „Generally Regarded as Safe“)
- geringer Cashbestand, wobei er, mit der Kreditlinie, IMO eigentlich reichen sollte bis die Profitabilität erreicht ist


next Steps ahead

-erster Erhalt &Verarbeitung von Canola war am 18. Februar, die erste Produktion sollte eine Woche später &die erste Auslieferung noch eine Woche später erfolgen
-etwa Ende April/Anfang Mai wird die volle Kapazitätsauslastung(Öl &Mehl) erwartet
-Zertifizierung der Produkte, die die internationalen Vertriebsmöglichkeiten verbessern sollen
-Veröffentlichung der ersten Produktions, sowie(operativen) Geschäftszahlen
-Aufnahme der Produktion von CONCENTREXX, angestrebt für Q3 ´09
-angestrebte, hoffentlich eintretende, erste Profitabilität im 2. HJ ´09
-Produktion der „Superkonzentrate“, angedacht ab Q1 ´10
-Produktionsbeginn der Isolate geplant ab Q1 ´11


mein Eindruck

Fällt mir etwas schwer, die Bedeutung von Deren Technologie und Patenten so richtig einzuschätzen, v.a. im Vergleich zu bisherigen Vorgehensweisen(wie grosser Fortschritt) &wie es im Vergleich zur Konkurrenz aussieht. Ich vermute aber, dass die nicht ganz klein ist &man es hier mit einem Unternehmen zu tun hat, bei dem nicht nur immer die Innovationen beschrien werden, sondern vorhanden sind. Wie sich das dann mal in Zahlen niederschlägt ist noch eine ganz andere Sache.

Ist auch schwer zu übertragen, was das für den Kurs bedeuten könnte. Ein durchaus denkbares Szenario könnte in meinen Augen sein, dass der Kurs die nächsten 1 -2 Jahre nur vor sich hindümpelt &in 2011 dann irgendwann durch die Decke geht.

Zu berücksichtigen dürfte sein, dass Teile der Quellen erschienen sind, als diese ganz rabenschwarze Entwicklung der Weltwirtschaft noch nicht in diesem kompletten Ausmass klar waren(aus etwa Q3/Q4 ´08). Nachdem ich jetzt die neuesten Schätzungen gesehen hab, hab ich die alten Zahlen mal stehengelassen, aber die neuen noch angefügt, mal zum Vergleich. Über einen längeren Zeitraum dürften die Verkaufserlöse pro „Einheit“ denke ich auch wieder etwas ansteigen(wobei dann die positiven Auswirkungen wiederum auch nicht so groß wären, wie bei anderen Geschäftsmodellen –siehe die „Crush Margins“). Das größte Problem scheint mir erstmal zu sein, dass, durch zu viele unbekannte Variablen, es hier noch nicht so richtig möglich ist zu überschlagen, wie die nächsten paar Geschäftszahlen aussehen könnten. Eine der wichtigsten Sachen dürfte sein, dass sie so schnell wie möglich den operativen Break Even errreichen(um zumindest für´s 1ste kein Geld mehr zu verbrennen). Ich will genau deswegen erstmal die Entwicklung von Denen abwarten und gucken, ob sich vielleicht mal ein guter Einstiegszeitpunkt ergibt. Habe auch noch ein paar Fragen, die ich Denen mal schicken will –wer auch noch welche hat, einfach mal was sagen. Bei 4 -5Mal Unternehmen anschreiben, hab ich bis jetzt erst ein einziges Mal eine Antwort bekommen, zweifel da schon langsam an mir selber –hoffe ja die Quote langsam mal zu verbessern. Also ich finde die interessant &wenn ein paar Sachen wie erhofft laufen, dann dürfte hier IMO beträchtliches Potenzial vorliegen.

Ich hab keine Aktien –liege aber in Lauerstellung.


Info´s &Quellen

Summary
www.bioexx.com/images/stories/pdfs/ir/corporatesummary_fall2…

Presentation – Apr09
www.bioexx.com/images/stories/pdfs/ir/bxi%20presentation%20a…

Fraser Mackenzie – Sep08
www.bioexx.com/images/stories/pdfs/ir/frasermackenziebxianal…

2008 North American Frost & Sullivan Award for Technology Innovation
www.bioexx.com/images/stories/pdfs/research/frost_awardartic…

FII Report on Feed Quality Parameters and Preliminary Market Feasibility of BioExx Meal – Oct07
www.bioexx.com/index.php?option=com_content&view=article&id=…

POS Pilot Plant
www.pos.ca

Feeds Innovation Institute
http://feeds.innovation.usask.ca

ein paar R &D Artikel von Deren Website
www.bioexx.com/index.php?option=com_content&view=article&id=…


Meldungen 2009

BioExx Completes Major Canola Oil Distribution Contracts – Jan 12, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

BioExx Accepts First Delivery of Canola Seed , Final Preparation for First Production Nears – Jan 19, 2009
http://bioexx.com/index.php?option=com_content&view=article&…

BioExx Commences Production at Saskatoon Plant – Mar 2, 2009
http://bioexx.com/index.php?option=com_content&view=article&…

BioExx Commences Commercial Sales Activity and Advances to 24 Hour per day Production – Mar 31, 2009
http://bioexx.com/index.php?option=com_content&view=article&…

BioExx Produces Superior Protein Isolates and Hydrolyzed Protein Concentrates from Canola – Apr 1, 2009
http://bioexx.com/index.php?option=com_content&view=article&…


Head Office

219 Dufferin Street, Suite 100B
Toronto, ON, CANADA
M6K 3J1
Phone: [phone]
Fax: [phone]
e-mail: [e-mail]


Kritische Ansichten, Ergänzungen u.ä. immer reinbuttern, nur auf dieses ziellose, unkonkrete schlechtmachen, pushen/bashen etc. kann ich gut verzichten.
________________________________________________________________

Das ist keine Kauf/Verkaufsempfehlung -Investments müssen auf eigenen Recherchen und Einschätzungen des Chance/Risiko-Verhältnisses basieren!!

[Popeye82]

die letzten 3 Meldungen stell ich mal separat rein:

BioExx Commences Production at Saskatoon Plant - Mar 2, 2009
http://bioexx.com/index.php?option=com_content&view=article&…

"TORONTO, Monday, March 2, 2009 – Bio-Extraction Inc. (BXI: TSX-V) (“BioExx” or “the Company”) is pleased to announce that it has commenced production of its canola processing operations at its Saskatoon facility. Ramp up will start gradually during the first few weeks to allow for process optimization and product quality adjustments, with an expectation to reach full 24/7 operations over the next 60 days.

With a rated input capacity of 40,000 metric tonnes of canola seed per year, the BioExx processing operation will initially produce specialty non-GMO expeller oils for food markets, and a high-energy meal for animal feed markets. Following the successful ramp of this phase, the Company will bring on-line its proprietary extraction operations in Q2, followed by its protein concentrate operations in Q3.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com


The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release. The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, the demand for BioExx’ products, the availability of funding, and the anticipated costs of BioExx’ plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’ expectations and projections.


CONTACT INFORMATION

Bio-Extraction Inc.:
Chris Schnarr
Chief Financial Officer
[phone] x111
[e-mail]

Investor Relations:
Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[Popeye82]

BioExx Commences Commercial Sales Activity and Advances to 24 Hour per day Production - Mar 31, 2009
http://bioexx.com/index.php?option=com_content&view=article&…

"TORONTO, Tuesday, March 31, 2009. Bio-Extraction Inc. (BXI: TSX-V) (“BioExx” or “the Company”) is pleased to announce that it is now commencing commercial delivery of its oil and meal products from its Canola processing facility in Saskatoon, Saskatchewan. As of March 30, 2009 it has also commenced 24 hour per day production.

After the initial start-up on March 2, 2009, BioExx has worked through the anticipated challenges at the plant, including various equipment issues, minor design modifications, stress testing various components, and gradually increasing throughput and yield. As a result of cumulative successes, BioExx has elected to move from daytime production to 24 hour production. The facility is still anticipated to take another 30 days to reach full capacity, but production volumes are now high enough that the Company expects to be shipping truckload quantities of its products on a near daily basis.

“We are extremely pleased with the professional, dedicated, and energetic approach that each member of the Saskatoon team has demonstrated during start-up”, said BioExx CEO, Chris Carl. “There have been some very challenging days to be sure, but we are very pleased with the performance of the plant at this point, and we look forward to continuing to ramp production and revenues through to full capacity.”


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com


The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release. The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, the demand for BioExx’ products, the availability of funding, and the anticipated costs of BioExx’ plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’ expectations and projections.


CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[Popeye82]

BioExx Produces Superior Protein Isolates and Hydrolyzed Protein Concentrates from Canola - Apr 1, 2009

Highlights

+ BioExx now has proven its ability to produce Protein Isolates
+ Despite economic uncertainty, proteins remain in high demand on global scale
+ Independent testing shows BioExx proteins are superior across a range of metrics
+ Ideal for uses as an additive in foods, sports drinks, juices, and infant formulas
+ Represents significant economic upside versus existing product mix
http://bioexx.com/index.php?option=.....tid=43:news&Itemid=8…

"TORONTO, Wednesday, April 1, 2009 – Bio-Extraction Inc. (BXI: TSX-V) (“BioExx” or “the Company”) is pleased to announce that it has successfully produced at pilot scale a very unique and high-value canola protein isolate (“ISOLEXXTM”) and hydrolyzed protein concentrate (“VITALEXXTM”). Third-party product testing suggests that ISOLEXXTM is superior across a range of parameters when compared to soy protein isolates which currently dominate the vegetable protein market. In fact, on particular metrics, ISOLEXXTM compares favourably with whey protein isolates, which are dominant at the high end of the isolate market.

Characteristics of ISOLEXXTM, as tested, include:

+ Protein Purity of 92.8%.

+ Strong nutritional profile, comparing favourably to soy, casein (cow’s milk), and other high-end protein sources.

+ Excellent amino acid profile, being balanced and capable of providing adequate amounts of all the essential amino acids.

+ Possessive of higher levels of key amino acids such as valine, methionine, leucine and isoleucine, which are important in muscle building, and threonine which is important for brain activity, as well as the sulphur-containing amino acids cysteine and methionine which are known to have powerful anti-oxidant properties.

+ Excellent solubility, which increases the bio-availability (i.e. the body’s ability to absorb and utilize a protein), and also provides an indicator of the ability of the product to dissolve in various liquids under various conditions.

+ Very low levels of anti-nutritional factors, especially as compared to soy, which inhibit the body’s ability to benefit from the available proteins.

+ Low in fat, carbohydrates, sugar, salt, calories, gluten free, lactose free, non-allergenic.

+ Excellent functional properties, including emulsifying, foaming and foam stability, gel formation and firmness, water immobilization, and water binding – generally better than soy protein isolate and in some cases superior to eggs and to whey protein isolate.

+ Clean/bland taste, with no discernable odor often associated with vegetable proteins.

Potential product uses include nutritional beverages, nutritional supplements, infant formulas, meat products and meat substitutes, baked goods, sauces and creams, confectionaries, milk and egg replacers, laundry detergents, conditioning shampoos, hand creams, and skin cleansers.

BioExx has also developed and produced, at lab scale, Hydrolyzed Protein Concentrates (“VITALEXXTM”), at a purity of 88.8%. As part of the same production process, protein molecules are separated into two groups, those which are water soluble at alkaline pH and those which are water insoluble at alkaline pH. Water soluble proteins are produced into isolates, while water insoluble proteins are produced into VITALEXXTM by hydrolyzing the proteins into amino acids and peptides. VITALEXXTM shows high solubility across wide pH range, from acidic to neutral to alkaline conditions, as well as excellent digestibility. It is expected to be a particularly suitable ingredient for infant formula, and nutritional beverages such as protein fortified soft drinks, fruit juices, sports drinks and other protein enhanced beverages.

“We are very pleased to be able to share this watershed news today. Although we still have work to do in regulatory matters and to optimize the product for selected applications, we now have a clear path to the delivery of these two unique, superior, and very high value products to our market”, said Chris Carl, BioExx CEO. “This materially changes the economic landscape of the BioExx business. The ability to produce superior quality Isolates and HPC’s from the same feedstock that at present is used primarily to produce oil and animal feeds represents a quantum leap in the food value obtained from a pre-exiting agricultural crop. To have proven that this is now viable at a pilot scale, with a commercial scale facility already in its initial stages represents a stage of development which only BioExx has been able to achieve.”

These results also underscore the strong commitment BioExx has made in R&D led by its VP Business Development Samah Garringer, its Director of R&D Laurence Parslow, and its team of third party experts including POS Pilot Plant in Saskatoon and the Feeds Innovation Institute at University of Saskatchewan. Additional product testing was also completed at the University of Alberta, EUROFINS Scientific, and the German Institute for Food Technology.

The superior BioExx protein products have their origins in the unique low-temperature and patented BioExx oil extraction technology, which avoids negative changes in the properties of the proteins that are typically caused in traditional, higher temperature oil extraction processes. This results in an “improved starting point” to separate proteins from the meal that remains after the oil extraction. This has helped facilitate the development of a unique and simplified process for protein separation, and also results in very unique canola proteins.

This simplified approach and much improved process and products are the subject of a U.S. patent-pending, as filed in May, 2008. The BioExx process and products have been subjected to extensive third-party scientific and legal review and scrutiny, including a detailed review of relevant and published prior art.

BioExx intends to produce these two products at all of its production facilities, beginning in early 2011, including its 40,000 MT per year Saskatoon facility. Leading up to that date, BioExx will work with its major protein customer, Helm AG, as well as end users and other potential customers to optimize the products for their highest-and-best-use applications. In addition, BioExx will work towards GRAS standing with the US FDA (and equivalent authorities in Canada and the EU), to facilitate the use of ISOLEXXTM and VITALEXXTM as food ingredients.

“We have completed a battery of tests on the BioExx canola protein isolate and believe it is a very good and unique product”, said Mr. Thomas Arnold, Executive Director Nutrition of Helm AG. “We look forward to working with BioExx and our customers to conduct further studies to tailor the product for our targeted high-value applications, and ultimately to delivering a very strong product which is in great demand in the markets we serve.”

Early production yield estimates suggest BioExx would produce approximately 60 kg of CPI and 120 kg of HPC for each metric tonne of canola seed processed. Current market pricing is found in the range of $6,000 - $8,000 per metric tonne for CPI and $4,000 - $6,000 per metric tonne for HPC’s. At the low end of this price range, this represents potential additional and incremental revenue from proteins at the 40,000 MT per year Saskatoon facility of approximately $25 million per year, versus feed-grade protein concentrate products.

About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com

The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release. The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, the demand for BioExx’ products, the availability of funding, and the anticipated costs of BioExx’ plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx’ expectations and projections.

CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[og6]

Hast Dir ja wirklich Mühe gegeben!
Kann man die Aktie wirklich nicht in Deutschland handeln?
Woher nimmst Du dann Deine Motivation?

[Popeye82]

Antwort auf Beitrag Nr.: 36.970.880 von og6 am 15.04.09 12:08:11

Danke. Nein, kann man leider wirklich nicht, vielleicht wird das ja irgendwann nochmal was.


Naja, die Motivation kommt hauptsächlich aus 2, 3 Sachen -zum einen, wennn sie zeigen, daß sie das auch in vernünftige Geschäftszahlen ummünzen können(in Abhängigkeit zu den Produkten die sie schon auf dem Markt haben), dann hab ich vor hier langfristig einzusteigen. Das Geschäftsmodell an sich ist IMO wirklich genial &ungewöhnlich, ausserdem interessiert mich die Richtung, wie ich ja schon gesagt habe, sehr. Solche und ähnliche Unternehmen werden IMO teilweise in Zukunft mit zu welchen der großen Gewinner gehören. Ob BXI dazugehört, abwarten.

V.a. da mir halt die zugrundeliegende Branche gefällt &ich auch immer mehr merke, daß es die "Größe" grundsätzlich nicht ausmacht(bei Rohstoffunternehmen bspw. IGVs etc.), das viel interessantere läuft IMO vielmehr über die Margen, sowie halt das was raus kommt, wenn man die Umsätze nimmt, alle operativen Kosten +Investitionen, unter realistischen Annahmen(möglichst konservativ), abzieht -das ist in meinen Augen für einen(z.B. auch Institutionellen) Investor eine viel relevantere Zahl -umso höher das Verhältnis ausfällt, desto interessanter wird es grundsätzlich. Ist das Verhältnis möglichst hoch, dann wird das Unternehmen, IMO, fast immer Mittel eintreiben können.

Naja, und in dem Punkt könnte BXI IMO ziemlich ungewöhnlich sein -da sie "von 2 Seiten angreifen"/mit den späteren Produkten, Ihre Umsätze und Margen sehr sehr deutlich steigern könnten, ein netter Mix. Diese Kombination könnte arg interessante werden -denn damit feilt man an genau den Punkten, die für eine Hebelwirkung nötig sind. Und wenn sie´s mit der 1sten Anlage erfolgreich hinbekommen, dann kämen noch die weiteren ins Spiel.

Dazu kommt noch, daß ich versuche meine Researchqualitäten doch immer wieder ein kleines bisschen ausbauen und ich, auch wenn ich zig Sachen verfolge, beim anlegen doch, inzwischen, eher versuche ein konzentriertes Prinzip zu verfolgen.

Das so in etwa.

Gruß,
Popeye

[og6]

Antwort auf Beitrag Nr.: 36.971.685 von Popeye82 am 15.04.09 13:58:14

Danke für Deine Ausführungen! Doch mir fehlt es dann aktuell an Motivation, ein Unternehmen zu begleiten, von dessen Erfolgsaussichten ich begeistert bin, doch davon selber derzeit nicht provitieren kann.
Um so edler Deine Mühe!!

[Popeye82]

Antwort auf Beitrag Nr.: 36.972.703 von og6 am 15.04.09 16:03:24

Hi og6,

Werd ich ja ganz verlegen, aber das ist reiner Selbstzweck. Ich hab nur von ein paar Sachen deutlich andere Vorstellungen als so Einige.


Ich versuche grad ein paar Fragen zusammenzustellen, um die Denen mal zu schicken. Wer noch welche hat -bitte mal was sagen.

Gruß,
Popeye

[Popeye82]

Sehe grad noch, daß Pinetree 4.15Mio Aktien &1Mio Warrants hält:
www.pinetreecapital.com/investees_sector.asp

Ob das nun eine Auszeichnung ist, darüber kann man sich sicher streiten. Da die letzten Angaben, die ich dazu gefunden hab vom 30.09. sind, müsste das eigentlich danach passiert sein.

[Popeye82]

Notice of 2008 Results Conference Call, Live Conference Call: Dial-in Numbers: 416-340-8061 / 866-225-2055; Saskatoon Plant Update - Apr 22, 2009
www.bioexx.com/index.php?option=com.....tid=43:news&Itemid=8…

"TORONTO, ONTARIO – April 22, 2009 – Bio-Extraction Inc. (TSX-V: BXI) will release its fiscal 2008 financial results following the close of markets on April 28, 2009. Management will host a conference call on April 29 at 10:00 a.m. (Eastern Time) to review the financial results.

Instant Replay:
Dial-in Numbers: 416-695-5800 / 800-408-3053
Passcode: 2552482
Available Until: May 6, 2009 11:59 PM

The call will also be audio-cast live and archived for 90 days at www.bioexx.com .


Saskatoon Plant Update
Ramp-up progress continues with ongoing increases in shipments and quantity and quality of both meal, and expeller grade non-GMO oil, in Phase 1 of the operation. This week the plant has moved from 24 hour operation on a 4 day per week basis to now operating on a 24 hour, 7 day week per week basis. As production volumes and quality continue to grow, the Company will move closer to its short-term goal of operating on a break-even or positive cash flow basis at the plant. These efforts are supported by continued strength in canola crush margins, at or near levels not seen since 2004. Equipment for the Phase 2 extraction process has begun to arrive on site and some of this equipment will be deployed in achieving the full quality and quantity goals for Phase 1 in the near term.

As the fabrication of the Phase 2 equipment has continued, two of the Company’s vendors have brought forth recommendations to modify the solvent recovery equipment to allow for a two-step recovery process rather than the one-step design BioExx has used historically. After much debate, the Company has agreed that it would be prudent to pursue this course with the primary benefit being a further mitigation of scale-up risk for solvent recovery. There will also be a significant secondary benefit accruing from added efficiency in protein isolate production by eliminating a drying and re-wetting step that would otherwise occur in the protein process. Adoption of this plan will result in Phase 2 start-up moving to mid-third quarter, but the Company is hopeful that this will also offer a faster path to the start-up of Phase 3 protein production.

“We continue to be very pleased with the tremendous effort of our entire Saskatoon production and engineering teams and the ongoing success that they are having. It is through these efforts that we are able to manage design improvements such as this without any lasting impact to the schedule and to help us further improve the economics of our core value proposition, protein production.” said BioExx CEO, Chris Carl.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com


CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[Popeye82]

Antwort auf Beitrag Nr.: 37.029.387 von Popeye82 am 23.04.09 19:22:58

Also ich bin kurz nach der letzten Meldung eingestiegen. Vor allem da das m.A. nach, in Kombination mit der vom 1.04. ziemlich positive Meldungen -v.a. aber auch genau die Knackpunkte mit betreffend(!), waren.


Wollte das eigentlich disziplinierter machen: erst konkrete Zahlen abwarten -oder vielleicht sogar erst noch die 2, 3 oder 4ten Quartalszahlen, je nach Entwicklung. In dem Sinne liegen da noch keine Fakten auf dem Tisch(dessen sollte man sich gut bewusst sein), die letzte Meldung war da aber, für mich recht unerwartet, positiv. Also jeder muss selber wissen was er macht/wie er das einschätzt, ich hab auf die Chancen &Risiken hingewiesen. Für mich hab ich´s auch so gehalten, daß ich erstmal maximal 1/3 der angedachten Größe gekauft hab, die es mal werden sollte, wenn sich das weiter positiv entwickelt.

Wen es interessiert, aber noch zu wackelig ist, der sollte erst Schwarz auf Weiss ein vernünftiges Zahlenwerk abwarten. Horizont sollte hier wohl mind. bis in 2011 rein sein(voraussichtliches Erreichen letzte Phase von Anlage1). Sollte sich das gut entwickeln, würde ich aber auf jeden Fall auch versuchen, daß anvisierte aus/aufbauen der weiteren Anlagen mitzunehmen -was dann noch mal deutlich länger wäre.

Gruß,
Popeye

[Popeye82]

BioExx Announces Priced Private Placement - Apr 28, 2009
www.marketwire.com/press-release/Bio-Extraction-Inc-TSX-VENT…

"TORONTO, ONTARIO--(Marketwire - April 28, 2009) - Bio-Extraction Inc. (TSX VENTURE:BXI) ("BioExx") is pleased to announce it has priced a private placement of 5,800,000 Common Shares at $0.52 per share for gross proceeds of $3,016,000 (the "Private Placement"). Closing of the Private Placement is scheduled for May 12, 2008, subject to the approval of the TSX Venture Exchange and other customary conditions. The Common Shares will be subject to a four month statutory hold period.

Canaccord Capital Corporation acted as lead agent on the Private Placement, and Fraser Mackenzie Limited, Loewen Ondaatje McCutcheon Limited, and Wellington West Capital Markets Inc. (collectively, the "Agents") also participated. The Agents have the option to increase the number of Common Shares sold on the Private Placement up to 9,800,000. In consideration for their services, the Agents will receive a cash commission equal to 7% of the gross proceeds, and broker warrants in an amount equal to 6% of the number of securities sold under the Private Placement at an exercise price equal to $0.55 per common share, with a term of 18 months from the closing of the Private Placement and exercisable after February 1, 2010.

The net proceeds from the private placement will be used for capital expenditures at the BioExx Saskatoon facility, particularly related to protein separation equipment for the production of high-end proteins, for the further development of the Company's second commercial plant, and for working capital and general corporate purposes.

"We are pleased to accept additional funding into our treasury on what we believe are fair terms relative to the current and historical trading range of our shares, and having regard to the hold period on the private placement shares. This capital represents a prudent strengthening of our balance sheet for our shareholders, and it does so at a time of difficult and highly uncertain capital market conditions. It also augments our ability to continue on our path of consistent and successful business plan execution, and further drives our tireless efforts towards exploitation of high-end protein markets", said Chris Schnarr, Chief Financial Officer of BioExx.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx' patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx' low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE:BXI), please visit www.bioexx.com .

CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[Popeye82]

BioExx Announces 2008 Results - Apr 28, 2009
http://bioexx.com/index.php?option=.....tid=43:news&Itemid=8…

[Popeye82]

Hab das auch grad woanders reingestellt, Zusammenfassung eines kanadischen User des heutigen Conference Calls(nachträglich auf Deren WS abrufbar)

"now 24/7 at plant, 4 work teams

28 employees, engineering brought inhouse

plans for next few months:

- break even cash flow from plant - ie cover the plant costs
- phase 2, and phase 3
- ramp up to 100% capacity by end of 2009
- coming confirmation of 2nd plant, double the size of plant 1

Financial:

- 140K a month in Admin currently
- 85K a month in R&D
- some govt funding of R&D
- will continue spending on R&D to remain on leading edge
- Dec 31 - net working cap $3m plus

- crush margins have remain healthy
- long term commodity bullish
- crush mgn highest since 2004
- canola - farmers have not hedged, can help the crush mgn short term
- they lock in their margin in the futures margin, so the result will be more predicatable and no undeeded risk
- this will help to leverage future cash flow into credit mkts for growth
- they expect a long term bullish demand for protein, and high quality trusted sources
- Chinese protein sources have been reduced or banned (by EU) due to melanine issue


(...)

Am taking notes as they talk - apologies for an inaccuracies!

- for phase 2 - equipment is to arrive soon

- "In feed" - by end of June expect close to 100% capacity

- goal was to get to 80% oil extraction, and has been achieved

- oil within spec but are improving quality

- at no time have they had more than 2% inventory due to demand for anything they have produced. Demand is very strong, and Helm is able to sell whatever it is they are able to produce.

- moving out production as it is made, leaving plant every day

- Phase 2 - decided to add in a piece of equipment to increase concentrate, expected in June

Phase 2 and 3 equiment bringing on at same time - ramp up by mid Q3 - expect 6 weeks to get the quality they want (ie 80% of target)

- super concentrates 75%-80%

- focussing on the quality first, then ramp up production

- feedback to the quality of Canola protein has been good from the industry, some new customers

- milestones - next one is when does the plant breakeven, will issue press rel

- 3 levels of products - concentrates, super concentrates, isolates

- now are completing testing and lab work for 'grass work', 1 year program to finish early 2010

- Helm has 1st rate of refusal on future plant product. Working relationship is very productive. BXI held back 30% to look to expand into new markets. Helm gets 70%, but can take all, and probably will in 1st year.

- recent financing issue - providing some cushion for growth plans. Big debate internally, but they have all the money they need to get through the isolates phase. This includes assumption that warrants will be exercised. Sounds like they didn't really need the money to complete plans for this plant 1.

- they dont see any downside surprises currently, they are looking to continue progress and hope to provide upside surprises if anything


(...)

Overall it sounded very positive. Not in a promotional way, these guys just sound like they really know what they are doing and are are executing well. I also get the feeling that they are very creative and always looking for ways to improve their process and how to increase the value of what they sell. I think they are also getting great feedback and support from Helm.

I'm impressed, gives me the confidence to hold on long term, good mgmt and also an environment with strong pricing power and long term secular growth. One thing that stood out is that they are not planning to take on commodity risk, they will be locking in profits in the futures market by buying and selling their input and product. This will provide more stable outlooks, which can help them secure debt financing for their growth. Shows they have the financial acumen as well as the technological acumen.

Several analysts on the call, will be interesting to see if they change anything. "

Gruß,
Popeye

[Popeye82]

Financial Statements
www.bioexx.com/images/stories/pdfs/Financials/fs%20-%20decem…

AMD &A For the quarter and year ended December 31, 2008 - Apr 24, 2009
www.bioexx.com/images/stories/pdfs/Financials/mda%20-%202008…

[Popeye82]

Private Placement Increased - May 6, 2009
rivate-placement-amount-increased&catid=43:news&Itemid=83" target="_blank" rel="nofollow ugc noopener">http://bioexx.com/index.php?option=com_content&view=article&id=162rivate-placement-amount-increased&catid=43:news&Itemid=83

[Popeye82]

BioExx Announces Closing of Private Placement - Thursday, 14 May 2009 00:00

- Saskatoon Plant Status Update -
www.bioexx.com/index.php?option=com.....tid=43:news&Itemid=8…

"TORONTO, Thursday May 14, 2009 – Bio-Extraction Inc. (BXI:TSX-V) (“BioExx”) is pleased to announce that it has closed its previously announced private placement (the “Offering”), sold by a syndicate of agents led by Canaccord Capital Corporation and including and Fraser Mackenzie Limited, Loewen Ondaatje McCutcheon Limited, and Wellington West Capital Markets Inc.

Including the exercise of the increased Agent’s Option as previously announced, the Offering consisted of 10,200,000 common shares at $0.52 per share for gross proceeds of $5,304,000. The common shares sold pursuant to the Offering will be subject to a four month statutory hold period.

Plant Update
The Saskatoon plant is now generating regular sales through the shipping of truckload quantities of 100% of its production. Quality of the products has steadily increased since start-up, with meal quality now meeting or exceeding market specs, and oil expected to soon meet or exceed premium specs. The plant is now fully staffed with 19 employees and has operated steadily on a 7/24 basis since April 20th. Management expects that certain Phase 2 components which are scheduled to be installed in the coming weeks should further increase volumes and unit prices, thus moving the Company closer to operating breakeven at the plant. Crush Margins remain healthy with futures markets pointing to continued strength. In the interim, engineering and procurement work continues at a strong pace towards Phase 2 Extraction start-up in mid-Q3, followed closely by Phase 3 Proteins.

About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com .

CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

[Popeye82]

Antwort auf Beitrag Nr.: 37.042.671 von Popeye82 am 26.04.09 17:46:35

Also ich überlege stark es mit dem 2/3 zu versuchen. Das wichtigste sollte denke ich sein, daß sie natürlich möglichst bald den Break Even schaffen, aber v.a. immer &immer wieder versuchen den Prozess etwas zu optimieren, sowie daß sich die Verwässerung m.d. Zeit einigermassen in Grenzen hält(von Seiten der SH-User wird da meist mit etwa 200Mio Shares f.d. bis zum aufbauen der 5ten Anlage kalkuliert).


Also meine Begeisterung für das Unternehmen wächst immer mehr. Hier könnte über die nächsten Jahre eine Menge drin sein -&sich ein sehr starkes EBITDA und EPS entwickeln.


Risikolos ist es aber auf keinen Fall -von daher dürfte es wirklich drauf ankommen, wie man das Geschäftsmodell und dessen Chancen selber einschätzt.

Gruß,
Popeye

[og6]

Antwort auf Beitrag Nr.: 37.187.390 von Popeye82 am 15.05.09 18:46:52

Hi! Also die sind ja doch in Deutschland handelbar!Zumindest über eine deutsche Plattform kann man in Toronto kaufen!
Dann bin ich beim Konkurrenten von Burcon natürlich auch bald dabei.

[MVAGO]

Antwort auf Beitrag Nr.: 37.194.532 von og6 am 17.05.09 18:03:15

Hi, Popeye82, das passt ganz gut zu meinen aktivitäten. habe mich am freitag wieder ganz schön über das schlitzohr in Toronto geärgert -order über 1750 stück zu 0,75 CAD wird gestückelt (1500 +250 ) und dann wohl 2x ordergebühren abgegriffen,bleibt letztlich nicht ganz transparent für mich , habs aber auch nicht weiter verfolgt( gekauft über Cortalconsors) -kamen so ordergebühren über nahezu 45€ zusammen - bei den langzeitaussichten sollte das aber egal sein -außer bei den verkäufen wird dann ebenso verfahren-kenne das von goldexplorer die in deutschland nicht gehandelt werden. jetzt interessiert mich aber wirklich wie du das abwickelst und wie hoch die ordergebühren dabei sind.

[MVAGO]

frage geht natürlich an og6!

[Popeye82]

Antwort auf Beitrag Nr.: 37.194.532 von og6 am 17.05.09 18:03:15

Hi,

Achso, ich dachte Du meinst, ob die in Frankfurt, Berlin ... handelbar sind.


Das mit dem EBITDA und EPS ist m.E. nach halt nicht nur ein Spruch -aber halt auch das Szenario, wenn alles einigermassen glatt geht. Schicke Dir die nächsten Tage mal eine BM.

Gruß,
Popeye

[Popeye82]

Antwort auf Beitrag Nr.: 37.194.645 von MVAGO am 17.05.09 18:26:08

"das passt ganz gut zu meinen aktivitäten"


Hallo MVAGO,

Beruflich -oder wie Du anlegst?

[MVAGO]

Antwort auf Beitrag Nr.: 37.194.734 von Popeye82 am 17.05.09 18:44:56

die "aktivitäten" bezogen sich einzig auf die aktuelle Order!

[og6]

ALso meine Teilausführungen kosten nichts extra über S-Broker.

[Popeye82]

große Transaktion beim Zulieferer, dürfte aber eigentlich keine speziellen Auswirkungen auf BXI haben:

Viterra to buy Australia's ABB for $1.2 billion - Reuters, SASKATOON - 19 MAY 2009 22:42 BST

- SASKATOON, Saskatchewan (Reuters) - Viterra Inc , Canada's top grain handler, has agreed to buy Australia's ABB Grain Ltd in a $1.2 billion share and cash deal, giving Viterra better access to Asian markets -
http://uk.reuters.com/article/innovationNews/idUKTRE54I6ZO20…

"SASKATOON, Saskatchewan (Reuters) - Viterra Inc (VT.TO), Canada's top grain handler, has agreed to buy Australia's ABB Grain Ltd (ABB.AX) in a $1.2 billion share and cash deal, giving Viterra better access to Asian markets.

Viterra's (VT.TO) proposed acquisition would add "meaningfully" to earnings in the first year, the company said on Tuesday, and could bring synergies of about A$30 million ($23.3 million) a year. Job cuts are not expected.

The combined company -- the name of which has not been determined -- would have the geographic advantages of crop supply from different hemispheres, hedging it against weather-related risk.

Buying ABB would likely help the Canadian company lower its transport costs by enabling it to ship grain through Australia to high-growth markets in Asia, instead of shipping directly from Canada.

Viterra Chief Executive Mayo Schmidt said the deal would position the company well to supply Asia with imports of wheat, barley and canola, which he estimated would grow 39 percent over 10 years.

"There's quite a bit to feel good about and that's the scale and diversification and the fact it's being financed fairly prudently," said Anil Passi, senior vice-president of DBRS, a Canadian credit rating agency.

The deal values ABB shares at A$9.11-A$9.41, a premium of up to 9.4 percent from ABB's last traded price. The offer includes a special cash dividend of 41 Australian cents to be paid by ABB. Its shareholders also have other options

Shares of Viterra on Tuesday afternoon rose about 2.9 percent on the Toronto Stock Exchange, while ABB (AY9.F) shares gained 7.8 percent to 4.96 euros in Frankfurt before Australian trade opened on Wednesday.


MORE ACQUISITIONS POSSIBLE

DBRS said the larger scale and diversification from the acquisition, along with balanced financing, should allow Viterra to keep its current rating.

Even so, DBRS is reserving judgment on the deal until it becomes apparent if Viterra is planning more acquisitions, he said.

"If they did something else big after this before this got some traction, then we think they might ... bite off more than they can chew," he said.

Indeed, the new company may make further acquisitions based on strong balance sheets and a low debt load, Schmidt said, with the most attractive targets being those in value-added grain processing.

There's room on the balance sheet for the company to make further acquisitions in Australia such as Graincorp Ltd., analyst David Newman of National Bank Financial said in a note to clients.

ABB directors have unanimously approved the deal and recommended shareholders vote to approve it in the absence of a better offer.

Viterra attempted global expansion in 1996 when it was known as the Saskatchewan Wheat Pool. Its acquisitions in Poland and Mexico helped push the company almost into bankruptcy in 2003 before a new management team carried out the successful acquisition of Canada's Agricore United.

"This has been well-planned," Schmidt said when asked about the current deal. The companies have similar cultures and histories that make them a good fit, said ABB Managing Director Michael Iwaniw.

But Canadian farmers are fearful that as the grain-handling industry consolidates, they'll have fewer options for sales, said Ron Bonnett, vice-president of the Canadian Federation of Agriculture.

The company was formed more than 80 years ago as a cooperative to give farmers an option for selling their crops.

"It's a concern that we may forget some of the lessons of history but at the same time, farmers themselves don't have deep enough pockets sometimes to play this game," Bonnett said.

($1=$1.16 Canadian)

(Reporting by Rod Nickel and Denny Thomas; editing by Frank McGurty) "

[donnerpower]

Sollte bald wieder runter auf 0,10-0,20$ laufen !!!

[Popeye82]

Antwort auf Beitrag Nr.: 37.223.610 von donnerpower am 20.05.09 22:47:22

Na dann geh mal Short(falls möglich, k. Ahnung)!!

[Popeye82]

Bio-Extraction: Notice of Q1 Results Conference Call - May 25, 2009
www.baystreet.ca/users/newswire/viewarticle.aspx?id=28164

[Popeye82]

Hallo,

Hätte mal eine Frage, trage mich bei Unternehmen von Denen ich Aktien halte(manchmal auch noch andere) gern in den Verteiler ein -hier bekomme ich, wenn ich´s versuche immer eine Fehlermeldung???

Hat das schonmal jemand von euch versucht -geht´s euch ähnlich, oder klappt´s???

Grüße,
Popeye

[Popeye82]

Es gehen wohl Übernahmegerüchte um. Das ist an sich nichts neues, wurde schon seit einigen Wochen immer mal wieder erwähnt. Aber hier wird zum ersten Mal von einem offiziellem eingegangenem Gebot gesprochen -aus dem SH:

"They are asking for a vote on a bid from another company for all the shares. The official bid came in yesterday. I have read about it on a dozen different web sites. Its easy to find if you google bxi takeover bid. No one is saying how much the offer is though. Maybe its only $1.00.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27165… "

Prinzipiell würde das für mich schon Sinn machen -sobald der Prozess nachgewiesener Massen wie etwa erhofft funktioniert,
müsste man sich wahrs. einen kleinen Goldesel geschaffen haben. Beim googlen hab ich allerdings nichts konkretes gefunden(würde gern mal wissen wo der das her hat?)! Von daher sollte man IMO nicht unbedingt mit rechnen, aber es dürfte schon eine Möglichkeit sein -würde hoffen, daß sie es wenn ablehnen.

Gruß,
Popeye

[Popeye82]

Antwort auf Beitrag Nr.: 37.254.028 von Popeye82 am 26.05.09 16:15:39

eine kurze Anmerkung noch dazu:

Bis jetzt konnten die 2 User, die das ins Spiel gebracht haben, noch keine Quellen dazu nennen(ich konnt nix dazu finden -&andere auch nicht) -von daher sieht das erstmal nur nach heisser Luft aus(möchte hier keine falschen Erwartungen schüren).

Hab mal eine Anfrage zu den Quellen reingesetzt -mal sehen, ob was greifbares zurückkommt.

Gruß,
Popeye

[Popeye82]

BioExx Announces Q1 2009 Results, Conference Call: Friday, May 29, 10:00 a.m., Dial-in Numbers: 416-340-8061 / 866-225-2055 - Thursday, 28 May 2009
http://bioexx.com/index.php?option=.....tid=43:news&Itemid=8…

"TORONTO – May 28, 2009 – Bio-Extraction Inc. (TSX-V: BXI) (“BioExx” or “the Corporation”) announced today its financial results for the quarter ended March 31, 2009. Complete financial statements and Management’s Discussion and Analysis have been filed for public review at www.sedar.com.

“The first quarter of 2009 was marked by a final push to get our Saskatoon plant into operation, which occurred on February 28. The Saskatoon team did an excellent job overcoming several engineering issues to achieve initial production and they then spent much of March making final equipment adjustments and fixes to allow for steady-state operations to being in earnest in early April,” said Chris Carl, BioExx CEO. “Since then, we have moved to full 7/24 operations and made strong progress in a number of areas, and continue to trend very positively on all metrics in our drive towards profitability.”

From the commencement of commercial sales on April 1, efforts have been focussed in three successive areas, namely product quality, oil yield, and seed throughput:

+ Product quality of meal has increased dramatically since initial production with selling prices having more than doubled in the past two months, to a point where meal is now selling at a premium to standard commodity meal prices. Oil quality has also improved markedly, with pricing now near or at standard commodity rates, with an expectation that pricing could surpass commodity levels in the near term.

+ Oil yields from seed have increased from 50% initially to an average of near 80%, thus meeting all expectations for Phase 1 operations.

+ Finally, throughput volumes of seed are currently at about 50% of final capacity, with a clear plan to reach full capacity over the coming weeks as some Phase 2 equipment is installed.


The net result of these improvements is an 80% month-over-month revenue growth from April to May, and an anticipation of similar revenue growth over the next two months.

“In addition to concentrating on maximizing revenue and margin from our Phase 1 operations, we are also making excellent progress toward implementation of the Extraction and Protein phases of production (Phases 2 and 3) and we remain very optimistic about the added revenue and margin that will be achieved in these key areas,” said Chris Carl.

Expenses

The Corporation incurred expenses of $1,064,090 during the first quarter of 2009, versus $1,059,427 in the prior quarter and $808,002 in the comparable prior year period. The small increase results from increases in Office and general expenses as a result of the continued intensification of the Corporation’s activities, together with the inclusion of Plant Commissioning and Start-up expenses for operations at the Saskatoon plant prior to commencement of product sales. These two increases are netted against a reduction in Stock-based compensation versus the comparable prior year period, as a result of fewer stock option issuances this quarter.

Interest Revenue

During the quarter, the Corporation earned $10,996 of interest revenue, from interest-bearing marketable securities. This is down from the prior quarter and comparable prior year period, as a result of the reducing cash balances held by the Corporation which accrue to continued capital spending towards completion of the Saskatoon facility.

Net Loss

The Net Loss for the quarter was $1,054,823, compared to $1,008,178 in the prior quarter and $750,827 in the first quarter of 2008, with changes flowing primarily from the same factors driving changes in Expenses as discussed above. On a per share basis, the Net Loss is $0.01 for each period.

Working Capital and Liquidity

As at March 31, 2009, current assets were $3,895,293, including cash of $1,762,582. Against current liabilities of $2,300,593, this results in net working capital of $1,594,700 (exclusive of availability of additional funds under the Corporation’s various credit facilities). This compares to current assets of $5,277,238 and net working capital of $3,681,929 at December 31, 2008. The relatively large Accounts Payable balances, at December 31, 2008 and March 31, 2009 relate primarily to planned capital expenditures on the Saskatoon plant. Subsequent to quarter end, on May 14, the Corporation closed a private placement for gross proceeds of $5,304,000.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com

CONTACT INFORMATION

Bio-Extraction Inc.:

Chris Schnarr
Chief Financial Officer
[phone] x272
[e-mail]

Investor Relations:

Scott Koyich
President, Brisco Capital Partners
[phone]
[e-mail]

Glen Williams
The Equicom Group Inc.
[phone] x111
[e-mail] "

Quaterly Conference Call - May 29, 2009
http://events.onlinebroadcasting.com/bioexx/052909/index.php

[Popeye82]

Antwort auf Beitrag Nr.: 37.194.645 von MVAGO am 17.05.09 18:26:08

Hi MVAGO,

Mal eine Frage -wie bist Du denn zu 0,75 CAD gekommen? Rein aus der Erinnerung, war das Hoch nicht um die 0,60 CAD -und so hoch kann der Spread doch nicht gewesen sein, oder??

Grüße,
Popeye

[Popeye82]

MD &A, Q1 ´09 - May 28, 2009
www.sedar.com

[Popeye82]

ATH soweit ich das sehe.


Trotzdem cool bleiben -die Wette geht über mehrere Jahre.

Grüße,
Popeye

[Popeye82]

Interview -"Canola processor Bio-Extraction is ramping up production at its brand new plant and gaining new revenue streams from sales of canola oil and proteins. BNN chats with Christopher Carl, president, Bio-Extraction, on the market for specialty proteins.":
http://watch.bnn.ca/commodities/jun.....s-june-3-2009/#clip1…

[MVAGO]

Antwort auf Beitrag Nr.: 37.297.291 von Popeye82 am 01.06.09 18:38:32

HI Popeye , aufmerksam !!
hatte sie doch zu 0,55CAD bekommen und nicht wie irrtümlich geschrieben zu 0,75CAD! an den hohen ordergebühren änderts nix.
kann man über usa vielleicht billiger beziehen?

MVAGO

[Popeye82]

der Zulieferer übernimmt ein ähnliches Unternehmen &im SH wird u.a. recht wild spekuliert, ob BXI in absehbarer Zeit übernommen wird. Halte das zwar von der Sache her für nicht unwahrscheinlich, wenn ist es allerdings wahrs. noch viel, viel zu früh dafür:

Viterra Strengthens Value-Added Processing Business: Acquires Canola Crush Operation - Marketwire - Jun 15, 2009
www.marketwire.com/press-release/Viterra-Inc-TSX-VT-1003822.…

[Popeye82]

BNN Market Call(ab etwa 12:50), sie haben wohl auch eine ordentliche Portion getankt, zwar nicht viel neues dabei, aber er pusht auch nicht, Burcon wird auch kurz erwähnt. Die gesteigerte mediale Beachtung hat sicher seinen Teil zur Entwicklung zuletzt beigetragen -sollten sie nochmal unter 0,50 CAD gehen, kauf ich wahrs. nochmal etwas nach:
http://watch.bnn.ca/market-call/june-2009/market-call-june-2…

[Popeye82]

ist jetzt ein bissschen unkreativ , aber ich kopier einfach mal rein, was ich woanders einleitend dazu angefügt hab:


der Link zur Meldung auf die Homepage funktioniert bei mir gerade nicht(?) -wahrscheinliche Vorverlegung der Isolate Produktion(voraussichtlich erstmal halbe Kapazität der Isolate) noch dieses Jahr!!!! Sollte eigentlich für einen Schub sorgen. Wenn das auch so aufgeht(mit mit solchen Sachen inzwischen ziemlich vorsichtig geworden) ist das eine Knallermeldung. Sie wollen das Geld wohl möglichst auf "non-dilutive" Wege besorgen, aber eventl. könnte dadurch noch ein PP Thema werden, kann ich jetzt aus dem Stand nicht abschätzen. Damit soll v.a. auch die 2te Anlage schneller angeschoben werden. Den GRAS Status gibt´s wahrscheinlich auch bis Ende des Jahres, die noch ausstehenden Zertifizierungen für Kanada wohl auch:

BioExx Announces Plan to Advance Protein Isolate Production to 2009 - Baystreet - 6/23/2009

- Highlights - Isolate production can be accelerated to late 2009 from early 2011 - Isolates to be incorporated into single system capable of full range of proteins - Earlier implementation of Isolates would enhance margins and reduce operating risk - GRAS, HACCP, GMP Plus, and ISO 22000 all expected by year-end -
www.baystreet.ca/users/newswire/viewarticle.aspx?id=37639

"TORONTO, ONTARIO -- Bio-Extraction Inc. (TSX VENTURE: BXI) ("BioExx" or "the Company") is pleased to announce that it has developed a plan to commence production and sales of its high-value Protein Isolate and Hydrolyzed Protein products (together "Protein Isolates") before the end of 2009. Originally, BioExx had planned to reach this very significant milestone in early 2011. The advanced schedule, which does require additional equipment, flows from the enhancements to the design of its extraction process as announced on April 22, combined with continued progress with regulatory certifications and strong market demand.

The planned system builds upon the existing design utilizing provisional patent applications in the United States (and subsequent PCT applications) for both its Protein and Extraction processes, and will now allow for the production of all grades of proteins from one integrated process. The key additional equipment in the new BioExx protein system is well proven in a broad range of food processing applications, including the production of whey, soy, and pea proteins.

The original plan to commence Isolate production in early 2011 involved a significant additional expenditure to build what was essentially a separate process added to the initial lower-value Protein Concentrate plant. The accelerated Isolate producing process will require that additional planned capital expenditures be made earlier, but will avoid the redundancy of some equipment that would have occurred by installing the systems in separate phases. To fund the accelerated process, the Company intends to access a combination of proceeds from the exercise of outstanding share purchase warrants which expire in January 2010, and other non-dilutive sources of capital that may be available. To achieve the goal of producing Isolates by the end of 2009, BioExx will seek the cooperation of warrant holders to exercise their warrants on a steady basis between now and expiry. If the warrants are exercised at a slower pace than desired, the accelerated start-up date could shift commensurately to as late as June 2010.

"Despite the many prior accomplishments by BioExx, we believe this is the most significant milestone achieved to date," said BioExx CEO Chris Carl. "The production and sale of high-value proteins has always been our end goal and the key driver of shareholder value in this business. To be able to reach the Isolate production goal much earlier than planned, and in a manner which can deliver enhanced upside while at the same time mitigating risk, is an accomplishment of which we are very proud."

To smooth the implementation and scale-up of Isolate production, BioExx will initially install a system which will run at approximately half of target Isolate capacity. As production and cash flow grows, additional equipment will be added to increase capacity to full plan. This approach is expected to facilitate production volumes which are in line with typical ramp-up rates while at the same time deferring and reducing at-risk capital.

The Company believes that in addition to driving higher revenues and margins by entering its higher-value protein markets earlier, this accelerated plan has several risk mitigation benefits that include:

- The protein system to be deployed would be capable of producing the entire range of specialty proteins, versus an implementation capable of producing only lower-end Protein Concentrates;

- Converting from a Concentrate-only system would require additional equipment and processes for Isolates, some of which would be redundant, and while this was originally thought unavoidable, it is not acceptable in the presence of a demonstrated ability to implement an integrated system capable of producing both products;

- An accelerated deployment of the Isolate system provides for an extra year's experience in Isolate production and sales which is a key benefit for the much larger second facility which would then be able to commence production of Isolates at start-up;

- Successful implementation should result in enhanced cash flow on an earlier schedule, through the production and sale of high margin Isolates, which typically sell for about $6,000 per metric tonne versus Concentrates at $1,000 per metric tonne, and which should result in better access to, and a lower cost of, capital for funding of the second plant.

To enable food-grade specialty protein sales in the United States, BioExx will require GRAS (Generally Regarded As Safe) status. GRAS is a self-affirmed food safety designation which is administered by independent third parties in accordance with the regulations of the US Food and Drug Administration. Based on efforts to date, BioExx expects to self-affirm its GRAS status before the end of 2009, which would allow it to commence the sale of Isolates. In the event that this designation is unexpectedly delayed, the integrated nature of the BioExx protein system will still allow BioExx to produce and sell Protein Concentrate products for markets that do not require GRAS, such as specialty feeds.

The Saskatoon plant will also need to have demonstrated that it has implemented and maintained its procedures in a manner that complies with HACCP, GMP Plus, and ISO 22000. Certification for all of these processes with respect to Phase 1 operations is well advanced and nearing completion. BioExx expects to complete preliminary work with respect to Protein production prior to the planned start-up later this year.

Specialized protein markets are very strong and are widely expected to continue to grow over the long term, driven simply by demand fundamentals exceeding supply. BioExx continues to receive very strong interest in all of its proteins products, with considerable emphasis on Isolates, from around the globe. By working through its primary distributor and in some cases directly, BioExx is excited to be able to offer a solution that will enable these customers to be serviced considerably earlier than originally anticipated.

About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx' patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx' low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE: BXI), please visit www.bioexx.com .

(...) "

[Popeye82]

hier ist noch ein Post, was nicht als konkret(also eher als Indikator) zu sehen ist, aber darauf hindeutet, wo es mit Anlage2 hingehen könnte, hab leider keinen Zugriff auf die Coverage´s. Das dürfte an sich auch Sinn machen, da N. Dakota wohl ein gutes Umfeld für die Pflanzen &somit für um die 90% der US Canola-Produktion verantwortlich ist:


" (...) As a heads up, it looks like Plant #2 may be in North Dakota. BXI hosted an analyst tour last week and apparently there was a delegation of 8 people from various levels of state and municipal government as well as state and local bankers from North Dakota on the tour. I haven't seen that posted anywhere on here yet, but it was in a Wellington West research piece from last week.

Should be fun tomorrow..

GF
www.stockhouse.com/Bullboards/Messa.....;r=0&s=BXI&t=LIST "

[Popeye82]

Neues ATH. Stehen seit einiger Zeit bei den Brokern im Average auf Strong Buy.

Sollte sich das Vorziehen der Phase3 tatsächlich dermassen vorziehen lassen, dann wird das hier noch sehr angenehm. Die primäre Frage dabei scheint mir zu sein, in wiefern sie das nötige Kapital dafür wirklich durch besagte "non-dilutive sources" aufbringen können -der Fall könnte eine potentielle Hebelwirkung dann aber nochmal merklich antreiben.


Auch wenn es nach Pusherei aussehen sollte, stell ich das mal rein:

""I have seen a couple of analysts reports in the past couple of days and boy is it fun to daydream...
Canaccord analyst says greater than $2.00 per share in EPS in five years is possible. Wellington Analyst (which raised their target to $1.70) ran some metrics for plant 2... wow..

Plant #1 can do 30MM in EBITDA at 100% run rate on the Isolates
Plant #2 can do $65MM in EBITDA at 100% run rate on the isolates

That is $95MM in EBITDA possible by 2011 on probably 170-190MM shares outstanding.. somewhere in the range of $0.55/share in EBITDA with massive growth (3 more plants and licensing agreements) ahead.. what sort of multiple do you think that would attract...

All of this is however contingent on Phase 2 and 3 working. The nice thing is that Phase 3 looks much lower risk than previously thought as they are using proven equipment and technology. That leaves the Phase 2 extraction as the big wild card. What is great about the new timeline on the isolates is that we will find out within about 6 months whether this is going to all come together

I have said it before and I will say it again... this is the best looking small-cap company I have seen. This could be a major homerun in the making.

Of course, I have done my DD and you should do yours... Don't rely on this board, analysts reports or anything other than your own homework.

GF
www.stockhouse.com/Bullboards/Messa.....;r=0&s=BXI&t=LIST "

Gruß,
Popeye

[Popeye82]

da sie ja von 2 Unternehmen gesprochen haben, die sich an ähnlichem versuchen, denen gegenübers sie aber, neben technisch/Verfahrensmässigen Vorteilen, einen merklichen zeitlichen Vorsprung haben, neben Burcon dürften das wahrs. die anderen sein -ein privates Unternehmen:
www.mcnbioproducts.com

[Popeye82]

Antwort auf Beitrag Nr.: 37.487.479 von Popeye82 am 29.06.09 17:26:10

Achso, größeres Thema in den kanadischen Stockboards war noch, wie man die Warrantholder denn zu einem vorzeitigen einlösen animieren könnte. Der Tenor ging dann dahin, dass Denen das wahrs. mit ein paar kleinen Vorzügen versüsst wird. Hoffe, dass die nicht zu süss ausfallen, aber das scheint mir doch Sinn zu machen &recht wahrscheinlich(zumindest der Versuch in die Richtung).

Gruß,
Popeye

[Popeye82]

Kursziele sollte man ausschalten, aber sofern es stimmt, sind doch ein paar interessante Info´s dabei/hört sich hervorragend an -v.a. 5tens, aber z.B. auch, hat er Recht, damit, dass langsam das Thema Lizenzierung ein größeres werden dürfte -wenn 10tens stimmen sollte ...

"Hello everyone, I have a big position on BXI from 45 cents (over 200,000) and I did some DD today.

The info gathered is from someone in "the know" that I trust and I had to know whether to hold or sell my shares for profit . Conclusion - HOLD until $ 5.00 within 2 years WHY ?

1. The management are honest, hard working and are actually minimizing the huge potential of their patented methodology
2. MCN and Burcon have inferior separation methods and are higher cost
3. Burcon already has GRAS for canola protein isolates and BXI GRAS is imminent
4. Canola commodity price is hedged and protein isolates sales and prices quaranteed and highly needed
5. The warrants will all be exercised by expiry Jan 2010 as most are held by institutions and already pledged to the company so that the cash will be there for all equipment purchases
6. The high recent volume is from the 65 % insitutional investors who "have been sold" on the execution capabilty of the mangement
7. Current production and sales is "massive "and will be cash flow positive by Q4 2009 and ther eis sufficient capital from non=dilutive sources to pay for the new equipment
8. Orders for the equipment is in and delivery immminent
9. PEI research facilities have moved to Saskatoon - new plant being planned by engineers
10. No new shares will need to be issued as cash flow is increasing exponentially
11. Major world food companies are interested in these BXI patents which have successfully shown and proven the laboratory and pilot protein isolates procedure to be commercially cost effective
12. 40,000 MT to 80 to 160 to 240,000 MT may also accelerated
13. No reverse split needed as stock should be over $ 5 in ONE YEAR
14. Bay street expects this BXI to be off venture and on the TSX in due course

Follow the money and trade houses
Bye fro now and good luck to all the patient longs who were in 2007 at .30 cents and 2008 at .40 cents
Managment has made good on all their executive plans they work hard and are diligent

Mike

www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27256… "

[Popeye82]

BioExx ahead of protein production target, Recent discovery aids plan to ramp up isolates production - The StarPhoenix - Jun 2, 2009

- By Joanne Paulson -
www.thestarphoenix.com/BioExx+ahead+protein+production+targe…

"Things are going swimmingly at the BioExx plant in the North Corman Industrial Park just outside Saskatoon.

The company poised to produce fish and baby livestock feed from canola, and already crushing oil, will also ramp up production of high-value proteins before the end of the year. That's at least one year earlier than the company anticipated. The plant just opened in March.

"There are several grades of protein that can be derived from canola, and the highest grade is something called protein isolate," explained CEO Chris Carl in an interview this week from Toronto.

Isolates can be used in high-value foods such as baby formula, nutrition bars and energy drinks.

"We did not expect to be making these isolates until 2011," said Carl. "With some design changes that our engineers and POS (Pilot Plant) have been working on, we have advanced that to the point where we think we'll be making and selling isolates before the end of this year.



- Laurence Parslow, director of research and development with BioExx; the company plans to spend millions at its North Corman Industrial Park plant to produce high-value proteins from canola -


"The value of all of this has gone up rather dramatically. We do process the seed, we take the oil out, we will still produce an animal feed-based meal, but we will now produce an entire range of specialty protein products including the very high protein isolate before the end of 2009."

Indeed, BioExx (formally Bio-Extraction Inc.) wasn't sure it could make the protein isolates -- yet. A discovery made just in the last few weeks pointed the company in a new direction.

"As often is the case in new technology, we set out to solve one concern (in the extraction process) that we had," said Carl. "In solving that, we accidentally created an opportunity to make our isolates more quickly using standardized equipment in a design we already were working with."

With the ramped-up deadline, BioExx will spend more money at the Saskatoon plant this year than originally planned.

"We'll be spending several million dollars more than anticipated this year. The construction activity will begin in earnest again over the next couple of months," said Carl.

"We will be doing some more hiring at the site. We'll probably hire at least another eight people over what we had anticipated, bringing employees at the plant in excess of 30 people."

BioExx uses proprietary low-temperature extraction, employing temperatures under 60 Celsius. After that threshold of heat, the solubility of the protein starts to be affected or "denatured," said Carl.

The unique process doesn't make the protein better, or increase the amount, but it makes the protein far more "bioavailable" for absorption in the body.

Canola is also an excellent source of vegetable protein in the first place.

"Protein that comes from canola has double the protein efficiency ratio of the protein that comes out of soy," said Carl. "Canola proteins tend to have much higher nutritional value than other vegetable proteins."

Carl said it's too early to estimate the ultimate annual value of the proteins and oils coming out of the Saskatoon plant. However, for context, he noted the plant will process 40,000 tonnes of canola seed annually, at market price -- which today is about $450 per tonne.

"We can make a pretty healthy margin once we are selling our proteins," he said.

Seventy per cent of what BioExx will produce from canola meal is contracted for sale to Helm AG, a German company operating in 35 countries around the world. Helm will largely use the protein for aquaculture and baby livestock feeds.

"We reserve 30 per cent of our protein production to sell to other end customers, or work with other, similar companies. There are a number of companies we are in discussion with that will take up the other 30 per cent of our production."

BioExx is also working toward several certifications to allow it to sell proteins into human food markets.

While some market watchers are concerned about the amount of canola available in Western Canada this year due to growing conditions, BioExx is not concerned about its own plant.

"We are a very small processor, and so we use probably less than one per cent of the canola that would be grown in Canada. So from that perspective we don't have a high worry," Carl said.

"Secondly, we have a very good relationship with Viterra, who is the seed supplier. Thirdly, we're using a sort of unique variety of canola that is not necessarily the No. 1 choice of large processors. We're not quite as concerned about getting crowded out from that perspective."

Carl said it's important to point out that while BioExx is doing something different, that doesn't mean it's the only system for all canola processing.

"While we think we have a novel way of doing things, at no time are we suggesting that the way big crushers are doing things is bad.

"What they do at the scale they do it at, they do it in the best possible way as far as we're concerned."

BioExx is publicly traded on the Toronto Stock Exchange under the symbol BXI.

[e-mail]
© Copyright (c) The StarPhoenix "

[Popeye82]

BioExx Awards Stock Options, Officers' Options will not Vest until Protein Isolates are Shipped - July 2, 2009
http://cxa.marketwatch.com/TSX/en/Market/article.aspx?guid=h…

[Popeye82]

Es ist wohl ein erstes aktualisiertes Coverage, nach der letzten Meldung, rausgekommen. Und, sagen wir mal so, es sieht wohl nicht schlecht aus.

Deren Fazit -sie halten ein EPS von 2CAD innerhalb von 5 Jahren bei 5 voll ausgelasteten Anlagen für möglich -das allerdings bei fast dem 2ppelten an ausstehenden Aktien(!!).

Dazuzusagen ist sicher, dass man das mit Vorsicht geniessen muss -vor allem, da man sich vor dem Hintergrund, dass der CEO gerade noch in dem Zeitungsartikel von vorgestern meinte, dass es noch zu früh für genaue Zahlenkalkulationen wäre, schon fragen muss, worauf die Ihre Annahmen eigentlich aufbauen. Diese Analysten immer.

Aber wie auch immer, ich denke, dass das durchaus mal eine grobe Richtung werden kann, hab mir so ein eigenes Ziel gesetzt, was ich mir hiervon mal erhoffe.

[Popeye82]

NAI500 announces July additions to the 500 list - NAI500 - Jul 2, 2009
www.earthtimes.org/articles/show/nai500-announces-july-addit…

[Popeye82]

Mir hat gestern jemand noch ein paar Coverage´s geschickt(allerdings alle von vor der vorletzten Meldung) -sollte das jemanden interessieren, müsste er mir mal via BM seine Mailadresse durchgeben.

[Popeye82]

im SH wird das zuletzt thematisch immer dünner &spammiger, aber das fand ich nochmal einen ganz interessanten Gedanken. Ist total hypothetisch -aber bei einer potentiellen Übernahme wäre das wohl schon ein Umstand, der einem größeren Unternehmen nicht gefallen/davon abhalten(?) dürfte -was mir ja gut gefallen würde, wenn die das abschrecken sollte :

"Bxi has long term contracts with Helm and Viterra. In a way, do these not act as a poison pill against the company being bought? For example a company like Cargill would not want to be constrained as to who they sell their product to or who they buy their canola from.
http://www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&… "

[Popeye82]

Da waren noch ein paar Sachen mehr, die ich eigentlich rüberkopieren wollte, aber die Postingfrequenz hat doch ordentlich zugenommen, finde die deswegen gerade nicht mehr:


"RE: Are We Missing Something

The only dark side is if the tech does not work, but it has worked flawlessly in a 700 ton plant and uses much the same equipment as conventional processing, except it is a bit simpler and is therefore less risky because there is no heating process equipment, which occurs at 2 distinct phases in a conventional system.

Investor's anticipation was not able to overcome funds idiotic selling of their warrants in the fifty cent range until recently when the news got too interesting. Make up your own mind whether the tech will work at all, but that is all that can go wrong, because no matter how low the canola spread goes, the hexane plants that depend on this spread will all suffer much more than bxi. I don't know anything about the hexane plants ability to shut down without incurring heavy operating costs when they startup again, but a prolonged low canola spread would have to shut down hexane plants eventually, in which case the price of canola would drop to the point that the spread would go back up. Simple hog cycle sales pricing based on supply and demand, as they call it in business class.
The tech not even have to work to a high degree of efficiency for the plant to be more profitable than today's hexane plants, but that will change in future to some small but unknown degree with BUs technology helping hexane plants.

A 100% successful bxi plant is 8.3 times as profitable as a hexane plant depending on pricing.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27275… "

[Popeye82]

hier hat jemand mal Auszüge eines aktuellen Coverage´s eingestellt, der hat das ein bissl blöd gesplittet, von daher ist das jetzt wohl auch ein bisschen zu merken, Graphiken &dergleichen waren wohl schlecht reinzukopieren, hab´s mal versucht einigermassen übersichtlich zu halten:

"CLARUS SECURITIES - Bio-Extraction Inc. (BioExx) SPECULATIVE BUY -
July 14, 2009

- Steven Gold, CFA [phone]
Aman Atwal, Associate [phone] -
(BXI-TSX.V, $1.03) 12-Month Target Price: $2.30

Growth Through Protein


Highlights

+ BioExx is a value-add processor of oil seeds, with a current focus on canola. In addition to conventional canola oil and meal, its patented technology allows for the separation of high-purity proteins. The result is revenue per tonne of canola seed processed in excess of 11x that of the traditional method.

+ A 40,000 mty commercial canola seed processing plant in Saskatoon is nearing completion. A total of 780k mty of capacity is planned by 2014E.

+ Commercial agreements are in place at the Saskatoon plant to supply high purity proteins to Helm AG (Germany) as well as oil and meal to Shafer Commodities (Canada).

+ Revenue could grow from <$5 million in 2009E to $43.0 million in 2010E and $131.6 million in 2011E as capacity grows and premium-priced, high-purity protein isolates begin to represent an increasing portion of overall revenue (~70% in 2011E).

+ Industry-leading crush margins will allow for strong EBITDA margins of 50-60% while turning EPS-positive in Q2/10E and growing
to $0.23 in FY2011E.

+ Near-term catalysts for the stock include attaining GRAS status (expected in Q4/09) and the successful start-up and subsequent production of the 40,000 mty plant in Saskatoon.


Conclusion and Recommendation

We are initiating coverage with a SPECULATIVE BUY recommendation and a 12-month target price of $2.30 per share.


Valuation

We are using 2011 as our target year for BioExx at which point the Company should have 120k mty of capacity online with another 660k mty planned by YE2014. To derive a target multiple for BioExx, we specifically consider Hanfeng Evergreen Inc. (HF-TSX, BUY) which has a similar business model in that it takes a conventional commodity through a proprietary, value-adding process and then sells the end product at a premium price.

Given Hanfeng is expected to triple its production over the next 2-3 years to 2.0-2.5 million mty, we consider its P/E of 9.0x FY2011 EPS. Given BioExx’s capacity growth (nearly 20x increase in capacity growth over the next five years) as well as its industry leading EBITDA margins of 50-60% compared with Hanfeng’s at 13-17%, a target P/E multiple of about 10x applied to our 2011 EPS estimate of $0.23 is appropriate, resulting in a target price of $2.30 per share.


Base Case Value

We consider a base case valuation for BioExx by taking into account only the current 40,000 mty plant. On a normalized basis (excluding start-up and other one-time costs associated with bringing the plant online), that one plant should achieve EBITDA margins of 50-60% and annualized EPS of ~$0.12. If we apply our 10x P/E multiple we can derive a minimum value today for BioExx of $1.20/share.

We are initiating coverage on Bio-Extraction with a SPECULATIVE BUY recommendation and 12-month target price of $2.30 per share for an implied ROR of 130%.


Investment Risks

Ramp-up Risk: The Company will have to overcome scale-up risk as it applies its technology to its new 40,000 mty processing plant. Although the new plant is small relative to the average industry plant, applying the technology to a larger scale could present challenges.

Regulatory Risk: In order to approve protein products for human consumption, GRAS status must be attained. BioExx is working with external third parties to achieve GRAS self-affirmation, which is expected later this year. Delays in receiving this approval could impact BioExx’s production plans and expected revenue.

Debt Financing: We expect the majority of the Company’s capex to be
raised via debt financing and there is no assurance that it can raise the amounts required to build capacity to the targeted 780k mty. Failure to do so could result in less than expected capacity and revenue as well as higher than expected dilution coming from larger than expected equity issuances.

Competition: The three oilseed processing giants, ADM, Bunge and Cargill have a significant size advantage to BioExx, with access to greater resources. Given this, there is a possibility that a new and better process could be introduced, which would remove BioExx’s “cool extraction” competitive advantage and leave it unable to compete on a scale basis.

Commodity Risk: The Company’s reliance on a commodity as a primary input places it in a position to be significantly affected in the event of a material impact on canola production, such as poor yields. This could impact the crushing margin given a sporadic rise in seed prices and result in a delay in flowing back those costs to customers in the form of price increases.

Counterparty Risk: BioExx procures its canola seed supply from Viterra only, and sells the majority of its products to single buyers. Setbacks in terms of delivery or payment among these parties could negatively impact the company’s operations
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part2...

"The current 40,000 mty plant under construction will be the first commercial scale implementation of the technology. Although the protein production process is unique, it is based on well-founded protein production principles and conventional equipment and as such, we expect no major problems with the scale-up. It is also worthwhile noting that the “Big 3” canola processing giants like ADM Corp. (ADM-NYSE), Bunge Inc. (BG-NYSE) and Cargill Inc. (private) consider their “smaller” plants to be 600k mty or larger.

Given their dominance in the $150 billion annual soy, wheat and canola processing market, the “Big 3” are focused on oil and meal extraction using traditional processing methods. Nevertheless, the size of the protein market is so large ($16 billion today and growing to $25 billion by 2015) that we do not see them as a threat to BioExx. In allowing for an extra component (protein) of the canola seed to be processed and then sold, the Company can achieve crush margins of more than 11x that which the Big 3 realize from canola oil and meal alone.


Exhibit 3. Crush Margins

+ Traditional Crush Margin = Value of canola oil & meal - price of canola seed

+ BioExx Crush Margin = Value of canola oil, meal & proteins - price of canola seed


Traditional Method

+ Canola oil $1,000 40% $400

+ Canola meal $250 60% $150

$550
$450
$100


BioExx Method Product
Selling Px/MT canola seed of canola seed processed

+ Canola oil $1,000 40% $400

+ Canola meal $250 42% $105

+ Protein isolates $6,000 18% $1,080

$1,585
$450
Crush Margin (per MT) $1,135

Crush Margin per MT
Revenue from BioExx method
Revenue from traditional method
Less cost of canola seed per MT
Less cost of canola seed per MT
Source: Company presentation, Clarus Securities Inc.

BioExx’s technology will enable the extraction of high-purity proteins (isolates) and will be marketed for human consumption in beverages, food products and non-food applications:

+ Beverages (soft drinks, fruit juices, energy drinks, infant formulas)

+ Foods (energy/snack bars, meat, tofu, sauces, dairy products, egg substitutes)

+ Non-food (detergents, creams, soaps, hair products
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part3...

"Protein GRAS Approval Expected This Year

While the Company does not require full FDA approval for its products, it is well on its way to achieving the required self-affirmed GRAS (Generally Regarded as Safe) status for its proteins intended for human consumption (super-concentrates and isolates). Management has targeted Q4/09 to receive this certification.


Product Markets

As populations grow and emerging countries become wealthier and more health conscious, the market for protein is expected to grow from almost US$16 billion today to more than US$20 billion in 2011 and US$25 billion in 2015 (source: Global Strategy Analysts Inc.). This is in addition to the annual canola oil and meal markets worth $22 billion and $7 billion, respectively.


Exhibit 5. Protein Market
Source: Global Strategy Analysts Inc., Company presentation

As global demand increases, protein production also must increase and must become more efficient (a measure of protein quality). Soy and wheat protein have the dominant market share within the non-animal protein group (consists of wheat, pea, soy and canola) but are less efficient than canola protein. As a non-animal protein alternative, canola is clearly the best choice as only egg white-based proteins have greater overall efficiency.


Exhibit 6. Protein Efficiency
Source: Global Strategy Analysts Inc, Company reports

Canola protein concentrate ranks higher on the efficiency scale than soy or wheat proteins, but, the challenge has been to extract that protein from the canola concentrate (meal).


Commercial Agreements

BioExx has a 10-year supply deal to source 100% of its Saskatoon plant canola seed requirement from Viterra Inc. (VT-TSX, NR), which may be extended to include future plants where applicable. Output from BioExx’s Saskatoon plant will be sold mostly to two major players. The Company has an agreement to sell 70% of its high-value protein production to industrial chemicals and nutrition marketer Helm AG of Germany. In addition, BioExx has an agreement to sell all of its canola meal and half of its oil production to Canada-based Shafer Commodities Inc. at market prices. The balance of the oil is to be sold under an agreement with Sunora Foods Inc., also based in Canada.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part4...

"Outlook and Forecasts, Capacity Growth – Zero to 780k mty in Five Years

The Company is currently commissioning its first plant that will process 40,000 mty of canola seed per year. Each plant should produce a basket of canola oil (40% of output), meal (40-42% of output) and protein isolates (18-20% of output). The cost of this plant is ~$25 million with expansions to that plant to be funded out of cash flow. Management has outlined a total capacity target of 780k mty by 2014. We expect the majority of the new plants to be located in Saskatchewan or elsewhere in the Canadian and US agricultural region given the proximity to canola seed feedstock.


Exhibit 8. Capacity Growth
Source: Company, Clarus Securities Inc.

Revenue over that time is forecast to grow from <$5 million in 2009 to $43.0 million in 2010 and $131.6 million in 2011 as high-priced, protein isolate production ramps up and eventually accounts for the majority of the company’s revenue. Despite its lower volumes compared to oil and meal production, isolate production will represent ~70% of total revenue given its premium-pricing in the market place.


Exhibit 9. Volume and Revenue Estimates, Canola Oil Meal Protein Isolates Revenue
Source: Company, Clarus Securities Estimates

As crush margins expand due to the overwhelming contribution from the production of isolates, the Company will realize strong EBITDA margins of 50-60% using long-term pricing forecasts as follows:


Exhibit 10. Pricing Forecasts (C$/mt)

Product LT price (per mt) 5-year high 5-year low

+ Canola oil $1,000 $1,502 $554

+ Meal $250 $304 $133

+ Protein concentrates $1,000 n/a n/a

+ Protein super-concentrates $2,500 n/a n/a

+ Protein isolates $6,000 n/a n/a

Source: Clarus Securities Inc., Canola Council


The most significant variable cost in our model is that of canola. In February, 2008, canola seed prices hit highs of nearly C$659/tonne and touched $250/tonne in late 2005. More recently, seed prices have fallen to C$440-$450/tonne. Our model assumes US$450/tonne. However, these wide swings are muted in part by a similar swing in oil and meal prices which result in crush margins not having the variability that seed costs can have.


Exhibit 11. EBITDA Margin Sensitivity to Canola Seed Prices

+ Canola seed price (C$/mt) $300 $350 $400 $450 $500 $550 $600

+ EBITDA margin 62% 58% 55% 52% 48% 45% 42%

Source: Clarus Securities Inc.


We expect the Company to begin paying tax in mid-2010 and have assumed a blended tax rate of 32%. As capacity and sales start to ramp up, we expect the Company will become EPS-positive in Q2/10 with FY2010E EPS of $0.03 and $0.23 in 2011E as new capacity comes online (another 80k mty is planned for 1H/11 startup).


Balance Sheet & Capex

As of Q1/09, the Company had $1.7 million in unrestricted cash and $3.3 million in long-term debt (75% of which is payable in 2011 or later). The Company also has $8.8 million of in-the-money purchase warrants outstanding. In our model, we have assumed the Company will build a total of 780k mty of capacity at a total cost of about $485 million over the next five years. Capex should be funded primarily by debt and cash flow. We have modeled a relatively small $15 million equity issue as cash flow should ramp-up over time.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "

[Popeye82]

hier hat jemand mal Auszüge eines aktuellen Coverage´s eingestellt, der hat das ein bissl blöd gesplittet, von daher ist das jetzt wohl auch ein bisschen zu merken, Graphiken &dergleichen waren wohl schlecht reinzukopieren, hab´s mal versucht einigermassen übersichtlich zu halten:

"CLARUS SECURITIES - Bio-Extraction Inc. (BioExx) SPECULATIVE BUY -
July 14, 2009

- Steven Gold, CFA [phone]
Aman Atwal, Associate [phone] -
(BXI-TSX.V, $1.03) 12-Month Target Price: $2.30

Growth Through Protein


Highlights

+ BioExx is a value-add processor of oil seeds, with a current focus on canola. In addition to conventional canola oil and meal, its patented technology allows for the separation of high-purity proteins. The result is revenue per tonne of canola seed processed in excess of 11x that of the traditional method.

+ A 40,000 mty commercial canola seed processing plant in Saskatoon is nearing completion. A total of 780k mty of capacity is planned by 2014E.

+ Commercial agreements are in place at the Saskatoon plant to supply high purity proteins to Helm AG (Germany) as well as oil and meal to Shafer Commodities (Canada).

+ Revenue could grow from <$5 million in 2009E to $43.0 million in 2010E and $131.6 million in 2011E as capacity grows and premium-priced, high-purity protein isolates begin to represent an increasing portion of overall revenue (~70% in 2011E).

+ Industry-leading crush margins will allow for strong EBITDA margins of 50-60% while turning EPS-positive in Q2/10E and growing
to $0.23 in FY2011E.

+ Near-term catalysts for the stock include attaining GRAS status (expected in Q4/09) and the successful start-up and subsequent production of the 40,000 mty plant in Saskatoon.


Conclusion and Recommendation

We are initiating coverage with a SPECULATIVE BUY recommendation and a 12-month target price of $2.30 per share.


Valuation

We are using 2011 as our target year for BioExx at which point the Company should have 120k mty of capacity online with another 660k mty planned by YE2014. To derive a target multiple for BioExx, we specifically consider Hanfeng Evergreen Inc. (HF-TSX, BUY) which has a similar business model in that it takes a conventional commodity through a proprietary, value-adding process and then sells the end product at a premium price.

Given Hanfeng is expected to triple its production over the next 2-3 years to 2.0-2.5 million mty, we consider its P/E of 9.0x FY2011 EPS. Given BioExx’s capacity growth (nearly 20x increase in capacity growth over the next five years) as well as its industry leading EBITDA margins of 50-60% compared with Hanfeng’s at 13-17%, a target P/E multiple of about 10x applied to our 2011 EPS estimate of $0.23 is appropriate, resulting in a target price of $2.30 per share.


Base Case Value

We consider a base case valuation for BioExx by taking into account only the current 40,000 mty plant. On a normalized basis (excluding start-up and other one-time costs associated with bringing the plant online), that one plant should achieve EBITDA margins of 50-60% and annualized EPS of ~$0.12. If we apply our 10x P/E multiple we can derive a minimum value today for BioExx of $1.20/share.

We are initiating coverage on Bio-Extraction with a SPECULATIVE BUY recommendation and 12-month target price of $2.30 per share for an implied ROR of 130%.


Investment Risks

Ramp-up Risk: The Company will have to overcome scale-up risk as it applies its technology to its new 40,000 mty processing plant. Although the new plant is small relative to the average industry plant, applying the technology to a larger scale could present challenges.

Regulatory Risk: In order to approve protein products for human consumption, GRAS status must be attained. BioExx is working with external third parties to achieve GRAS self-affirmation, which is expected later this year. Delays in receiving this approval could impact BioExx’s production plans and expected revenue.

Debt Financing: We expect the majority of the Company’s capex to be
raised via debt financing and there is no assurance that it can raise the amounts required to build capacity to the targeted 780k mty. Failure to do so could result in less than expected capacity and revenue as well as higher than expected dilution coming from larger than expected equity issuances.

Competition: The three oilseed processing giants, ADM, Bunge and Cargill have a significant size advantage to BioExx, with access to greater resources. Given this, there is a possibility that a new and better process could be introduced, which would remove BioExx’s “cool extraction” competitive advantage and leave it unable to compete on a scale basis.

Commodity Risk: The Company’s reliance on a commodity as a primary input places it in a position to be significantly affected in the event of a material impact on canola production, such as poor yields. This could impact the crushing margin given a sporadic rise in seed prices and result in a delay in flowing back those costs to customers in the form of price increases.

Counterparty Risk: BioExx procures its canola seed supply from Viterra only, and sells the majority of its products to single buyers. Setbacks in terms of delivery or payment among these parties could negatively impact the company’s operations
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part2...

"The current 40,000 mty plant under construction will be the first commercial scale implementation of the technology. Although the protein production process is unique, it is based on well-founded protein production principles and conventional equipment and as such, we expect no major problems with the scale-up. It is also worthwhile noting that the “Big 3” canola processing giants like ADM Corp. (ADM-NYSE), Bunge Inc. (BG-NYSE) and Cargill Inc. (private) consider their “smaller” plants to be 600k mty or larger.

Given their dominance in the $150 billion annual soy, wheat and canola processing market, the “Big 3” are focused on oil and meal extraction using traditional processing methods. Nevertheless, the size of the protein market is so large ($16 billion today and growing to $25 billion by 2015) that we do not see them as a threat to BioExx. In allowing for an extra component (protein) of the canola seed to be processed and then sold, the Company can achieve crush margins of more than 11x that which the Big 3 realize from canola oil and meal alone.


Exhibit 3. Crush Margins

+ Traditional Crush Margin = Value of canola oil & meal - price of canola seed

+ BioExx Crush Margin = Value of canola oil, meal & proteins - price of canola seed


Traditional Method

+ Canola oil $1,000 40% $400

+ Canola meal $250 60% $150

$550
$450
$100


BioExx Method Product
Selling Px/MT canola seed of canola seed processed

+ Canola oil $1,000 40% $400

+ Canola meal $250 42% $105

+ Protein isolates $6,000 18% $1,080

$1,585
$450
Crush Margin (per MT) $1,135

Crush Margin per MT
Revenue from BioExx method
Revenue from traditional method
Less cost of canola seed per MT
Less cost of canola seed per MT
Source: Company presentation, Clarus Securities Inc.

BioExx’s technology will enable the extraction of high-purity proteins (isolates) and will be marketed for human consumption in beverages, food products and non-food applications:

+ Beverages (soft drinks, fruit juices, energy drinks, infant formulas)

+ Foods (energy/snack bars, meat, tofu, sauces, dairy products, egg substitutes)

+ Non-food (detergents, creams, soaps, hair products
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part3...

"Protein GRAS Approval Expected This Year

While the Company does not require full FDA approval for its products, it is well on its way to achieving the required self-affirmed GRAS (Generally Regarded as Safe) status for its proteins intended for human consumption (super-concentrates and isolates). Management has targeted Q4/09 to receive this certification.


Product Markets

As populations grow and emerging countries become wealthier and more health conscious, the market for protein is expected to grow from almost US$16 billion today to more than US$20 billion in 2011 and US$25 billion in 2015 (source: Global Strategy Analysts Inc.). This is in addition to the annual canola oil and meal markets worth $22 billion and $7 billion, respectively.


Exhibit 5. Protein Market
Source: Global Strategy Analysts Inc., Company presentation

As global demand increases, protein production also must increase and must become more efficient (a measure of protein quality). Soy and wheat protein have the dominant market share within the non-animal protein group (consists of wheat, pea, soy and canola) but are less efficient than canola protein. As a non-animal protein alternative, canola is clearly the best choice as only egg white-based proteins have greater overall efficiency.


Exhibit 6. Protein Efficiency
Source: Global Strategy Analysts Inc, Company reports

Canola protein concentrate ranks higher on the efficiency scale than soy or wheat proteins, but, the challenge has been to extract that protein from the canola concentrate (meal).


Commercial Agreements

BioExx has a 10-year supply deal to source 100% of its Saskatoon plant canola seed requirement from Viterra Inc. (VT-TSX, NR), which may be extended to include future plants where applicable. Output from BioExx’s Saskatoon plant will be sold mostly to two major players. The Company has an agreement to sell 70% of its high-value protein production to industrial chemicals and nutrition marketer Helm AG of Germany. In addition, BioExx has an agreement to sell all of its canola meal and half of its oil production to Canada-based Shafer Commodities Inc. at market prices. The balance of the oil is to be sold under an agreement with Sunora Foods Inc., also based in Canada.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "


Part4...

"Outlook and Forecasts, Capacity Growth – Zero to 780k mty in Five Years

The Company is currently commissioning its first plant that will process 40,000 mty of canola seed per year. Each plant should produce a basket of canola oil (40% of output), meal (40-42% of output) and protein isolates (18-20% of output). The cost of this plant is ~$25 million with expansions to that plant to be funded out of cash flow. Management has outlined a total capacity target of 780k mty by 2014. We expect the majority of the new plants to be located in Saskatchewan or elsewhere in the Canadian and US agricultural region given the proximity to canola seed feedstock.


Exhibit 8. Capacity Growth
Source: Company, Clarus Securities Inc.

Revenue over that time is forecast to grow from <$5 million in 2009 to $43.0 million in 2010 and $131.6 million in 2011 as high-priced, protein isolate production ramps up and eventually accounts for the majority of the company’s revenue. Despite its lower volumes compared to oil and meal production, isolate production will represent ~70% of total revenue given its premium-pricing in the market place.


Exhibit 9. Volume and Revenue Estimates, Canola Oil Meal Protein Isolates Revenue
Source: Company, Clarus Securities Estimates

As crush margins expand due to the overwhelming contribution from the production of isolates, the Company will realize strong EBITDA margins of 50-60% using long-term pricing forecasts as follows:


Exhibit 10. Pricing Forecasts (C$/mt)

Product LT price (per mt) 5-year high 5-year low

+ Canola oil $1,000 $1,502 $554

+ Meal $250 $304 $133

+ Protein concentrates $1,000 n/a n/a

+ Protein super-concentrates $2,500 n/a n/a

+ Protein isolates $6,000 n/a n/a

Source: Clarus Securities Inc., Canola Council


The most significant variable cost in our model is that of canola. In February, 2008, canola seed prices hit highs of nearly C$659/tonne and touched $250/tonne in late 2005. More recently, seed prices have fallen to C$440-$450/tonne. Our model assumes US$450/tonne. However, these wide swings are muted in part by a similar swing in oil and meal prices which result in crush margins not having the variability that seed costs can have.


Exhibit 11. EBITDA Margin Sensitivity to Canola Seed Prices

+ Canola seed price (C$/mt) $300 $350 $400 $450 $500 $550 $600

+ EBITDA margin 62% 58% 55% 52% 48% 45% 42%

Source: Clarus Securities Inc.


We expect the Company to begin paying tax in mid-2010 and have assumed a blended tax rate of 32%. As capacity and sales start to ramp up, we expect the Company will become EPS-positive in Q2/10 with FY2010E EPS of $0.03 and $0.23 in 2011E as new capacity comes online (another 80k mty is planned for 1H/11 startup).


Balance Sheet & Capex

As of Q1/09, the Company had $1.7 million in unrestricted cash and $3.3 million in long-term debt (75% of which is payable in 2011 or later). The Company also has $8.8 million of in-the-money purchase warrants outstanding. In our model, we have assumed the Company will build a total of 780k mty of capacity at a total cost of about $485 million over the next five years. Capex should be funded primarily by debt and cash flow. We have modeled a relatively small $15 million equity issue as cash flow should ramp-up over time.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27286… "

[Popeye82]

Antwort auf Beitrag Nr.: 37.573.963 von Popeye82 am 15.07.09 07:43:42

Beim 1sten Versuch hatte er mir eine Fehlermeldung angezeigt, merkwürdig.

[Popeye82]

BioExx Confirms Progress on Early Warrants Exercise Program - Jul 16, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, – JULY 16, 2009 – On June 23, 2009, Bio-Extraction Inc. (TSX-V: BXI) (“BioExx” or “the Company”) announced its plans to accelerate the production and sale of high-value protein isolates from early 2011 to late 2009, subject to the receipt of sufficient funds from the early exercise of outstanding share purchase warrants which expire January 29, 2010.

BioExx is pleased to report that it has made strong initial progress in this regard, including funds already received from warrants exercised, as well as affirmative indications from certain warrant holders of their intention to exercise warrants in the near term. Providing indicated funds are received before the end of July, and that the balance of the warrant funds are received before year end, BioExx expects to maintain its timeline of bringing isolate production on-line before the end of 2009. In the interim, BioExx continues to investigate other non-dilutive sources of capital that may be used in conjunction with the warrants.

BioExx wishes to sincerely thank those warrant holders who have supported the accelerated protein isolate production plan, and looks forward to delivering on what it believes is a very positive and accretive plan for all its shareholders.(...) "

[Popeye82]

Antwort auf Beitrag Nr.: 37.598.223 von Popeye82 am 18.07.09 07:46:31

INTERVIEW-Bio-Extraction to turn profit in 2010, CEO says - Reuters - 07/17/09
www.stockhouse.com/Bullboards/Messa.....;r=0&s=BXI&t=LIST

"WINNIPEG, Manitoba, July 17 (Reuters) - Bio-Extraction Inc expects to turn a profit in the first quarter of 2010, after the small agricultural technology company becomes the first in the world to commercially produce a high-purity form of canola protein later this year.

BioExx has already raised more than half of the C$7 million ($6.25 million) it needs to accelerate production of the canola protein, called isolates, to late this year from 2011, at its Saskatoon, Saskatchewan plant, CEO Chris Carl said in an interview with Reuters on Friday.

The company, currently listed on the TSX Venture exchange, should qualify for a listing on the senior Toronto Stock Exchange sometime next year, Carl said.

BioExx stock has doubled in value since the company announced on June 23 it plans to accelerate protein isolate production. The stock was down 4 Canadian cents at C$1.10 on Friday morning.

($1=$1.12 Canadian) (Reporting by Rod Nickel; editing by Rob Wilson) "

[Popeye82]

Finde das immer nicht so toll, wenn sich Leute aus dem Unternehmen über den Aktienkurs auslassen, aber naja:

"You are correct, the price of a stock is not the qualifier to get on TSX but certain other criteria (capital in bank or patents or sales etc ) that in combination will satisfy the overall capacity to be a viable enterprise and not just a deveopmental concept or exploration company looking and drilling

When I did speak to Chris back in April I did raise the TSX move and he re[plied that his criteria would be sales revenue and earnings and he did allude to early 2010 (probably after the Q1 positive EBITDA with solid earnings We may co-incidentally be at $ 5 then anyway,

This morning when I received a call back at my office from IR at BXI (that was made 2 days ago. Sean caught me in the middle of work and I could not fully report his info. First, I said that was ther egooing to be a pull back in SP as we had $ 1.09 at that time with low volume. He said that there are PLENTY of eager buyers waiting in the wings to accumulate this stock as the PP was over prescribed and they have had offers daily for more.

He did say that certain funds were mainly responsible for the high volume and the uptrend should continue (end of day was $ 1.19)

But they do not want more dilution and will have enough cash as per the NR to fund operations into the Q4. There is growing revenue daily and will be cash flow positive maybe end of Q3 or early Q4.

He said ther are purchase orders going out daily for standard equipmenrt as has been used in the Whey protien industry for years. No shortage and no delays. The limiting factor now is simply time as the techology has been proven in the lab and there are no glitches in the engineering.

They have hired a quality control manager to assist th eplant manager and currently are looking for shop mechanics and lead hands to move things around in the plant and dela with product. Also more office staff for accounting and billing

He did mention that Chris Schnarr CFO is very conservative and will have extra funds on hand just in case

Also he did say that some staff had been in Europe (probably Germany - Helm ) for some PR work and some analyst may report BXI and IF there is EU interest and buying --look out share price - but they want liquidity and 3-4 million shares per day is very good for that

Other than that he closed off by stating that CEO Chris Carl is the opposite of a promoter - he is a doer and a planner executive par excellance what he says he does slowly but surely. The past NR say it all and today;s article in the FP gives that company a wonderful Canadian success story The first comapny in the World to succesffuly and profitabley produce high grafe protein from Canola seeds. Burcon notwithstanding the more the merrier
Move over Soy protein Canola protien is better and lower cost for BXI with lower temp patent

Good weekend to all
Mike
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27296… "

[Popeye82]

Es gab zuletzt auch eine ganze Menge anderer Erwähnungen, stand im Endeffekt aber nicht viel neues drin -ATH heute übrigens wieder.

Gruß,
Popeye

[Popeye82]

Das ist hier nochmal was zu den, wie schon gesagt, möglichen weiteren Anwendungen, die eventl. später nochmal eine Rolle spielen könnten:

"Besides extraction of edible oils, BioExx’s extraction technology can also be utilized to extract pharmaceutical and nutraceutical compounds such as Omega-3 fatty acids, paclitaxel, artemisinin, lutein, betulin, lycopene and beta carotene from plant, fish, and marine sources. The technology can also be applied in the cleansing of metal swarf from industrial lubricants, the recycling of specialty plastics and glass, as well as in the
production of biofuels... "
www.bioexx.com/images/stories/pdfs/research/frost_awardartic…

[Popeye82]

Antwort auf Beitrag Nr.: 37.460.605 von Popeye82 am 24.06.09 19:06:34

Bekanntgabe des Standortes der 2ten Anlage -North Dakota war absolut richtig. Versuche mal nicht zu euphorisch zu werden -aber ...

BioExx to Expand to USA for Second Protein Facility, Selects Minot, North Dakota as Location - Jun 22, 2009

Highlights

+ BioExx to construct wholly-owned 80,000 MT per year Canola processing facility

+ Infrastructure readily available at competitive cost at the Minot Site

+ Financing to comprise up to 50% local debt and incentives with balance to be leveraged from Saskatoon facility

+ Minot is a business friendly community for environmentally sustainable processors
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, – JULY 22, 2009 – Bio-Extraction Inc. (TSX-V: BXI) (“BioExx” or “the Company”) is pleased to announce that, after extensive review, it has selected Minot, North Dakota as the location for its second Canola Protein processing facility. BioExx is a Canadian company that extracts oil and high-value proteins from oilseeds for the global food market utilizing patented low-temperature extraction and proprietary protein separation technology.

BioExx technology can generate up to five times as much food value from a tonne of canola compared to conventional processes and this can have a potentially large impact on global food production in the long term. Purified protein has become much more important in food and beverage production in order to satisfy growing global demand. The protein additive market is currently a USD $16-billion industry, and is projected to grow to over $25 billion in the next seven years. The most significant trend within this market is the substitution of plant proteins for animal proteins, driven by improved economics and greater environmental sustainability.

The location decision was made after reviewing several domestic and international alternatives and comparing each across a variety of metrics including:

+ Feedstock supply

+ Infrastructure availability and competitive costs to support plant (land, rail, energy, labour)

+ Availability of favourable funding programs

+ Discussions with local utilities, design engineers and construction contractors

+ Local, regional, and national support


As a result of this effort, BioExx is pleased to have signed a Letter of Intent with the City of Minot, through its economic development arm, the Minot Area Development Corporation (“MADC”) to locate the facility on a 10 acre lot in their fully developed and fully serviced Value-Added Agricultural Complex.

As outlined in the Letter of Intent, BioExx will now proceed with the final development stages of the project (including environmental permitting, site analysis, building design, and supplier and customer contracting). Subject to meeting certain credit requirements, MADC will bring forth a complimentary financing and incentive package. In completing prerequisite development activities by late 2009, BioExx expects to finance the Project following a successful ramp up of Protein Isolate operations in Saskatoon. Construction would then commence as soon as ground and weather conditions permit in Spring 2010. This would lead to a goal of bringing the plant on-line and starting production ramp-up in early 2011.

Subject to BioExx meeting certain credit requirements, the MADC, in conjunction with private lenders and the state-owned Bank of North Dakota, has proposed to provide approximately 50% of the required USD $50 million project cost in the form of loans and/or capital leases. Favourable loan terms could be available for qualifying companies through a program under which the US Department of Agriculture guarantees a portion of the total debt package. While maintaining conservative debt service ratios, BioExx intends to finance the balance of the requirement to the greatest extent practicable by leveraging cash flows from its Saskatoon plant once it has ramped up its protein production operations. BioExx intends to finance the facility using traditional forms of debt and intends to avoid any types of financing that would be highly dilutive to shareholders or that would involve future oriented conversions to equity.

“Minot is an agriculture and business friendly community that has put tremendous effort into providing infrastructure that meets the requirements of companies looking for a new base of manufacturing operations,” says Chris Carl, CEO of BioExx. “This allows us to meet our goal of expanding internationally and into a different growing region, while at the same time enjoying a reasonable proximity to our first plant location.”

BioExx remains deeply focussed on completion of its Saskatoon protein production operation, and as such is creating an independent development team comprised of a Toronto-based development manager and associations with Minot-based engineering firms.

“We are pleased to have BioExx, a Canadian-based company, expand into Minot, North Dakota. Minot has put significant capital investment into the Value-Added Agricultural Complex to build-out strategic assets that companies like BioExx can leverage,” said Minot Mayor Curt Zimbelman. “We believe with the investment made in the Ag Complex, Minot can help BioExx become a world leader in the industry of high value proteins.”

Minot is the fourth largest city in North Dakota, near the Canadian border and is already twinned with the town of Moose Jaw, Saskatchewan. It is well served by both road and rail, as a hub for North Dakota agriculture. North Dakota has a strong economy and is one of the largest growers of Canola in the United States.

“We’ve worked hard to diversify our agriculture industry by providing the incentives that will encourage value-added ventures throughout North Dakota,” said North Dakota Governor John Hoeven. “North Dakota leads the nation in oilseed production, and BioExx’s expansion into the state will create value-added opportunities and provide another market for growers.”


Business Risks
BioExx would like to remind its shareholders, and other interested parties, that it is not yet in full operation at its first specialty protein facility in Saskatoon, and accordingly is subject to the normal business risks of all companies at this stage of development. The Company has completed the building and the 40,000 tonne per year crushing facility with the extraction and protein processing portion of the facility still under construction. BioExx is pleased with its progress at the Saskatoon facility and is proud of all that it has achieved to date to mitigate as much as possible these normal business risks.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’ patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’ low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX-V: BXI), please visit www.bioexx.com (...)"

[Popeye82]

ob sie den Rest komplett über Schulden hinbekommen kann ich nicht sagen, aber eins denke ich auch -sobald sie einmal nachweisen sollten, dass die Technology funktioniert, dürften sie in einer sehr starken Position bei künftigen Verhandlungen über weitere Anlagen sein, weil sich die betreffenden Regionen dann etwas darum "reissen" dürften(insbesondere natürlich: Steuern -bei weitaus höheren Umsätzen/Gewinnen als bei vergleichbaren Unternehmen):

"Govt is excited since they will get lots of tax from bxi plant which gets 5 times the normal revenues.

The remainder of the plants should be 100% debt. Because Minot does not have the opportunity to see the plant in operation they just went with 50%, but bxi should be able to strike a harder deal with the next plants, unless competition arrives. That is why bxi will build them as fast as possible.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27306… "

[Popeye82]

Antwort auf Beitrag Nr.: 37.573.963 von Popeye82 am 15.07.09 07:43:42

Habe gerade das vollständige Clarus Coverage bekommen -bei Interesse, wie gesagt, per BM mal die Mailaddresse durchgeben.

Gruß,
Popeye

[Popeye82]

noch eine BNN Erwähnung(ab Minute4):

The Street : August 5, 2009 : Agrium & Trade of the Day
http://watch.bnn.ca/clip200299#clip200299

[Popeye82]

die Entwicklung der Crush Margins zuletzt dürfte wahrs. vorerst einen Strich durch die Rechnung auf dem Weg zur 1sten Profitabilität machen, könnte eventl. kurstechnisch für ordentlich Druck sorgen, mal schauen -sollte der sehr groß ausfallen, kaufe ich eventl. nochmal nach:

BioExx Adds Protein Specialist to Advisory Board - Aug 10, 2009
www.marketwire.com/press-release/Bio-Extraction-Inc-TSX-VENT…

"TORONTO, ONTARIO--(Marketwire - Aug. 10, 2009) - Bio-Extraction Inc. (TSX VENTURE:BXI), known as BioExx or the Company, is pleased to announce the appointment of Dr. Edward Wein to its Scientific Advisory Board. Dr. Wein will play an active role in the final stages of the GRAS and related product certifications for Protein Isolate products to be produced by BioExx at its Saskatoon facility and future facilities, as well as advising the Company regarding the development of specific food product applications. This will include specialized and on-going testing to determine and verify the applicability and/or superiority of BioExx proteins to specific food product opportunities.

With a PhD in Biochemical Engineering from University of Toronto, Dr. Wein has a distinguished career of more than 30 years in the food, functional food, and food ingredients markets with a special emphasis on proteins. Dr. Wein has served as an adjunct professor at the University of Guelph, Faculty of Engineering; advisory board of Ryerson University department of Chemical Engineering; and is a past member of the Canada Expert Committee on Food Biotechnology. He has also held senior R&D and commercialization positions at Canada Packers Ltd. (now Maple Leaf Foods), Ault Foods (now Parmalat), Nexia Biotechnologies Inc. and Bariatrix Products International. Dr. Wein is currently a consultant for a variety of companies conducting research in food products, nutraceuticals, and nutritional and food supplements, in North America, Europe and the Middle East.

"We welcome Dr. Wein as an important member of our Science team who brings to BioExx a wealth of critical experience in the protein world," says VP of Business Development, Samah Garringer. "His practical experience in the development, production and sale of similar products will help ensure BioExx completes a smooth transition into the sale of its VitalexxTM and IsolexxTM products and then continues to optimize its protein product portfolio over the longer term."


Operations and Market Update
BioExx has continued to install equipment designed for the second phase of its operations and as a result, the key operating metrics of quality, yield, and throughput have continued to improve. The plant is now able to produce food-grade degummed expeller oil, with an expectation of producing super-degummed expeller oil before the end of the current quarter. BioExx has continued to produce a premium value meal since May of this year.

Although the Company is pleased with the operating performance of the plant, canola industry crush margins have recently declined toward the low end of the five year trading range. While the Company does not expect this market condition to persist in the long term, it does create challenges with respect to breakeven operations at the plant based on interim crushing operations. The plant continues to forecast break-even or better operations if and when crush margins return to previous levels. Regardless, the Company does not consider the current crush margin weakness to be economically meaningful in the context of its longer term business plan as its crush-only operation is temporary in nature, pending the start-up of protein production operations.

BioExx is also pleased to confirm that long lead time equipment items for its Extraction and Protein phases have been ordered for 2009 delivery. Unless there are unforeseen delays in equipment delivery, BioExx continues to work from a schedule that allows for installation and start-up before the end of this calendar year.

In response to an article published by Reuters on August 6 regarding salmonella contamination problems in the meal produced at several Canadian canola processing plants, BioExx is pleased to report that as a result of its rigorous HACCP quality assurance program, regular testing of the BioExx meal has shown no such problems at the BioExx plant to date.


Other News
BioExx has agreed to extend its contract with Brisco Capital Partners to provide Investor Relations services for another year commencing August 10, 2009. As part of the extension, BioExx is granting Brisco an Option to purchase 100,000 common shares at a strike price of $1.44, having a two year term and vesting over 12 months. This replaces a previous option which is expiring.

In keeping with the spirit of warrant holders who have exercised warrants prior to their maturity, at the request of the Company, BioExx CEO Chris Carl has sold shares to generate after-tax proceeds sufficient to repay a loan to the Company (as disclosed in the BioExx financial statements), in the amount of $250,000 plus accrued interest, that was not due until March 2010. Mr. Carl also anticipates selling a small percentage of his holdings over the balance of the year to raise necessary funds to repay some third party debts incurred in the past six years during the building phase of the Company.


About Bio-Extraction Inc.
Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx's patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx's low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE:BXI), please visit www.bioexx.com. (...)"

[Popeye82]

Antwort auf Beitrag Nr.: 37.746.241 von Popeye82 am 10.08.09 16:33:45

Im schlechten Falle könnte das weitere, nicht geplante, Verwässerung bedeuten. Positiv dürfte sein, dass jetzt wahrs. mal ein großer Teil der Trader &Zocker rausgeschüttelt wird.

[Popeye82]

hatte ich ganz übersehen, eine neuere Presentation -auf S.16 ist nochmal zu sehen, wie sich das halbwegs auswirken sollte -sofern Stufe3(Isolate) funktioniert(was ja im Endeffekt die "BXI Kurzstory" ist). Wenn jemand interessiert sein sollte, sich der Stärken/Besonderheiten aber nicht so richtig klar ist -der sollte sich mal genau das angucken:

Presentation - Jun09
www.bioexx.com/images/stories/pdfs/ir/bxi%20presentation%20-…

[zuckerdepot]

sehr geehrter popeye,

was ist das besondere an diesem pennystock ?

es macht miniumsätze und dabei noch hohe verluste.
es ist eines von tausenden unternehmen die an die börse gebracht werden um nach 2-3-5 jahren wieder zu verschwinden.

glauben sie das dieses miniunternehmen es tatsächlich schaffen wird jemals geld zu verdienen ? bisher wurde nur massiv geld verbrannt. und mit umsätzen von nur einigen millionen ist das unternehmen ohnehin sehr spekulativ.

wie ist da ihre planung für die nächsten 5 jahre.
wo denken sie liegt BioExx in 5 jahren bei umsätzen und gewinnen ?

[Popeye82]

Notice of Q2 Results Conference Call - Aug 21, 2009
www.marketwire.com/press-release/Bio-Extraction-Inc-TSX-VENT…

"TORONTO, ONTARIO--(Marketwire - Aug. 21, 2009) - Bio-Extraction Inc. (TSX VENTURE:BXI) will release its Q2 2009 financial results following the close of markets on August 27, 2009. Management will host a conference call on August 28 at 10:00 a.m. (Eastern Time) to review the financial results.


Live Conference Call:
---------------------
Dial-in Numbers: 416-340-8018 / 866-223-7781


Instant Replay:
---------------
Dial-in Numbers: 416-695-5800 / 800-408-3053
Pass code: 8506614
Available Until: September 11, 2009 11:59 PM

The call will also be audio-cast live and archived for 90 days at
www.bioexx.com .(...) "

[Popeye82]

Gestern wurden die Q2 Ergebnisse bekanntgegeben -stelle die Meldung dazu dann nochmal rein:

UPDATE1-BioExx closer to funding canola protein - Reuters, WINNIPEG - Thu Aug 27, 2009

- By Rod Nickel -

- + Fundraising on track-analyst

+ BioExx 2Q loss per share 2 cents vs 1 cent

+ Loss C$2.3 mln vs C$0.79 mln -
www.reuters.com/article/rbssHealthcareNews/idUSN273339422009…

"WINNIPEG, Manitoba, Aug 27 (Reuters) - Bio Extraction Inc (BXI.V), a small agricultural company with a fast-rising stock, has raised C$6.3 million ($5.8 million) of the C$7 million it needs to become the first company to commercially produce a high-purity protein from canola, the company said on Thursday.

BioExx has raised the funds through investors exercising warrants to buy shares as it moves into the final stages of building its protein isolate plant in Saskatoon, Saskatchewan.

"We think they're on track," said Peter Prattas, an analyst with Fraser Mackenzie. "That's a big step toward meeting their goal."

The protein isolates will be distributed to food companies for use in protein sport drinks and baby formula. It would be the first time anyone has commercially produced canola protein for human consumption.

BioExx reported a net loss of C$2.3 million, or 2 Canadian cents a share, in the second quarter, compared to C$796,126, or 1 Canadian cent a share, during the same quarter last year, as it ramps up crushing of oil and meal.

The oil and meal products helped BioExx earn revenue for the first time, but they are of lower value than the protein isolates.

The loss is in line with expectations, given the company's early stage, Prattas said. The challenge for BioExx will be to continue moving toward the valuable isolate production while sustaining losses in the short term, he said.

Crushing margins, a measure of the profit in crushing oilseeds, have fallen since the second quarter, Prattas said.

The company plans to add four more plants in the next four years.

The company's stock on the TSX Venture Exchange has more than doubled since June 23, when BioExx said it was accelerating its timetable to start producing canola isolates to the end of this year.

BioExx stock closed 2 Canadian cents lower at C$1.35.

Fraser Mackenzie is maintaining its 12-month price target at C$2. ($1=$1.08 Canadian) (Editing by Janet Guttsman) "

[Popeye82]

Also teilweise werden die Diskusssionen da recht heftig geführt -wobei er noch mindestens zu den Gemässigten zählen dürfte:

"Mr. Short the markets You should sell your BXI shares and go back to the Burcon board.

BU promotes Canola Protein Isolates and they have Supertein and Puratein and Crarisoy as a "test products".

They have many patents but then can never block BXI because Isolexx and Vitalexx are produced with a unique patented ITFM HFC-134a low temp solvent that is beyond the Burcon domain of protection.

The CC today answered exactly that question (I was the one that raised it) and there is no fear on the part of BXI for that. Intellectual property law protects BXI and the law firm hired by BXI is top notch.

Burcon has no plant and no production facilities yet. They do have Hong Kong $$ and ADM as sugardaddys to bail out their bills. They are beholden and enslaved to them for handouts of cash to get GRAS etc. Burcon has been dicking around for 10 years to get canola protein isolates and all they have now are a pile of patent papers.

BXI relied on risking the seed personal money and then risking the early investors money with PP and then the suport of warrant holders. The shareholders of BXI have put in real money as their support of the share price and they believe in the CEO and managment.

It will just take 4-6 more months of more "investment" but the wait will be worth it.

BXI is trying their best with limited resources and they are slowly succeeding.
They will be Cash flow positive by Dec 2009 and they will have big earnings by March 2010.

Give then a chance already.

Q1 2009 no plant no revenue Q2 2009 growing revenue and negative cash flow Q3 and Q4 2009 more revenue and will be POSITIVE CASH FLOW by Dec 2009. Jan 2010 starts protein $ - no need to worry as there is no NO CASH CRUNCH

In Jan 2008 they had a theoretical dream of canola protein production and by Feb 2009 a plant and by Jan- Feb 2010 they WILL have truckload of protein already sold to AG Helm. NOT in baby formulas as you critically alleged but other products that have already been customer tested and approved. The baba formula addition may be a longer way of as you are correct - it will require GRAS/FDA approval in the USA.

BXI will sell canola protein in Europe (non GMO) through HELM at first and then later in USA (via N.Dakota).

I respect Burcon for what they do and in fact their progress DIRECTLY helps BXI in the general public and industry recognition and acceptance of Canola Protein superiority over Soy plant protein and animal protein.

Please don't unnecessarily denigrate or castigate BXI as "amateur" or in other demeaning terms.

GROW UP !

Both Burcon and BXI are well meaning companies with hard working men and women trying to make a living.

The protein market is large enough for 2 to succeed (16 Billion and growing) and there is no need fro legal wrangles or hassles.

Good luck to both BU and BXI and to the long shareholders of both who are optimistic and supportive of the entrpreneurs who dream a success story and then TRY hard and DO it.

Those type of MEN and WOMEN do not just sit in front of a computer like a litte kid who rants off some unconstructive criticism laced with venom .

If you "short the markets" for a living I have some advice for you

GET A REAL JOB AND CONTRIBUTE TO THE SOCIETY THAT YOU LEECH OFF AS A PARASITE !

MIKE
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27407… "

[Popeye82]

muss man sich wenn etwas Zeit für nehmen -um die 36min:

Second Quarter Results - August 28th, 2009 10:00 AM ET
http://events.digitalmedia.telus.com/bioexx/082809/index.php

[Popeye82]

Antwort auf Beitrag Nr.: 37.803.227 von zuckerdepot am 18.08.09 16:47:20

"sehr geehrter popeye,

was ist das besondere an diesem pennystock ?

es macht miniumsätze und dabei noch hohe verluste.
es ist eines von tausenden unternehmen die an die börse gebracht werden um nach 2-3-5 jahren wieder zu verschwinden.

glauben sie das dieses miniunternehmen es tatsächlich schaffen wird jemals geld zu verdienen ? bisher wurde nur massiv geld verbrannt. und mit umsätzen von nur einigen millionen ist das unternehmen ohnehin sehr spekulativ.

wie ist da ihre planung für die nächsten 5 jahre.
wo denken sie liegt BioExx in 5 jahren bei umsätzen und gewinnen ?"


Hallo Zuckerdepot.

Ihre Annahmen(aus dem anderen Thread) müssten in etwa hinkommen, allerdings dürften die Umsätze nicht stimmen -da sie derzeit noch kleiner sind &zum anderen existiert das Unternehmen schon länger, wenn man es bis auf seine "Wurzeln" zurückverfolgt -seit 2003 nämlich.


Das besondere ist, dass Bio-Extraction eine derzeit in der Art einmalige Verfahrensweise entwickelt hat, mit der es voraussichtlich möglich sein wird aus biologischen Ausgangsstoffen(für´s 1ste Canolasamen) 3weitere Produkte, nämlich Öl, Mehl &Proteine, zu gewinnen. Von letzterem gäbe es dann nochmal verschiedene Abstufungen. Voraussichtlich in sofern, als das der Prozess sich in verschiedenen Tests als erfolgreich erwiesen hat, der Ernstfall aber auch noch funktionieren muss. Dazu kommen dann auch noch einige andere Sachen, wie z.B. die, noch ausstehende, Lizenz für nötige Standards. Der große Unterschied zu vergleichbaren Unternehmen würde dann darin bestehen, hab ich alles schon in der Einleitung geschrieben(wozu mach ich das eigentlich ??)dass sie durch diesen Prozess weitaus höhere Umsätze, sowie auch Nettomargen erreichen können. Und wenn man mal ein bisschen rechnet, dürfte klar sein, dass diese Effekte zusammengenommen nochmal eine Potenzierung ausmachen -&damit eine immense(!) Verdienstkraft ausmachen würden. Dazu lässt sich dieses Model, sofern es einmal in der Praxis funktioniert, dann ja noch erheblich horizontal, geographisch expandieren.

Zu den "5Jahres Projektionen" -wie ja schon im Eingangsposting geschrieben, ist das Ziel innerhalb von 5Jahren 5Anlagen, mit einer Gesamtkapazität von knapp 800.000t/anno, zu bauen. An den zeitl. Angaben würde ich mich nicht zu sehr festbeissen, allerdings hat sich das ja zuletzt eher nochmal, unerwartet &deutlich, beschleunigt. Diese Kapazität würde dann für einen Umsatz von um die 1Mrd. $ rum gut sein. Ich hatte ja schon im Eingansposting geschrieben das konkrete Prognosen schwer zu kalkulieren sind, was jetzt durch die "Crush Margins" auch nicht ganz einfach ist -da würde ich momentan einfach auf die letzte Presentation verweisen, in der sie ja, in der letzten Phase, von Gross Margins von ~57%(!!) ausgehen. Vielleicht klingelt´s ja langsam, was hier das besondere ist/werden kann. Dazu habe ich bisher von den Verantwortlichen einen ausgezeichneten(!) Eindruck und sie verweisen immer wieder darauf, dass versucht wird so weit wie möglich ohne verwässernde Effekte auszukommen. Vielleicht wird meine leicht positive Einstellung dem Unternehmen gegenüber ja langsam klarer.


"es ist eines von tausenden unternehmen die an die börse gebracht werden um nach 2-3-5 jahren wieder zu verschwinden. ..."

Das sind genau diese Aussagen, die mich einfach unungemein ärgern, in meinen Augen wirklich extreeemer Scheuklappenblick -aber jeder halt wie er´s für´s richtig hält. Es sagt ja keiner was dagegen vorsichtig zu sein, das Chance/Risikoverhältnis anders, wesentlich schlechter, einzuschätzen etc. . Aber sich keine 10Minuten nehmen &dann solche Ausssagen machen, find ich nicht wirklich dolle. Da stellt sich für mich dann halt die Frage, was man dann auf die restlichen Einschätzungen geben soll. Die meisten Aussagen im "Value Thread" hätte ich locker widerlegen können(so einen Frost &Sullivan Award bekommt man m.W. z.B. nicht als Xbeliebige Pommesbude, alleine ein Blick auf die Partner hätte da abgeholfen, mal abgesehen davon, dass Unternehmen von Weltrang Interesse bei Ihnen angemeldet haben) -aber ein bissl Eigeninteresse sollte ja mal als erstes da sein.

Ich finde es nur aufschlussreich, dass die größten Fundamentalexperten das so oft ohne große Recherche hinbekommen.
Wollte jetzt nicht nochmal alles wiederholen, gibt sicher noch mehr zu sagen -ansonsten einfach fragen.

Gruß,
Popeye

[zuckerdepot]

Antwort auf Beitrag Nr.: 37.881.830 von Popeye82 am 30.08.09 20:21:41

"Sind jetzt wieder nur allgemeine Lehrbuchweisheiten, damit kommt man aber nicht immer weiter, bzw. sind sie für sich genommen manchmal mehr hinderlich als nützlich.

Wenn die Firma kein Cashflow generiert und sich nicht refinanzieren kann, bin ich froh allgemeine Lehrbuchweisheiten beherzigt zu haben als Pleite zu sein.


Nicht einen Blick auf die Unternehmensspezifika geworfen, aber mit so einem profundem Urteil zu Stelle

Als Außenstehender hat man außer ner bunten Internetseite kaum Infos.

Bei ner Marktkapitalisierung von über $100 Mio erscheint mir in diesem Wert reichlich Luft zu stecken:

Revenue 2008: $0,291 Mio
Net Loss 2008: $3,466 Mio

Wenn BioExx nicht den Stein der Weisen gefunden hat, ist in der Aktie das (eventuelle) Wachstum der nächsten Jahrzehnte eingepreist.

Bei aktuellem Börsenwert und 30% Wachstum für die nächsten 20 (!) Jahre ergibt sich ein Börsenwert von $55 Mio.
(0,291 + 1,3^20 = 55)

Das entspräche dann einem KUV von 2. Zukünftige Wettbewerber wie Bayer, BASF etc. werden in dieser Zeit wahrscheinlich ähnliche KUV haben.


-ich versteh´s einfach nicht.

Aktien mit derart schlechten Kennzahlen fallen bei mir durchs Raster. Die Wahrscheinlichkeit, dass man zum Spielball von Zockern wird, ist einfach zu hoch. 95% bei w : o scheinen aber weiterhin viel Spaß damit zu haben. Zwinkern"
-------------------------------

der anleger seaplane hat es auch gut zusammengefasst und darum kopiere ich seinen beitrag noch einmal hier rein und ergänze :

guten abend seaplane,

sie haben genau das gesehen was ich auch gesehen habe. die BioExx ist für mich ein geeignetes mittel um geld zu vernichten. ernsthaft und seriös investieren sieht meiner meinung nach anders aus.

anzumerken ist noch das bereits das vorgänger unternehmen der BioExx pleite gegangen ist und die aktionäre böse über den tisch gezogen wurden. auch das vorgängerunternehmen hatte miniumsätze - keine gewinne.

- geschäftsmodell fraglich / nur spekulation / nur hoffnung
- umsätze mickrig
- gewinne nicht vorhanden / verluste reichlich vorhanden
- in 3-5 jahren droht wieder eine pleite oder dann wird mal eben wieder umfirmiert und neue aktionärsgelder verbrannt
- bewertung ist utopisch und lässt damit keinen spielraum mehr
- selbst bei niedriger bewertung bleibt nur das prinzip hoffnung

--------------------

sehr geehrter popeye82,

wo liegen denn Ihrer meinung nach die gewinne und umsätze in den nächsten 3 jahren oder 5 jahren oder nehmen sie einfach einen zeitraum den sie wünschen um die aktuelle bewertung zu rechtfertigen.

wäre schön wenn sie auf die frage nach umsatz & gewinn dieses penny stock noch antworten könnten. dann könnten sie selber ausrechnen ob die aktuelle bewertung jemals sinn machen kann

[Popeye82]

MD &A - Aug 27, 2009
www.sedar.com

[Popeye82]

BNN Interview; Robert McWhirter comments on BXI - Sep 15, 2009
http://watch.bnn.ca/#clip213502

[Popeye82]

da sich die vermutete 1ste Profitabilität zuletzt ja nochmal etwas verschoben hat wurde zuletzt noch einmal Geld einsammeln nicht unwahrs. . Bin mir nicht ganz sicher, ob sich das dadurch in Wohlgefallen auflösen könnte, müsste man nochmal gucken. Unterstreicht IMO trotzdem wieder, dass sie von Seiten BXIs mit allen nur möglichen Mitteln versuchen wirklich Verwässerung zu vermeiden &generell aktionärsfreundlich zu handeln. Das kanadische Agri-Opportunities Program ist mir schon bei 1, 2 anderen Sachen über den Weg gelaufen &sollte IMO zumindest nochmal die Seriösität unterstützen:

BioExx Announces $2.95 Million Agri-Opportunities Funding; Also Provides Operations Update - Sep 23, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, ONTARIO-- September 23, 2009 - Bio-Extraction Inc. (TSX VENTURE:BXI), known as BioExx or the Company, is pleased to announce that it has been conditionally approved for a repayable contribution of $2,958,000 by Agriculture and Agri-food Canada, under its Agri-Opportunities program. Subject to completion of a definitive agreement, the proceeds from the contribution will be used for capital equipment, installation, and commissioning for the BioExx protein isolate production system at its Saskatoon canola processing plant. The contribution is interest-free, unsecured, and is repayable in five equal annual instalments beginning in April, 2013.

"We are very pleased to have been approved for funding under the Agri-Opportunities program", said Chris Schnarr, BioExx Chief Financial Officer. "It is this type of support and these types of programs that help leading-edge companies commercialize processes and products, such as we are doing at BioExx. This fostering of innovation is important to the creation of value and helps drive investment, economic growth, and job creation. We are thrilled to have been selected for participation in this valuable program."

The Honourable Gerry Ritz, Canadian Minister of Agriculture and Agri-Food, hosted a press conference at the BioExx processing facility in Saskatoon on Wednesday, September 23, 2009 at 5:00 p.m. ET, to officially announce the funding arrangement with BioExx and to discuss the Agri-Opportunities program.

Based on its patented low-temperature oil extraction and patent-pending protein separation processes, BioExx has developed a family of unique canola protein isolate and hydrolyzed protein products to be produced at its Saskatoon plant. These products are well-suited to a multitude of food and beverage applications, such as baked goods, meat products, energy bars, fruit juices, and sports drinks. Being able to access a program such as Agri-Opportunities is of great assistance to BioExx in developing a balanced capital structure and reducing its overall cost of capital to support this technically innovative and important protein isolate processing facility.


About Agri-Opportunities

The $134 million, Agri-Opportunities Program, launched in January 2007, is a five-year program that aims to accelerate the commercialization of new agricultural products, processes or services that are currently not produced or commercially available in Canada, and are ready to be introduced to the marketplace. Agri-Opportunities is delivered nationally by Agriculture and Agri-Food Canada. Funding is provided to projects that focus on new agri-food, agriculture or bioproducts, that can be expected to increase market opportunities for the Canadian agricultural industry across the value chain and generate demand for primary agricultural products.


BioExx Operations Update

Excellent progress continues to be made on completion of the extraction and protein isolate areas of the Saskatoon plant. Timing for GRAS self-affirmation continues to be projected well ahead of protein production, and equipment installation is set to commence by the end of October and carry on through to start-up. Unfortunately, it does appear that delivery of some equipment will be slightly later in the year than desired. While not significant, system start-up is now projected to commence in mid to late February rather than around year end. Every effort is being made to shorten the timetable but equipment delivery times do control critical path at this point in time.

Additionally, testing and market penetration activities have continued with BioExx's protein distribution partner, Helm AG. "The protein market faces a serious lack of high purity plant proteins and that supply gap is continually widening. The big advantage we have with the BioExx product is that it is strong in all required characteristics for food products, including superior nutritional value, good taste, functional properties, and solubility", said Mr. Sergej Lazovic, Executive Manager of Helm AG. "We have presented the company and the samples to customers that we have strong relationships with and can confirm that BioExx has been able to develop protein products that meet their needs very well. This includes representatives in the meat and spice, bakery, functional foods, and sports food markets. Consequently, there should be strong demand for BioExx protein in the market and there are already a number of very interested customers waiting for regular production to commence."

With respect to current operations, BioExx is pleased to report that it is now producing its targeted quality of super degummed (SDG) oil at higher than target yields (percentage of oil recovered from pressing) with ever increasing quantities being processed. This will allow shipping and sales of premium oil commencing in October, in addition to the premium meal already being sold. Current operating performance at the plant is very strong, with September average daily quantity of seed processed up 60% and average daily oil production up 67% versus the second quarter. BioExx is very pleased with this performance and looks forward to continued strength in operations from here forward as it moves towards protein production.


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx's patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx's low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE:BXI), please visit www.bioexx.com "

[Popeye82]

zuletzt ist man noch bei einem regionalem Wettbewerb in 2Finalrunden gekommen -Kategorie: "TIA New Saskatchewan Product Award" &"Investment":
www.saskchamber.com/files/documents/3_2009FinalistsMediaRele…
www.saskchamber.com

[Popeye82]

BioExx Annouces $10 Million Bought Deal Financing - Sep 25, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

"Bio-Extraction Inc. (TSX-V: BXI) ("BioExx" or the “Company”) announced today that it has entered into an agreement to sell to a syndicate of agents led by Canaccord Adams and including Wellington West Capital Markets Inc., Fraser Mackenzie Limited and Loewen Ondaatje McCutcheon Limited (the “Agents”), on a bought deal private placement basis, 8,000,000 common shares ("Offered Shares") at a price of $1.25 per Offered Share for gross proceeds to BioExx of $10 million (the "Offering").

The Agents have the option, exercisable in whole or in part up to 48 hours prior to the closing of the Offering, to offer for sale up to an additional 4,000,000 common shares of the Company for additional gross proceeds of up to $5 million.

BioExx intends to use the net proceeds from the Offering to fund capital expenditures at the BioExx Saskatoon processing facility and the proposed North Dakota processing facility and for general working capital and corporate purposes. In the context of its current business plan, BioExx believes that the net proceeds of the Offering will enhance the strength of the Company’s balance sheet and working capital position for the start-up and ramp-up phases of its Saskatoon protein isolate facility, with excess capital to be allocated to its planned North Dakota facility.

The Offering is expected to close on or about October 15, 2009 and is subject to regulatory approval. The Offered Shares will be subject to a four month hold period in Canada. (...)"

[Popeye82]

ab ca. 6:25 &dann nochmal ab ca. 12:15 zu BXI und BU:

BNN talks to Robert McWhirter, president, Selective Asset Management - BNN, Market Call - Sep 15, 2009
http://watch.bnn.ca/#clip213502

[Popeye82]

Special edition: Market insights; Mintel: Preparing for a functional foods turnaround - AP FoodTEchnology - Sep 15, 2009

- By Amanda Lintott, Mintel -
www.ap-foodtechnology.com/Publications/Food-Beverage-Nutriti…

"The intrinsic health benefits of foods are likely to become a key focus of functional food growth in Europe as industry prepares for a major shift in the coming year. As part of a special NutraIngredients series canvassing analyst insight, Mintel tells us why.

Functional foods have been one of the boom areas of the food market; however, growth has slowed as consumers have become increasingly sceptical about some of the claims made.

This has coincided with a boom in superfoods and naturally occurring nutritionally dense foods. Increasingly, brands are switching sourcing of ingredients to those which have intrinsic health benefits.

And Mintel predicts that this trend is set to continue, as final health claims rulings may well mean that the functional foods category will have to face a major shift in the coming year.


Shifting health claims landscape

Indeed, if (as we have so far seen through a string of negative opinions) the health claims currently used are no longer valid for use, the industry will have to have a major re-think about how to position and market their products.

There is likely to be a move away from some health ingredients that may not be backed by sufficient clinical evidence towards naturally good sources of food that are well understood by consumers and do not require complex explanations or claims.
Some of the major brands were early adopters of naturally occurring functional foods - such as Weetabix with its Oatibix brand, which uses oats as a great source of slow release energy.

However, naturally occurring functional foods are generally marketed by smaller companies. In fact, to date many of the big players have not made a major contribution to this growing trend, which means this trend offers enormous potential.


Waiting game

It is difficult to say for certain exactly which products will pass the health claim ruling, but an initial look at some of the positive opinions issued to date suggests a strong path ahead for calcium and vitamin D for bone health, plant sterols and stanols for cholesterol reduction, DHA for childrens’ eye health, and tomato extract for blood circulation.

Mintel's Global New Products Database (GNPD) highlights two of the more recent examples of this natural trend.

New in France from Lesieur is Lesieur Isio Actistérol Sauce Salad. Enriched with vegetable sterols, the dressing is claimed to reduce cholesterol in 3 weeks.

In the UK, Sirco Blueberry and Apple Juice is 100 per cent pure fruit juice made from concentrate with FruitFlow extract, which is an active tomato extract that helps maintain a healthy heart and benefits circulation. The all natural juice is cholesterol free and contains no artificial colours, flavourings, sweeteners or preservatives.

So for now, it remains a waiting game as final health claims rulings determine what lies ahead. The eyes of the industry will be on the European funtional foods market for what is set to be an interesting year.

To read the Mintel article on the US market, click here .
For more articles in this series, click here . "

[Popeye82]

BioExx Closes $15 Million Bought Deal Private Placement - Oct 15, 2009
www.marketwirecanada.com/mw/release.do?id=1060116&k=BXI

[Popeye82]

An Interview with Chris Schnarr CFO &Director, Bio-Extraction Inc. - David Pescod's Stocktalk - Oct 14, 2009

"It has become one of the most talked about junior stories in the Canadian markets of late and Bio-Extraction has just recently closed a financing, so it is time to catch up with Chris Schnarr, the CFO with Bio-Extraction.

David Pescod: Chris, I have to tell you that the volume BXI trades every day – you’ve got to be one of the most talked about stories on the Canadian markets. Just how did you attract this kind of attention?

Chris Schnarr: I think Dave it has certainly been a process, rather than an event. We’ve tried to remain very focused here over the past year and half on laying out our milestones and then putting our heads down and going to meet those milestones. I think it is that track record of consistent execution on plan that attracts attention both on the retail side as well as most certainly on the institutional side. The trading volume has really been a combination of success with both of those participant groups in the market.

D.P: The intention has to be centered on this protein that you hope to produce from agricultural products. But to an average person, what is it? I mean, everyone knows what a steak or a burger is , so what is it that you’ve produced and how would we recognize it?

C.S: Probably the best layman’s comparison to the proteins that we’ll produce would be the soy protein and whey protein powders that people might be very familiar with, that they would buy as supplements from GNC stores and such, to put in shakes and things like that. We will produce a protein powder not unlike that, with the difference that our particular protein will come from the seeds of the great Canadian canola plant. It could be used in a range of applications – everything from replacement of things such as soy and milk and eggs and whey in a vast range of baking products through to energy bars, sports drinks, and infant formula.

D.P: You think that the market is there for everything that you can produce?

C.S: Certainly very much so. Today, just on the food ingredients side, this is about a $16 billion U.S. annual market on its way to $25 billion. With the amount that we’ll produce not just in Saskatoon, but in our full five plant growth model here over about the next five years, with full delivery on that business plan we’d be something in the order of 1% to 2% of the global market, so there is certainly plenty of demand out there for protein and given the very special and unique characteristics of canola protein, that demand is particularly apparent.

D.P: You have two very important dates coming up in the next three to five months, what are they related to and exactly what is GRAS?

C.S: GRAS is the first of the milestones and we are targeting that for late November or early December. GRAS is essentially a U.S. Food and Drug Administration certification. It’s independently administered in that the party who wishes to achieve GRAS goes through a process of self certification that is required in order to allow them to sell any particular product for human food uses, which is of course the case with our proteins. That is the number one milestone. The second one which is slated for mid to late February is the actual commencement of commercial production of these proteins at the Saskatoon plant. Certainly that is a very, very big one. That’s what we’ve been working towards all these years here at the Company and it’s most definitely the one we are most focused on. I believe it’s the one that our shareholders are most looking forward to as well.

D.P: Is this GRAS approval something that is hard to get or should one be worried about receiving that approval?

C.S: As with any approval process, it’s never over until it’s over. The good news in this case is that this is nothing like, for example, the FDA drug approvals that people might be more familiar with. This is, as I mentioned, a self-certification process, so we conduct a battery of tests and build a binder of data on the product and its characteristics and test results with things like toxicity and toxicology. That is reviewed by an independent panel of experts who are familiar with the FDA regulations and they issue an opinion as to whether or not you are in compliance and if the opinion is favorable, you declare yourself GRAS and you are free then to begin selling your product into the human food uses. Based on everything we’ve seen to date and the feedback that we’ve got from legal council (who is acting on our behalf in that) we do feel very comfortable today that we will receive that as expected.

D.P: Now we have to ask one tough question here. This company has so far, only a very small plant in Saskatoon that is losing money, has very little revenue and yet you have an absolutely enormous market cap of over $200 million. How do you explain that?

C.S: I think we would explain it on the basis first of all of what I referred to earlier which is the consistency of execution over a long period of time in accordance with plan, that helps to develop and establish some credibility for the Company and the management team and begins to create a presumption in the mind of the market that that execution will continue going forward. It is of course, the future and the future earnings that people are acquiring when they are buying the stock today – not the historical earnings. When we look and see the confidence that the market has that we are able to execute on that plan and as we look forward from plant one to plant two and so on and you look at some fairly conservative assumptions in terms of expectations around that, you will find that the numbers quite firmly do drive and support these kinds of values and I think with considerable upside left in those as we continue to execute.

D.P: We’ve noticed a couple of analysts just gushing over you and your five-year plan (I think it’s always nice having analysts fawning over you) but I guess we should hear the five-year dream.

C.S: The five-year dream is to build five of these processing plants at successively larger scales. Over that period of time and over those five plants, that would put about 800,000 tons of processing capacity on the ground and it is done in a very gradual and measured fashion – one where we can believe to the greatest extent possible we can self-finance that additional capex in due course as we grow. It may sound a bit lofty, but I remind you that it is across five plants over some five years and it is still smaller than for example, one Cargill or ADM plant. So in the context of the scales in which this industry operates, it is actually a fairly conservative growth target.

D.P: At that time, how much do you hope to be producing and what kind of revenue?

C.S: With the 800,000 tons and across those five plants in the ground based on current pricing and not putting anything in there for an expectation of price increases over time, that would drive a revenue number somewhere just north of $1 billion. That’s the number we have on the wall here.

D.P: Thanks Chris! Now, we always like to ask folks in an interview like this, if you could suggest one stock (other than your own or a story with no conflicts of interest) what would it be and of course Chris, you travel in charmed circles, so we expect doubles or triples.

C.S: I think that there remains a double out there over a reasonable horizon and without taking an inordinate amount of risk by buying Viterra Inc. (T-VT). They are a company that I feel very comfortable with just given the experience that we’ve had with them in getting the perspective of a customer and a partner on the company. I believe they stand to be a tremendous beneficiary of the secular bull market in agriculture that we see remaining strong for a very long time. I believe they are doing some very good things at a strategic level in terms of their plans for expansion and the additional integration of their business. I just think they are a wonderful company. Strong balance sheet, sector leader, making good moves, I think very highly of Viterra.

D.P: Thank you very much Chris! "

[Popeye82]

BioExx Granted ISO 22000, HACCP and GMP Certification; Also Receives Saskatchewan ABEX Award for Best New Product - Oct 26, 2009
www.marketwire.com/press-release/Bio-Extraction-Inc-TSX-VENT…

"TORONTO, ONTARIO, Oct 26, 2009 (MARKETWIRE via COMTEX News Network) -- Bio-Extraction Inc. (TSX VENTURE: BXI) ("BioExx" or "the Company") is pleased to announce that it has received a Certificate of Registration that certifies that the Food Safety Management System of BioExx Specialty Proteins Inc. ("BSPI") has been assessed by NSF-ISR and found to be in conformance with ISO 22000:2005 where the Scope of Registration is Canola oilseed processing. NSF-ISR is a not- for-profit, non-governmental organization that is the world leader in standards development, product certification, education, and risk-management for public health and safety. BSPI is a wholly owned subsidiary of Bio-Extraction Inc. and is the owner and operator of the Company's canola processing facility in Saskatoon.

ISO 22000:2005 requires that all hazards that may be reasonably expected to occur in the food chain, including hazards that may be associated with the type of process and facilities used, are identified and assessed. Thus it provides the means to determine and document why certain identified hazards need to be controlled by a particular organization and why others need not. ISO 22000 integrates the principles of the Hazard Analysis and Critical Control Point (HACCP) system and application steps developed by the Codex Alimentarius Commission.

To successfully complete the ISO 22000:2005 audit, an applicant must also demonstrate that it has adequately installed both HACCP and GMP procedures and is practicing both to a level that is consistent with the requirements set out under ISO 22000:2005.

HACCP is internationally recognized as the primary means for enhancing food safety throughout the food chain, and is increasingly being used around the world. HACCP, or, Hazard Analysis Critical Control Points, is a standard designed to prevent, reduce or eliminate potential biological, chemical and physical food safety hazards.

Good manufacturing practices or "GMP" is a term that is recognized worldwide for the control and management of manufacturing and quality control of foods, pharmaceutical products, and medical devices. GMPs are guidelines that outline the aspects of production that would affect the quality of a product. In Canada, GMP is controlled and monitored by Health Canada.

"We are very proud of our Saskatoon team for achieving this important certification so early in the plant life-cycle. While firmly expected, we do believe this is an important milestone as it demonstrates a readiness to manage the critical issue of food safety, and the additional controls that will be required, as we commence our specialty protein production," says BioExx CEO Chris Carl. "We also believe that this is exemplary of the very strong importance that senior management puts on quality in every aspect of our operations."


ABEX Award

BioExx is very proud to announce that it is the recipient of the 2009 Achievement for Business Excellence (ABEX) Award in the category of Technology-In-Action New Saskatchewan Product. The award, which was issued by the Saskatchewan Chamber of Commerce on Saturday, October 24th, and sponsored by the Saskatchewan Research Council, goes to a business demonstrating exceptional performance in launching a new Saskatchewan- made product, technology or service, which is original and has strong commercial potential.

Laurence Parslow, General Manager of the Saskatoon Plant and Director of Research and Development for BioExx, accepted the award. "It is a great honour to be recognized in our community among so many other excellent Saskatchewan companies," said Mr. Parslow. "We are very excited about the new canola based protein products that we are bringing to market and we look forward to continued success working with some of the best minds and research organizations in the industry here in Saskatchewan."

The award also includes a $10,000 monetary prize provided by SRC's Technology-in-Action Fund. BioExx intends to use the funds either to make a donation, or to create a program of its own, aimed at assisting others in furthering their post-secondary, science-related education in Saskatchewan.


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx's patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx's low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE: BXI), please visit www.bioexx.com "

[Popeye82]

Notice of Q3 Results Conference Call - Nov 10, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

[Popeye82]

Einreichung eines Patentantrages, welches sie nicht selber nutzen würden, sondern später eventl. mal für Lizenzerträge gut sein kann -da die konventionellen Produzenten das abfallende Mehl als Tierfutter damit um das 3 -5fache im Wert steigern können:

BioExx Submits Patent Application to Produce Protein Concentrates from Toasted Meal; Also Provides Patent Portfolio Update - Nov 11, 2009
www.bioexx.com/index.php?option=com.....tid=43:news&Itemid=8…

"TORONTO, – November 11, 2009 – Bio-Extraction Inc. (TSX-V: BXI) (“BioExx” or “the Company”) is pleased to announce that it has filed a significant new patent application allowing for the production of Protein Concentrates (up to 70% purity) from oilseed meal produced in conventional, higher-temperature, processing facilities. While this technology would not be used in the specialty low-temperature processing facilities to be constructed and operated by BioExx, this does represent an opportunity for BioExx to leverage its intellectual property through licensees to rather simply and significantly increase the value of the meal produced in existing conventional facilities. This value increase is enabled by the ability to process conventional meal, which is primarily sold as lower value animal feed, to produce Protein Concentrates which may sell for three to five times the price of meal.

The initial licensing focus of the Company will be on canola and rapeseed meal markets. With 2007/08 crop year global production of conventional canola and rapeseed meal at 27.7 million metric tonnes (source: USDA), this represents a potentially significant and complementary new source of passive licensing revenue for BioExx over the medium to long term, in addition to the revenues from its core business of owning and operating high-value protein isolate production facilities.

Due to the fundamental limitations created by high temperature canola and rapeseed processing, the Protein Concentrates produced by this new method would be suitable only for use in specialty feed markets, and not suitable for the human-food Protein Isolate markets which are the core business and key focus of BioExx. It is not possible with this technology to produce the higher-value BioExx Protein Isolates, which are a completely different product, with much higher purity, solubility, and a significantly different amino acid profile. Although this new patent-pending process was created as an offshoot of the BioExx development work in that area, when these novel methods were modified for extension to standard toasted meal as an input, a high quality Protein Concentrate was created. The product shows a strong nutritional profile, suitable for specialty feed applications, with low anti-nutritional factors and a mix of soluble and insoluble protein.

BioExx believes that the new process technology may be made available as a relatively simple retrofit onto the back end of conventional canola processing facilities, and with a capital and operating cost profile that would drive an attractive return on investment for licensees. Without compromising its efforts on the primary business of constructing and operating additional and larger facilities to produce high-value protein isolates, BioExx plans to spend the next year working confidentially with selected licensees to fully develop this unique new technology, with a targeted initial commercialization within the next 24 months. Licensing in this manner is also intended to enable deployment and revenue generation without any significant additional capital expenditure by BioExx.

“While we are very excited about this new development, we have no intention of letting it impair our very strong progress or our timetable for protein isolate production in Saskatoon. Given that our team was able to complete this project in less than six months and at minimal cost, we see it as indicative of the broad reach of potential advancements that can and will be achieved through the application of our unique and growing portfolio of intellectual property,” said BioExx CEO, Chris Carl. “Our team remains firmly committed to and highly confident in the successful commercialization of our protein isolate production in Saskatoon in mid Q1 2010, and all work in that regard is proceeding well and according to plan.”


Patent Portfolio Update

BioExx also recently filed two additional patent applications that are directly related to the specialty proteins to be produced at BioExx facilities, bringing the total number of patents issued and pending to ten.

The increasingly broad patent portfolio that BioExx has developed protects its very unique and proprietary processes and products. The scope of this portfolio now covers:

+ Protection of scalable, economic low temperature extraction methods

+ Protection of unique solvent combinations to effect such extractions

+ Protection of unique solvent separation and recovery methods

+ Protection of unique methods of producing protein concentrates, protein isolates and hydrolyzed protein extracts from oilseeds

+ Protection of the unique products resulting from the foregoing processes


The BioExx protein patent claims also cover rapeseed, mustard seed, soy, and flax and hence are not limited to canola protein.

The BioExx process that is being deployed for commercial protein isolate production does not use high temperatures or process additives that cannot be fully removed from the end products, and specifically does not use salt solutions, in any form, at any stage in the process. The processes and products that BioExx has developed have undergone extensive scientific and legal review, including substantial product testing, to confirm their unique properties and assessment of freedom to operate in the marketplace


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx’s patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’s low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution in alleviating food scarcity. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSXV: BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Announces Q3 2009 Results - Nov 16, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

[Popeye82]

A science and industry model that works - UoS - Nov 13, 2009

- By Colleen MacPherson -
www.usask.ca/communications/ocn/09-nov-13/7.php

"The people involved in the university’s Feeds Innovation Institute (FII) are feeling quite proud of the 2009 ABEX Award that was presented recently to Bio-Extraction Inc. for best new Saskatchewan product. And rightly so.

Colleen Christensen, acting executive director of the FII, said the research, development and consulting service worked directly with Bio-Extraction on its award-winning protein isolate from canola “so this is a big deal for us. We supported the development of this canola meal through testing along the way. BioExx is currently producing and marketing animal feeds, and is working to produce canola isolates for human food in the future, which is an exciting prospect for us.”



- Colleen Christensen, acting director of the Feeds Innovation Institute, with some feed samples -


It is all in a day’s work for the FII which continues the tradition of outreach to the feed industry by the College of Agriculture and Bioresources. Christensen explained the organization was established about three years ago “but is a reincarnation of what has existed since the 90s,” namely the university’s Feed Testing Lab, and later the Prairie Feed Resource Centre. The FII continues to operate “at the crops and livestock interface,” she said, but with more stakeholders, including government and industry, and with a two-part mandate.

The first is to make available to industry the university’s wealth of analytical labs, “to make good use of the university’s resources.” In those labs, the FII does fee-for-service work for companies like Bio-Extraction, short-term and very specific jobs such as chemical analysis and compilation of data needed for product registration.

The other half of the mandate, explained Christensen, is to build research networks that link to and support industry. Those networks include U of S researchers as well as outside partners who work “in the pursuit of discovery. To make a really good feed, you need nutritionists but you also need plant scientists, engineering, economics people. These networks are always set up on the premise of a multi-disciplinary mix of researchers and industry to explore the opportunities and issues of animal feeds.”

One success story is the Feed Opportunities from Biofuels Industries (FOBI) Network which connects more than 60 researchers across disciplines and institutions, including the Universities of Alberta and Calgary, with industrial partners in the bio-ethanol industry. Christensen said that in 2008, prior to the FOBI, researchers at the U of S brought in about $1 million in government funding for individual initiatives. “But bringing projects and researchers together resulted in about $6 million in awards from the federal government last year.”

For students in the college, the FII provides many unique opportunities, including contract work that can become a thesis project, for example. “And it isn’t very often students are truly talking to industry. They can see the direct link between their work and industry.”

On a larger scale, success stories like that of the FII and Bio-Extraction “mean diversification of the economy, the creation of jobs and diversifying canola into new product streams.

“There are many ways to get our science out into the real world. The FII is one of the models … and it’s working well.” "

[Popeye82]

BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates - Nov 18, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, – November 18, 2009 – Bio-Extraction Inc. (TSX-V: BXI) (“BioExx” or “the Company”) is pleased to announce that it has completed the self-affirmation process to qualify its specialty canola protein products, IsolexxTM and VitalexxTM, as self-affirmed GRAS (“Generally Regarded as Safe”) for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. GRAS is a food safety standard, set and administered in accordance with the regulations of the United States Food and Drug Administration (“FDA”) which governs the use of additives, such as the BioExx protein products, in foods and beverages.

“Under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act (the Act), any substance that is intentionally added to food is a food additive, that is subject to premarket review and approval by FDA, unless the substance is generally recognized, among qualified experts, as having been adequately shown to be safe under the conditions of its intended use, or unless the use of the substance is otherwise excluded from the definition of a food additive.”
(Source: www.fda.gov/Food/FoodIngredientsPackaging/GenerallyRecognize… )

IsolexxTM is a canola protein Isolate, for use in human food products such as bakery products (bread, rolls, cakes, cake mixtures, cookies, biscuits, crackers, pancakes, sweet pastry, snacks, doughnuts, and pasta), vegetarian food products and meat analogues, nutritional products and protein bars.

VitalexxTM is a hydrolyzed canola protein extract, for use in human food products such as nutritional beverages (protein fortified soft drinks, fruit juices, high protein drinks), and nutritional products and protein bars.

“BioExx is proud of having achieved many key milestones in the past, but few have been more important than that of achieving self-affirmed GRAS status as we have today,” said BioExx CEO Chris Carl. “Now that the entire company has been geared toward becoming the world’s first commercial producer of canola protein isolates, obtaining self-affirmed GRAS was a critical requirement to be able to sell the products in the initial target market of the United States. Achieving this milestone in the time period that we have is also a testament to the exceptional work being conducted by our Vice President, Samah Garringer, and her entire team.”

The self-affirmed GRAS status was obtained as a result of a detailed process that required a thorough review of both the manufacturing process and the resulting chemical profile of each product by independent and qualified experts in the fields of toxicology and allergenicity. The GRAS review was completed by Keller and Heckman LLP based in Washington D.C., whose comprehensive food and drug practice is one of the largest in the world, having represented companies in front of the FDA in matters such as this for more than 40 years.

The confirmation received today is specific to the Brassica juncea variety of canola, which contains several specific properties that are highly desirable to BioExx including higher than normal protein content in the seed, and a non-GM (“genetically modified”) status. The more conventional canola variety, Brassica napus, requires a separate self-affirmation which BioExx may pursue in due course but this is not expected to be required for production at either the current Saskatoon plant or the planned Minot, North Dakota plant.

With the achievement of this major milestone, BioExx now has the basis to be able to sell IsolexxTM and VitalexxTM in the United States without obtaining additional approval from, or notification to, the FDA. BioExx is comfortable that the US protein food ingredients market is sufficiently large that its protein products may be absorbed there without difficulty, especially given that the US market is reported to be approximately $4.3 billion annually, and comprises almost a quarter of the entire world market. In the immediate term, attaining self-affirmed GRAS status also has the impact of drawing the attention of a very wide customer audience for the proteins that BioExx will soon be producing.

BioExx will require similar, but separate food safety certifications and possible government approvals or notifications for the sale of its protein products in other jurisdictions, including Canada and Europe, and thus has begun the certification process in both. Keller and Heckman LLP, together with its Brussels office, will assist BioExx in these efforts.


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food market. BioExx’s patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx’s low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution to global food and protein markets. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSXV: BXI), please visit www.bioexx.com "

[Popeye82]

MD &A - Nov 16, 2009
www.sedar.com

[Popeye82]

wie ja auch schon von mir etliche Male erwähnt:

"arne : china reduce canola seed orders
The plant will pay out in 1 year. The competitors effectively control the market in that in the long and medium run the price has to be high enough that they can make a buck, otherwise they would ALL have to shut down until the prices drop. The competitors probably make profit in the 10% range, max otherwise the prairies would have been flooded with so many hexane plants that there wouldn't be any exports.

Ergo, even high raw product prices are not very significant to bxi's ability to make a huge profit, because we are effectively the low cost producer and high prices can't last.
www.stockhouse.com/bullboards/Messa.....;r=0&s=BXI&t=LIST "


"RE: arne : china reduce canola seed orders
brnt has no clue how to make money. His answer is so far off the focus it isn't funny. I can see on the shapshot page when someone posts even if they are on ignore, so I just take him off ignore when he responds to something I have written to find how much his misinformation he is posting. Both plants may be somewhat similar in operating costs, but that is of small consequence.

What is important is BXI gets several times more revenue than a hexane plant, so much they can pay out their plant every single year. A hexane plant might pay out every 6 or 7 years. That is why bxi can never be squeezed out by competitors or input costs.
www.stockhouse.com/bullboards/Messa.....;r=0&s=BXI&t=LIST "

[Popeye82]

BioExx Minot Facility Passes Key Environmental Assessment; Isolate Construction Proceeding Well in Saskatoon - Dec 08, 2009
www.marketwire.com/press-release/Bio-Extraction-Inc-TSX-VENT…

"TORONTO, ONTARIO--(Marketwire - Dec. 8, 2009) - Bio-Extraction Inc. (TSX VENTURE:BXI) ("BioExx" or "the Company") is pleased to announce that it has received formal notice from the North Dakota Department of Health, Air Quality Division (the "NDAQD"), that it has completed its environmental review of the proposed BioExx canola processing facility to be located in Minot, North Dakota. Based on the design parameters of the facility, which includes the full capacity required to produce Protein Isolates, and the resulting effluents expected, NDAQD has determined that "the facility will not be classified as a major source under any applicable air pollution rules or regulations." Accordingly, BioExx may now proceed with applications for the standard, and ordinary course construction and operating permits.

BioExx was seeking this confirmation prior to advancing many of the engineering based development initiatives and with this confirmation in hand, will now start to increase its activities rather significantly. These activities will be primarily undertaken by personnel not directly involved in the completion of the Saskatoon facility so that no devaluation of effort occurs on that project. This will also trigger the advancement of several commercial development initiatives to support the project and to prepare it for financing and physical commencement in the second quarter of 2010 as previously disclosed.

"Successfully getting through the critical Environmental Assessment process is an important milestone to achieve for every new project that BioExx undertakes and signals that we are now entering the final development stages of the project. BioExx is very excited about moving the Minot project forward and to commencing construction as soon as possible, once the Saskatoon facility is fully operational," said BioExx CEO, Chris Carl.


Other News

BioExx is pleased to report that construction activities for the expansion of the Saskatoon facility to produce Protein Isolates are progressing well. At present, the company has been advised by its various suppliers that all equipment that has been ordered is on schedule and provided that this situation continues, the project is expected to remain on schedule, with an important interim milestone being the commencement of commissioning of equipment in late January 2010.


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx's patented technology allows for the use of significantly lower temperatures than conventional methods in extracting the active ingredients and oils from oilseeds, resulting in higher yields and higher-quality meal, oils and proteins. BioExx's low energy requirements, environmentally sound process, and high-yield production have the potential to make a valuable contribution to global food and protein supply. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX VENTURE:BXI), please visit www.bioexx.com "

[Popeye82]

Commodities: Advancing Canola Protein Biz - BNN - 12-08-09

- Bio-Extraction is making in roads in its efforts to advance the canola protein business. BNN talks to Christopher Carl, president, Bio-Extraction about its new self affirmed "Generally Regarded As Safe" designation. -
http://watch.bnn.ca/#clip243858

[Popeye82]

BioExx Announces Change of Name to BioExx Specialty Proteins Ltd. - Dec 30, 2009
www.bioexx.com/index.php?option=com_content&view=article&id=…

[Popeye82]

voraussichtlich anstehendes Listening an der TSX, die Anlage in Saskatoon übertrifft die Erwartungen &der Aufbau für die 1ste Hälfte der Isolategewinnung scheint gut zu laufen. Trotzdem wird sich, durch längere Lieferzeiten des benötigten Equipments, der Start der ganzen Proteinproduktion voraussichtlich von Ende Februar auf Ende März/Anfang April verschieben. Ziel der 1sten Isolate Auslieferungen für April geplant. Man arbeitet mit den Abnehmern zusammen &die scheinen zufrieden zu sein, desweiteren werden 2.45Mio Options für die Officers &Directors ausgegeben. Alles in allem m.E.n. nach Spitzen Update, man scheint auf dem Weg zu sein:

BioExx Receives Conditional TSX Listing Approval; Crush Plant Exceeding Expectations-Protein Plant Commissioning Soon Granting of Stock Options - MW, TORONTO - Jan 11, 2010
www.marketwire.com/press-release/Bioexx-Specialty-Proteins-L…

"TORONTO, ONTARIO--(Marketwire - Jan. 11, 2010) - BioExx Specialty Proteins Ltd. (TSX VENTURE:BXI) ("BioExx" or "the Company") is pleased to announce that it has received conditional approval to list its common shares on the Toronto Stock Exchange (the "TSX"). Final approval of the listing is subject to BioExx providing certain customary documentation as requested by the TSX, anticipated to be completed within a few weeks. Upon the change in listing to the TSX, the common shares of the Company will continue to trade under its present symbol "BXI".

BioExx is also pleased to report that its seed crushing facility in Saskatoon has reached performance parameters that now exceed original estimates. The plant is able to produce at higher daily seed tonnage and higher oil yield than anticipated in its original crush plant operating forecasts, while producing oil of a quality which exceeds all required specifications. Seed throughput is approximately 85 Mt per day, well ahead of the crush-only operation target of 70 Mt per day, and oil yields are at or above 85%, ahead of the crush operation target of 80%. The operating team continues to seek further improvements despite having already surpassed its original targets.

In addition, installation work for the first 50% of capacity for the Extraction and Isolate plant, internally referenced as Phase 2, is proceeding well. While commissioning (installing and bringing power to individual pieces of equipment) is expected to commence in January as planned, the start-up of the entire protein production line is projected to move from late-February to late-March or early April based on current schedule estimates. This small shift is primarily due to longer delivery times than anticipated for a few equipment items and for the hook-up of incremental gas and electrical services. Every step is being taken to mitigate these issues, and to bring the actual start-up forward to the earliest possible date. Notwithstanding any such start-up timeline revisions, the Company is still working aggressively towards its target of commercial protein isolate shipments in April.

"While we are not pleased with any delay in full plant start-up, especially given the monumental effort put forth by our BioExx team and its associates surrounding the project, we do not expect these date changes to have any meaningful impact on the various milestones we have set in place for the year. This is a first-of-its-kind facility and on balance it is proceeding extremely well. We have a very high degree of confidence and excitement regarding our protein process and our products as we get closer to start-up." said BioExx CEO Chris Carl. "With respect to the crush plant, we are especially pleased with the results that have been achieved, as we have now demonstrated an ability to operate at levels beyond what most believed the capability of the equipment to be. This is an important achievement on two fronts. First, it demonstrates the excellence of our plant operations team in its ability to run the plant better than expectations on each key metric, and second, it demonstrates the plant is ready to meet all of the performance requirements and quality specifications needed for the pending start-up of protein production."

Finally, BioExx continues to produce high quality isolates through internal and external pilot facilities (with the most recent production exceeding specifications at over 93% purity) so that market engagement with end customers can continue. This also allows the operating team to continue to gain additional experience with key process parameters in order to facilitate faster and optimized ramp-up of the full scale plant when it comes on line. Market feedback to date confirms the Company's expectation that its proteins are best oriented towards higher value applications, such as health and nutrition products.

The Board of Directors of the Company has also approved the issuance of stock options for the year 2010, inclusive of 2,450,000 options to Officers and Directors. These options are exercisable at $2.05 per share and will expire on January 11, 2015. After this issuance, and consistent with Company policy, the total issued and outstanding stock option amount remains at less than 80% of the amount which has been approved by the Company's shareholders. All options vest over 24 months, excepting that, and as was the case with the 2009 stock option issuance, those options issued to Officers will not begin vesting until after protein isolates have commenced shipping from the Saskatoon plant.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX VENTURE:BXI), please visit www.bioexx.com "

[Popeye82]

genau so ist es:

"Justout - eunice12 - Jan 15, 2010
It doesn't matter how many patents (since they all involve saline) bu has, bxi just needs enough patents to cover their non-saline process. BU's patents are irrelevant to bxi. BU did not invent canola, just a process to capture it.


BXI's plant will payout in 1 year. The calculations I have gone with are from one of the analyst reports, using their conservative pricing and production volumes. That is all you need to know about the economics, if you believe they can produce the products.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27831… "

[Popeye82]

Antwort auf Beitrag Nr.: 38.750.025 von Popeye82 am 16.01.10 10:33:59

"RE: RE: RE: TSX transition - eunice12 - Jan 16, 2010
Yes, I am sure they can payout in 1 year, or they could have using conservative long term average commodity pricing last April when I started following them. Consider that a hexane plant makes lots of money selling valuable oil but the meal only goes for $.25 per lb, then add in concentrates and isolates at $1 and $7.50 per pound and you can see we will make multiples of a hexane plant. Very few businesses are in that kind of advantageous space, kind of like a mine that can produce gold at $50 per ounce, which is why the stock traded at $1.50 until the last news about the backend hexane plant added another $.50.

They are in the commodity business though, so expect pricing to go up and down regularly. Irregardless, no one can muscle them off the puck by forcing prices down, so they will always make a profit. The calculations work out to $600M pretax cf in the 5th year with the 5th plant, so at that rate they could easily debt finance a doubling of production the next year.

They could finance even more expansion if they want to load up even more on more debt, since oil companies (which I am more familiar with) can have debt greater than 1 year's cf, and bxi's plants do not run out of product unlike an oil company who constantly has to replace reserves.
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=27831… "

[Popeye82]

BioExx Receives Final Approval to Commence Trading on TSX - Jan 20, 2010
www.marketwire.com/press-release/BioExx-Receives-Final-Appro…

[Popeye82]

Standard & Poor's Announces Changes in the S&P/TSX Venture Composite Index - Jan 21, 2010
http://finance.alphatrade.com/story/2010-01-21/CNW/201001211…

[Popeye82]

BioExx Named to 2010 TSX Venture 50; Ranked #1 in Clean Technology Sector - Feb 5, 2010
www.marketwatch.com/story/bioexx-named-to-2010-tsx-venture-5…

"TORONTO, ONTARIO, Feb 05, 2010 (MARKETWIRE via COMTEX) -- BioExx Specialty Proteins Ltd. /quotes/comstock/11t!bxi (CA:BXI 1.99, +0.06, +3.11%) ("BioExx" or "the Company") is pleased to announce that the TSX Venture Exchange has today announced that BioExx has been named as one of the TSX Venture 50 for 2010. The TSX Venture 50 is a composition of some of the strongest performers listed on TSX Venture Exchange, and is comprised of 10 emerging companies in five industry sectors that have been identified as leaders in Canada's public venture market.

The 2010 TSX Venture 50 are selected based on four equally weighted criteria that include return on investment, trading, analyst coverage and market capitalization growth, in the Clean Technology, Diversified Industries, Mining, Oil & Gas, and Technology and Life Sciences sectors.

"We are honoured to be named as part of this year's TSX Venture 50," said BioExx CEO, Chris Carl. "We believe that being selected as a part of this high-achieving group of companies is a reflection of the very hard work put forth by the entire BioExx team to bring to full commercialization our Specialty Protein technology. We are especially proud of our leadership ranking in the Clean Technology sector as we have consistently strived to achieve a unique combination of best-of-breed economics and sustainability. The access to capital provided by our listing on TSX Venture Exchange has allowed us to achieve the results we have to date, including our recent graduation to the Toronto Stock Exchange."

"We are pleased to celebrate the 2010 TSX Venture 50," said John McCoach, President, TSX Venture Exchange. "These outstanding companies are proven leaders in their respective sectors and we are proud to have them listed on TSX Venture Exchange. We wish them all continued success."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. /quotes/comstock/11t!bxi (CA:BXI 1.99, +0.06, +3.11%) , please visit www.bioexx.com "

[Popeye82]

abgesehen von der kleinen Verzögerung, durch die Anlieferung des Equipments, scheint man vollauf im Plan +sogar dadrüber zu liegen, die nächsten Monate werden spannend:

BioExx Reconfirms Start-Up Targets; Pilot Plant Isolate Quality Exceeding Expectations - Feb 16, 2010
www.marketwire.com/press-release/BioExx-Reconfirms-Start-Up-…

"TORONTO, ONTARIO--(Marketwire - Feb. 16, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx" or "the Company") is pleased to confirm that it continues to make strong progress toward the completion of construction of the protein isolate addition to its 40,000 MT per year canola processing facility operating in Saskatoon, Saskatchewan. All critical equipment will have been substantially installed by early March, leaving electrical and piping hook-ups and the remaining commissioning to be completed through mid-April. Equipment items will begin to be made operational in mid-March. At the peak, there will be nearly 100 installation contractors working on site and at the nearby piping fabrication shop.

BioExx is also pleased to announce that it has made further progress in optimizing the extraction and purity of its canola protein products as a result of its ongoing pilot programs. The most recent results show marked increases above previously announced specifications in both the nutritional quality and purity of the high-solubility high-functionality canola protein isolate ISOLEXX™, and the hydrolyzed canola protein extract, VITALEXX™. These results now show ISOLEXX™ to have a protein nutritional quality superior to soy, and most notably also to high-end whey and casein equivalents, based on amino acid scores calculated in accordance with the United Nations Food and Agriculture Organization (FAO) standard, with improved lysine levels and continuing superior levels of sulphur amino acids. VITALEXX™ has now been demonstrated to have both higher protein purity levels and higher amino acid scores that are nutritionally superior to competing soy, whey, and casein hydrolysates.

The Company also continues to work closely with its major protein partner, Helm AG, and in turn, with potential end-user customers who span a range from smaller niche producers to major multinational food and beverage companies. Feedback and interest to date continues to be very strong, and re-confirms the Company's expectations with respect to strong market demand and premium product positioning.

"We remain very excited about the results being achieved by all of the development and operating teams at BioExx, including the contractors involved in the final stages of this project," says BioExx CEO, Chris Carl. "There are some difficult days to be sure, when the multitude of interconnecting activities do not mesh exactly as planned, but any resulting delays are now generally expected to be measured in hours and days, rather than weeks and months. Overall, we are very proud of the strong progress being made. Coupled with the tremendous pilot results and the incremental operating knowledge that we are gaining through our pilot programs, and while we understand the only guarantee will be evidenced from actual commercial production, our confidence is very high."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[Popeye82]

BioExx Announces $15 Million bought deal financing - Mar 15, 2010
www.newswire.ca/en/releases/archive/March2010/15/c9962.html

"TORONTO, March 15 /CNW/ - BioExx Specialty Proteins Ltd. (TSX: BXI) ("BioExx" or the "Company") announced today that it has entered into an agreement to sell to a syndicate of underwriters led by Canaccord Financial Ltd., on a bought deal basis, 8,150,000 common shares ("Offered Shares") at a price of $1.85 per Offered Share for gross proceeds to BioExx of approximately $15.0 million (the "Offering"). BioExx has also granted the underwriters an over-allotment option to purchase up to an additional 1,222,500 common shares on the same terms and conditions, exercisable at any time, in whole or in part, up to 48 hours prior to the closing of the Offering, for additional gross proceeds of up to approximately $2.3 million.

The net proceeds of the Offering are intended to be used as may be required to continue funding the engineering, development, and construction work for the Company's second plant in Minot, North Dakota, to fund the further development of its proprietary and patent-pending "toasted meal" protein technology, and for general corporate purposes including capital expenditures and working capital associated with its Saskatoon facility.

"We believe the Offering will provide us with greater financial strength and flexibility through protein start-up in Saskatoon, together with an extended ramp-up window during which to demonstrate consistent volume growth, product quality, and customer acceptance. At the same time, we can also continue on plan with the development of our North Dakota facility and other business initiatives," said Chris Schnarr, CFO of BioExx.

The Offering is expected to close on or about March 30, 2010 and is subject to regulatory approval. The Offered Shares will be issued under a short form prospectus and as such will be freely tradable. The Offered Shares will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

The Company also confirms that it continues to make strong progress on completing construction of its Phase 2 Protein Isolate facility in Saskatoon. Equipment installation efforts and associated resource allocations are generally proceeding on schedule, with April milestones remaining as the short-term focus.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com. "

[Popeye82]

"Grow Canola 2.015" to Revolutionize Communication in Agriculture; Agronomic Updates by Web 2.0-Based System to Boost Canadian Canola Production - NW, SAN FRANCISCO - Mar 18, 2010
www.newswire.ca/en/releases/archive/March2010/18/c3072.html

"SAN FRANCISCO, March 18 /CNW/ - The Canola Council of Canada (CCC) announced today a new "Grow Canola 2.015" plan that will enable farmers to interact with virtual agronomists for immediate, customized information. This innovative communication system will help farmers reach the canola industry's production goal of 15 million tonnes by 2015. And according to a 2010 grower survey, when the CCC builds it, they will come: 91 percent of farmers with Internet access polled said they will probably or definitely use the "Grow Canola 2.015" system.

"Using e-mail, smartphone and social media platforms to provide canola growers with real-time agronomic updates will revolutionize agriculture," said Denise Maurice, CCC vice president of crop production at the CCC's 43rd annual convention in San Francisco. "'Grow Canola 2.015' will be the first communication system of its kind for farmers, serving as a model for other agricultural sectors."


The survey, which included 1,345 preliminary telephone screenings followed by 359 in-depth phone and 812 online interviews with Canadian canola growers, found that:

+ Growers with Internet access make up about 75 percent of the market and 95 percent of them find the Internet valuable to their farming operation. High-speed Internet access dominates the rural market at 87 percent.

+ Smartphone usage is expected to grow from less than 20 percent to 30 percent in the next year, representing more than 5 million acres of production.

+ Conducting research on the Internet is the number one activity growers intend to do more of in the next year. Farmers now prefer to receive agronomic information via e-mail, keeping pace with what technology can deliver any time of day.

+ Online diagnostic tools, access to agronomic researchers through webinars and receiving pest alerts are all communication methods that growers are interested in exploring.


Farmers say they are particularly keen to use a Web-based diagnostic tool to send text and/or photos to an expert for immediate assistance and to be able to localize agronomic information, such as variety performance, disease control, insect forecasts and weed control via a Web application.

"The 'Grow Canola 2.015' system will save me time researching and addressing agronomic issues and we all know that time is money, especially when combating pest and disease problems," said Greg Porozni, canola grower and director of the Alberta Canola Producers Commission.

Nearly $2.5 million in funding from the Canadian government and canola industry will allow for implementation of "Grow Canola 2.015" over four years, starting now until March 31, 2013. In addition, the CCC will provide in-kind support in agronomic advice and administration of the program.

"The CCC is most grateful to the government and industry for seeing the value in this fascinating project," Maurice concluded. "We aim to arm canola growers with Internet technology to help them produce the highest yielding and best quality crops possible."

For further information: Robert Hunter, Tel: [phone], [e-mail] "

[Popeye82]

ab 8:55:

Market Call : March 18, 2010 : [03-18-10 1:00 PM]; BNN speaks to Bob McWhirter, president, Selective Asset Management. FOCUS: Canadian technology stocks - BNN - Mar 18, 2010
http://watch.bnn.ca/market-call/march-2010/market-call-march…

[Popeye82]

Notice of 2009 Annual Results Conference Call - Mar 24, 2010
www.marketwire.com/press-release/Notice-of-2009-Annual-Resul…

[Popeye82]

da hat nochmal jemand den Link zur genauen Verfahrensweise eingestellt:

A reason to wait - Patent Details (reminder) - mike4541 - Mar 29, 2010
www.stockhouse.com/bullboards/MessageDetail.aspx?p=0&m=28078…
www.patentstorm.us/patents/7156981/fulltext.html

"While we all patiently wait for the actual Confirmation of Protein Ioslate production of Vitalexx and Isolexx in April (small quantities to start with and then much more in May and June) it is well too review the complex extraction process that requires precision Engineering anf Mechanical capability by examining the actual continuous flow process as listed in the Patent application
Go to this site :

www.patentstorm.us/patents/7156981/fulltext.html


It makes you appreciate the lenghty time required to "get it done right" !

A world's first commertcial production and with Clean Technology at that.

Regards to all :

MIKE "

[Popeye82]

BioExx Closes $17.3 Million Bought Deal Financing - Mar 30, 2010
www.marketwire.com/press-release/BioExx-Closes-173-Million-B…

[Popeye82]

BioExx Announces 2009 Annual Results; Conference Call: Wednesday, March 31, 10:00 a.m. ET; Dial-in Numbers: 416-340-8061 / 866-225-0198 - Mar 30, 2010

Summary of Q4 Events

+ Receipt of ISO 22000, HACCP and GMP Certification

+ Completion of US FDA GRAS Self-affirmation

+ Filing of Toasted Meal patent application

+ Receipt of environmental clearances for North Dakota plant

+ Strong plant operations performance in Saskatoon, accelerating through year-end to current

+ Continued weakness in canola crush margins but relative strength in protein markets

+ Further protein product quality validation from pilot programs

+ Solid progress in Saskatoon engineering, procurement, and construction towards protein production

...


"We are very pleased with all of the operating metrics that have now been achieved in our crush plant as we prepare for our more lucrative protein operations including recently running the plant on a full day basis at an equivalent of 40,000 MT annual capacity at much higher oil yields than even the equipment suppliers thought possible, as well as operating at full capacity for our lower yield, high protein quality in preparation for protein operations," said Chris Carl, BioExx CEO. "The management of schedules and expectations is challenging, particularly in a very sophisticated first-of-its-kind project of this nature, with potentially disruptive global market impact. Nevertheless, on current schedules, this would bring us to market with commercial products approximately one year from pilot production, less than one year from the Company's decision to accelerate its move into these markets, and less than two years from the original laboratory discovery work and patent filing. We believe this is a tremendous achievement and one in which we take great pride." ...
www.marketwire.com/press-release/BioExx-Announces-2009-Annua…

[Popeye82]

Antwort auf Beitrag Nr.: 39.250.288 von Popeye82 am 30.03.10 23:00:02

BioExx Announces 2009 Results - Webcast Link - Mar 30, 2010
www.gowebcasting.com/events/bioexx-specialty-protein-ltd/201…

[ValueFreak]

Hallo Popeye,

Du bist ja hier weitgehend Alleinunterhalter.

Interessanter Wert, passt natürlich auch gut zu dem Biofuels Thema (maximale Verwertung vom Raps) - habe mal die Februar Präsentation und die Ergebnisberichte quer gelesen:

http://www.bioexx.com/images/stories/pdfs/Financials/mda%20-…

http://www.bioexx.com/images/stories/pdfs/ir/bxi%20presentat…

Allerdings glaube ich nicht, daß der Laden vor 2012 in die Gewinnzone kommt und dazu werden zusätzliche Finanzmittel für das 2te Werk nötig sein (habe mal die 150 USD zusätzlichen Erlös für die high-end Proteine, die im letzten Abschnitt auf Seite 6 genannt werden, sowie die über 3 Quartale berichteten Mengen berücksichtigt).

Bis die ersten Lizensierungserlöse fliessen werden, schätze ich mal, daß mindestens 5 Jahre vergehen.

[Popeye82]

Antwort auf Beitrag Nr.: 39.274.182 von ValueFreak am 05.04.10 11:42:31

Hallo ValueFreak,

Bin gerade überrascht einen Beitrag abgesehen von eigenen zu sehen.


Mit der Gewinnzone ist nicht ganz so einfach zu sagen -sollte aber wahrs. weit vor 2012, noch dieses Jahr, erreicht werden. Was prinzipiell das relevanteste ist, ist das hier, "if the process works", ein (gewaltiges)"3dimensionales-Wertschöpfungsmodel" geschaffen wird//werden würde(deutlich höhere Umsätze, Gewinne, dazu noch die horizontale(geographische) Expansion, dazu gäbe es noch einige "Downstream Optionen". Weitere Finanzierungen werden noch nötig sein(Plan sind ja schlussendlich mind. 5Anlagen), mit so einem Payback besagter Anlagen werden sich hier aber höchstwahrs. noch einige andere Optionen, zur Finanzierung, auftun. Daher, Summa Summarum, meine größte Position.

Gruß
Popeye

[Popeye82]

CC Update:
www.file-upload.net/download-2410147/BioExx-Specialty-Protei…

[ValueFreak]

Antwort auf Beitrag Nr.: 39.275.353 von Popeye82 am 05.04.10 17:50:39

Im Gegensatz zu Cannacord glaube ich, daß mehr Geduld angesagt ist. Ich weiß nicht, woher die den hohen Umsatz bereits in 2010 herleiten. Schließlich arbeitet das erste Werk doch schon 3 Quartale und Cannacord projiziert einen Quantensprung im Umsatz schon dieses Jahr mit diesem einen Werk. Soviel können die high-end Proteine doch nicht ausmachen.

[Popeye82]

Antwort auf Beitrag Nr.: 39.276.039 von ValueFreak am 05.04.10 20:13:27

"Soviel können die high-end Proteine doch nicht ausmachen. ..."


Warum mehr Geduld? Natürlich. Die "high-end Proteine" sind ja gerade (zu einem großen Teil)"DIE Story".

[ValueFreak]

Antwort auf Beitrag Nr.: 39.276.167 von Popeye82 am 05.04.10 20:43:03

Sorry, als alter Fertigungsmann versuche ich auch immer das Kapazitätsmodell zu verstehen. In der von mir zitierten Präsentation wird auf Seite 18 der Acrobat Anzeige ein 40.000 tpa (metrische Tonnen pro Jahr) Werk modelliert. Bei Vollauslastung (!) generiert dieses Werk einen Umsatz von ca. 56 Mill. CAD.

Auf Anhieb habe ich nicht die offizielle Nennkapazität von Plant 1 gefunden. Nach dem ebenfalls von mir zitierten Bericht (Seite 12) müßte das Werk um die 4.000 Tonnen Raps pro Monat verarbeiten können, dies wären 16.000 tpa.

Das heißt, wenn ich das Modell nehme, komme ich umgerechnet auf die niedrigere Nennkapazität auf einen Jahresumsatz von 22,4 Mill. CAD für 2010. Jetzt gibt es aber zumindest im ersten Quartal noch keine Erlöse aus den hochwertigen Proteinen.

Auf Seite 19 der Präsentation sieht man auch, daß sich stufenweise die Größe der geplanten Werke erhöht. Ein größeres Werk bedeutet natürlich auch, daß höhere Anlaufkosten entstehen. Es wird versprochen, diese 5 Werke innerhalb von 5 Jahren zu realisieren. Nach diesen 5 Jahren wäre ein Jahresumsatz von 280 Mill. CAD möglich. Die zugehörigen Preisannnahmen stehen auf den Seiten 5 und 6 der Präsentation (die tatsächlich erzielten Ölpreise lagen ca. 20% niedriger als hier angesetzt). Leider habe ich noch nicht gefunden, welche Menge der hochwertigen Proteine aus einer Tonne Raps extrahiert werden kann. Der einzige Hinweis auf einen Mehrerlös steht auf Seite 6 des Berichtes - 150 CAD je verarbeitete Tonne Raps.

Hast Du eine Info, was das Werk 1 gekostet hat (Investition)?

[ValueFreak]

Antwort auf Beitrag Nr.: 39.276.421 von ValueFreak am 05.04.10 21:40:28

Im Absatz 2 muß es natürlich 4.000 Tonnen pro Quartal heissen.

[Popeye82]

Antwort auf Beitrag Nr.: 39.276.421 von ValueFreak am 05.04.10 21:40:28

"Sorry, als alter Fertigungsmann versuche ich auch immer das Kapazitätsmodell zu verstehen. ..."


Ist doch sehr gut. Bin begeistert, endlich mal Fragen. Für 1, 2 Sachen muss ich mal noch suchen, könnte daher einen Augenblick dauern.

[ValueFreak]

Antwort auf Beitrag Nr.: 39.276.674 von Popeye82 am 05.04.10 22:39:29

Hier habe ich schon mal eine Seite gefunden, wo der historische Verlauf der Preise für Saaten, Öl und Rapskuchen in Kanada dargestellt ist. Man sollte immer den Markt einer Firma im Auge haben.

http://www.canolacouncil.org/canolaprices.aspx

Auf der folgenden Seite gibt es auch Links zu Veredelungsthemen:

http://www.canolacouncil.org/canola_meal_research.aspx

[ValueFreak]

Antwort auf Beitrag Nr.: 39.276.716 von ValueFreak am 05.04.10 22:57:21

Hier ist auch eine Graphik zum Preisverlauf von Rapsöl - allerdings würde uns eigentlich der Preis für die Wertschöpfung interessieren. Denn bei hohen Rapsölpreisen nehme ich an, daß auch die Saaten teuer sind.

http://www.indexmundi.com/commodities/?commodity=rapeseed-oi…

Das Geschäftsmodell von Bio-Extraction müßte eventuell sogar am besten mit niedrigen Raps und Rapsölpreisen funktionieren, auch wenn dann die Umsätze niedriger ausfallen, denn die Materialkosten sinken entsprechend. Alles hängt davon ab, wie Mengen und Preise der hochwertigen Proteine sind.

[Popeye82]

ab ~7:00 nochmal, nichts aufregendes neues:

Market Call; BNN speaks to Lesley Marks, vice-president and portfolio manager, Jones Heward Investment Counsel. FOCUS: Canadian small caps - BNN - Apr 7, 2010
http://watch.bnn.ca/market-call/april-2010/market-call-april…


@ValueFreak,

Dauert noch ´ne Sekunde, habe leider noch nicht alles dazu gefunden.

Gruß
Popeye

[Popeye82]

"TSX Venture 50 Presentation", ab ~8:45:
http://w.on24.com/r.htm?e=203242&s=1&k=15E6312BC1C4DF6B2E56B…

[Popeye82]

"Patience - buygasstocksnow - Apr 9, 2010

Good Evening...
I generally don't post very much on here but I have been a shareholder for almost two years and I think it is worth making a few points...
I think a lot of retail investors are far too concerned about the timing of the start-up of Phase 2. I am more interested in them getting the process correct than getting it started quickly. In conversations with the company, this seems to be their focus as well. If they rush the installation and have some problems with the start-up, we will all be worse off. I give management full marks for getting us this close this quickly. Let's not lose sight of this fact. If we have to wait another month or more for the plant to start, they still have my full support. This company is bringing a complex new technology that is highly disruptive to the industry to commercial production. Some of you are asking for a specific date for it to start and I just don't see that as realistic. I think the one mistake the company made was giving reasonably specific dates for start up. I was very happy with the recent equity raise as this will give them plenty of cash to see Saskatoon through to completion. Yes.. they will need to raise a significant amount of equity for Minot once they prove Sask works. However, when they can generate ROE's of greater than 30% on this money, it is not dilutive in the long run.
Another point of interest is the milestones that some of the large institutional shareholders are looking for. A friend of mine knows one of the largest BXI shareholders through business and the milestone he is looking for is the first Commercial sale of Isolates. He is far less concerned with the timing of the start-up as he is convinced they can do it after seeing the plant. What's most important to him is proof that their will be demand for the proteins and a selling price at least similar to Soy to start will be achieved. If they hit that milestone, then the stock should perform extremely well. Imagine then what this technology will be worth to one of the big company's that have the capital to develop this product quickly.
I really don't want to jump into the Buy and Hold Versus Trading debate but we should really just drop it. The Buy and Hold Crowd have made money, the trading crowd has made money...what's the problem. I suspect both camps will continue to do well here.

Good Luck
GF
www.stockhouse.com/Bullboards/MessageDetail.aspx?p=0&m=28121… "

[ValueFreak]

Antwort auf Beitrag Nr.: 39.310.576 von Popeye82 am 11.04.10 16:43:24

Der Artikel von GF gefällt mir - er trifft den Nagel auf den Kopf.

[Popeye82]

es gibt nochmal weitere Verzögerungen von 6 -8Wochen bei der Inbetriebnahme der Isolate Produktion, da einige Teile wesenlich länger als gedacht für die Auslieferung benötigen. An der "toasted meal" Front scheint es dafür ganz gut auszusehen:

Protein Production Schedule Update - Apr 21, 2010
www.marketwire.com/press-release/Protein-Production-Schedule…

"TORONTO, ONTARIO--(Marketwire - April 21, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx" or the "Company") announced today that while it continues to make steady progress on the completion and commissioning of its canola protein isolate production facility in Saskatoon, Saskatchewan, two issues have recently been confirmed that are causing a deferment to the current schedule, including later delivery and installation times on the final sections of structural support steel for piping and electrical infrastructure, and later delivery times on some of the 1,800 valves and instruments being installed.

There are several valves and some electronic instruments that are experiencing much longer delivery times than expected, including some ordered several months ago and others ordered more recently. Similar issues have arisen with structural steel work not being completed as quickly as anticipated, thus delaying installation of certain cable trays which in turn support final wiring. These delayed deliveries are resulting in later completion dates for each process area, which results in later commissioning and postpones the overall start date by as much as 6 to 8 weeks versus previous contractor estimates, to late June or early July.

"Encountering a delay of this nature, especially when it looked like we had an earlier completion date in our grasp, is frustrating to all involved," said Chris Carl, BioExx CEO. "Despite these on-going challenges with the calendar, we remain pleased with the quality of work being completed by our engineering team and our installation contractors. We continue to believe that a moderately shifting date, while clearly disappointing in the short run, has no bearing on the tremendous opportunity for success that BioExx has as we bring our specialized and highly anticipated products to market."

Regarding other value drivers, BioExx continues to enjoy ever greater integration into its marketplace with important customer meetings and discussions ongoing, and reconfirmation from its international protein distribution partner, during their recent visit, of the great anticipation, and patience, of the end customer base that has been developed.

Another value driver is the continued development of the Company's second protein production technology. BioExx has recently completed its largest toasted meal pilot run to date, with very strong results, thus opening the door to further development and eventual commercial deployment of this promising technology.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[Popeye82]

Bei der Installation der Saskatoon Anlage(Isolate) stellen sich einige Verzögerungen ein(war IMO eigentlich davor schon weitgehend klar). Dürfte wahrs. zu einem guten Teil für den Druck auf die Aktie verantwortlich sein. Führt zu Verzögerungen im Bereich von 6 -8Wochen, erwarteter Start nun Ende Juni/Anfang August. Abseits davon scheint es an einigen "Subfronten" ganz gut zu laufen -Gespräche mit weiteren interessierten, potenziellen Abnehmern, einem der "Joker", dem "Toasted Meal" etc.:

Protein Production Schedule Update - Apr 21, 2010
roteins-production-schedule-update&catid=43:news&Itemid=83" target="_blank" rel="nofollow ugc noopener">www.bioexx.com/index.php?option=com_content&view=article&id=210roteins-production-schedule-update&catid=43:news&Itemid=83

"BioExx Specialty Proteins Ltd. (TSX: BXI) ("BioExx" or the “Company”) announced today that while it continues to make steady progress on the completion and commissioning of its canola protein isolate production facility in Saskatoon, Saskatchewan, two issues have recently been confirmed that are causing a deferment to the current schedule, including later delivery and installation times on the final sections of structural support steel for piping and electrical infrastructure, and later delivery times on some of the 1,800 valves and instruments being installed.

There are several valves and some electronic instruments that are experiencing much longer delivery times than expected, including some ordered several months ago and others ordered more recently. Similar issues have arisen with structural steel work not being completed as quickly as anticipated, thus delaying installation of certain cable trays which in turn support final wiring. These delayed deliveries are resulting in later completion dates for each process area, which results in later commissioning and postpones the overall start date by as much as 6 to 8 weeks versus previous contractor estimates, to late June or early July.

“Encountering a delay of this nature, especially when it looked like we had an earlier completion date in our grasp, is frustrating to all involved,” said Chris Carl, BioExx CEO. “Despite these on-going challenges with the calendar, we remain pleased with the quality of work being completed by our engineering team and our installation contractors. We continue to believe that a moderately shifting date, while clearly disappointing in the short run, has no bearing on the tremendous opportunity for success that BioExx has as we bring our specialized and highly anticipated products to market.”

Regarding other value drivers, BioExx continues to enjoy ever greater integration into its marketplace with important customer meetings and discussions ongoing, and reconfirmation from its international protein distribution partner, during their recent visit, of the great anticipation, and patience, of the end customer base that has been developed.

Another value driver is the continued development of the Company’s second protein production technology. BioExx has recently completed its largest toasted meal pilot run to date, with very strong results, thus opening the door to further development and eventual commercial deployment of this promising technology.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

2tes CC:

1st Quarter Financial Results - Ended March 31, 2010 - May 13, 2010

"TORONTO, ONTARIO – May 13, 2010 – BioExx Specialty Proteins Ltd. (TSX: BXI) announced today its financial results for the quarter ended March 31, 2010. Complete financial statements and Management’s Discussion and Analysis have been filed for public review at www.sedar.com.


Summary of Q1 Events

+ Continued progress toward isolate plant completion in Saskatoon

+ Further positive results in protein production pilot runs

+ Expanding success in pre-market customer engagements for protein products

+ Successful plant operations, including strong results from capacity test programs

+ Continued weakness in canola crush margins but relative strength in protein markets


“Due to the recent deferment in planned start date of the Saskatoon protein plant expansion, the project is now being tracked in a substantially more quantified manner on a daily basis. That tracking suggests that all expected timelines are being met up to the current date and all remaining third party deliverables have been indicated in timeframes that will allow the project to be completed as recently announced. Despite the improved tracking, the Company acknowledges that no schedule guarantee can be made prior to actual start-up. Ongoing pilot production continues to result in improving product quality and greater familiarity with key operating variables that will be useful during start-up,” said Chris Carl, BioExx CEO. ..."
www.bioexx.com/index.php?option=com_content&view=article&id=…
www.gowebcasting.com/events/bioexx-specialty-protein-ltd/201…

[Popeye82]

Antwort auf Beitrag Nr.: 39.529.246 von Popeye82 am 16.05.10 22:05:30

Das war dann wohl ge2ppelt.

[Popeye82]

kein Geniestreich, aber eine Erwähnung:

Quant Snapshot: Bioexx Specialty Proteins (TSX:BXI) - CL -May 23, 2010
www.cantechletter.com/2010/05/quant-snapshot-bioexx-specialt…

[Popeye82]

BioExx Now Commissioning Protein Isolate Facility; AGM Not Disrupted by G-20 Conference - Jun 10, 2010
www.marketwire.com/press-release/BioExx-Now-Commissioning-Pr…

[ValueFreak]

Antwort auf Beitrag Nr.: 39.663.736 von Popeye82 am 10.06.10 16:34:37

Schön, daß es Fortschritte gibt, Popeye.

Der Wert bleibt auf meiner Beobachtungsliste.

[Popeye82]

Antwort auf Beitrag Nr.: 39.665.209 von ValueFreak am 10.06.10 19:54:50

[Popeye82]

Antwort auf Beitrag Nr.: 39.674.880 von Popeye82 am 13.06.10 13:49:49

Mist, hatte gerade etwas mehr geschrieben, Posting abhanden gekommen. Dazu dann nochmal in kürze.

[Popeye82]

Food for thought - Mike4541 - Jun 28, 2010
www.stockhouse.com/bullboards/MessageDetail.aspx?p=0&m=28371…

"I understand the concern regarding the general market issues of deflation or inflation or stagflation and "double dip recession" debate. However, remember the specific niche that BXI is in.

As far as BioExx investors are concerned these points are worth noting :

1. BioExx has employed many skilled professionals recently and will add to the North Dakota workforce soon.
2. BioExx is on the cusp (hours/days/weeks NOT months) from announcing a breakthrough engineering feat.
3. The Canola Protein isolate products that will come out of Saskatoon will be unique and the world's first.
4. No matter what the economic situation is - Food is not discretionary.
5. In hard times animal source proteins (eggs meat milk whey) will be even more scarce and costly.
6. High quality - low energy - clean tech - Plant source protein (canola better than soy) will be the answer.
7. Watch for media interest in this defining technology.
8.The P/E will not be the only factor that will influence the share price but remember the
- transferable toasted meal licence fees
- bidding up by interested big food industry suitors (Viterra Cargill, Bubge, ADM etc )


The only question that remains now is :

Will there be a successful start up of Canola Protein Isolates now that the extended construction is over.

Ask Laurence Parslow !

MIKE "

[umkehrformation]

interessanter Vergleich der Scotiabank

man beachte den Umwelt und Bio-Aspekt ...harsh chemicals

Lignol Energy Corporation Comparables
Lignol is a unique company that produces both ethanol and high-value lignin using an enzyme-based
process. Most other cellulosic ethanol companies either use chemical-based processing (e.g., Verenium) or
gasify biomass to produce ethanol (e.g., Coskata, Range Fuels, and SunOpta). As mentioned earlier,
ethanol producers burn the lignin by-product as fuel for its process. There are a few companies that have
some similarities to Lignol, as listed below.


Burcon Nutrascience (TSX: BU) has a technology that separates protein from oil seeds, mainly canola
and soy. Proteins are used in the food industry (beverages, baked goods, dressings and sauces, and protein
powder). Burcon is similar to Lignol in that its extraction process does not use harsh chemicals and it
produces a protein product with superior quality. Lignol’s process produces a high-quality lignin product
without using harsh chemicals. The key difference is that Lignol’s product is used as a bio-chemical
intermediate in resins and polymers. Lignol’s HP-L lignin product can also be used as an animal feed
additive, although Lignol is not targeting this as its primary lignin market.


BioExx Specialty Proteins (TSX: BXI) extracts oil and active ingredients from canola. Its process uses
low temperatures compared to conventional processes that operate at high temperatures. The low
temperature minimizes the damage to proteins, allowing for the separation of higher-value proteins for
sale into the specialty feed and human food market. BioExx has a similar extraction process to Lignol in
that it produces a high-quality, high-value product. The key difference is that BioExx uses petroleumbased
heavy fuel oil in its extraction process, whereas Lignol uses enzymes and no harsh chemicals.


quelle: http://scotiabank.com/images/en/filesaboutscotia/23056.pdf

april 2010

[Popeye82]

Antwort auf Beitrag Nr.: 39.790.846 von umkehrformation am 08.07.10 01:39:45

Thx für das Dokument. Wie bist denn da dran gekommen?

Gruß
Popeye

[umkehrformation]

Antwort auf Beitrag Nr.: 39.795.814 von Popeye82 am 08.07.10 20:05:45

trial and error
gruß umkehr

[Popeye82]

Antwort auf Beitrag Nr.: 39.796.784 von umkehrformation am 08.07.10 23:08:53

Dann bitte so weitermachen.

Gruß
Popeye

[Popeye82]

BioExx Demobilizing Construction Force and Preparing for Start-Up of Protein - Jul 6, 2010
www.marketwire.com/press-release/BioExx-Demobilizing-Constru…

"TORONTO, ONTARIO--(Marketwire - July 6, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to confirm that it has commenced the process of demobilizing its Saskatoon construction and installation force, including having already eliminated the night shift and planning to reduce the workforce by 75% by the end of next week. The balance of the personnel will be reduced gradually with a core group remaining through and after the production of first protein to provide services required during start-up, as well as to complete ancillary and non-critical items thereafter.

While specific schedule risks do remain, the current state of near readiness suggests start-up within the next few weeks. The path to start-up has been challenged by several issues beyond BioExx control such as the abundant and severe rain in Saskatoon, that recently left a significant portion of the business park where the plant is situated under water, as well as industry-wide labour disruptions with the mechanical contractors' union which has been preventing most weekend and overtime work.

Commissioning has now commenced in the protein area and given that this area contains fewer vessels, valves and instruments than extraction, it is expected to take less time. Commissioning of extraction has proceeded well under the direction of the Company's automation systems contractor with no significant issues having been encountered. This level of success to date speaks to the quality of the engineering design as well as the integrity of the work completed by the Company's installation and commissioning contractors.

Technical staff from key equipment suppliers began arriving this week to assist in equipment start-up and operator training, with several of these vendors remaining on site through protein production. With start-up rapidly approaching, the entire BioExx team is ready and anxiously awaiting the opportunity to run the facility in its entirety to fulfil its goal to produce the world's first commercially available food-grade canola protein isolate.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[Popeye82]

Antwort auf Beitrag Nr.: 39.806.334 von Popeye82 am 12.07.10 11:23:45

"While specific schedule risks do remain, the current state of near readiness suggests start-up within the next few weeks."


BioExx Produces Near Isolate Quality Protein In First Commercial Scale Production - Aug 3, 2010
www.marketwire.com/press-release/BioExx-Produces-Near-Isolat…

"BioExx Specialty Proteins Ltd. (TSX:BXI) is very pleased to announce that it has successfully produced protein with a purity level of 82.5% from its first protein production run at its Saskatoon plant. The protein was produced from seed pressed in the BioExx crush plant and meal extracted in the BioExx pilot plant and then loaded into the full-scale extractors, with final processing in the full-scale protein plant. The results of this first protein are excellent considering that this was the first time this equipment has been used through to final protein production. The purity also compares favourably to the first run at each of the two established third-party pilot plant facilities BioExx has used in the past months.


At one metric tonne of meal input, this run was sufficiently large to confirm the efficacy of all of the full size protein equipment being used. Total yield is not measurable yet due to the protein particles being distributed throughout the very large dryer installed at the facility, which is expected on a batch run. Initial and observable indications provide the Company with a positive view of its ability to meet its target yields from the process.

The protein produced also demonstrated better colour and improved density versus protein produced in pilot runs, which are two characteristics important to customers. Protein taste was benign and not noticeably different from the pilot runs which had produced the desired results.


The production team believes that further production runs will result in higher purity levels by addressing the following items that were encountered on the first production run:

1. Purity was reduced by having to wait more than 24 hours from slurry preparation to utilizing the dryer due to start-up adjustments being made on the dryer. This kind of delay allows protein to precipitate out of the solution before the final drying step is completed, thus reducing protein purity.

2. Despite thorough advance cleaning, first runs on large dryers generally accumulate construction dust which also dilutes the measured purity.


Neither of these situations is expected to have as much impact in future runs, and a normal learning curve is almost certain to further improve overall results with the goal of quickly achieving isolate quality protein.

Start-up installation work and adjustments will be ongoing as BioExx runs additional trials and ramps toward continuous production. This includes final adjustments to, and testing of, the extraction portion of the plant which was bypassed on this run in favour of meal produced in the BioExx pilot plant, to allow the production team to maintain the highest level of control and diligence prior to the operation of each new equipment group. This more methodical approach has already proven successful, as every full-scale piece of equipment that was used in producing protein worked exactly as intended during the first production run.

"The BioExx operations team is very proud to have achieved such a high level of success on the very first run of the full scale protein production area. This occurred after more than 14 very long days without a break for our production managers, whose efforts went far and beyond expectation on behalf of the company," said BioExx CEO, Chris Carl. "There will be a few days of rest and then some adjustments before the next series of runs, but we are excited about moving forward. Producing this level of quality on the very first run is a landmark event, and a major milestone for the Company, and it gives us great confidence as we continue to ramp towards continuous full-system production and sale of the world's first food-grade canola protein Isolate."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Produces World's First Commercial Canola Protein Isolate to 95% Purity - Aug 09, 2010
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, ONTARIO – August 9, 2010 – BioExx Specialty Proteins Ltd. (TSX: BXI) is pleased to announce that it has successfully produced the world’s first commercial-scale canola protein isolate, known as Isolexx™. The product was produced in the second full-scale protein run at the Saskatoon facility and was repeatedly tested in both the BioExx lab and at the independent testing facilities of POS Pilot Plant Corp. Average indicated purity at BioExx was 95.8% and the average at POS was 94.8%, with all other characteristics being similar to or better than the product from the recent initial protein run.


The plant was also able to much more thoroughly recover the product that was produced, resulting in an exceptionally strong yield of protein isolate at over 90% of what has been forecast for long-term continuous operations. This was achieved by ensuring the batch run was operated as close to a continuous process as possible, thus avoiding the precipitate issues experienced in the first run and by controlling the operating parameters of the large spray dryer in an improved manner.

Being the first company to produce and deliver canola protein isolates to the multi-billion dollar global protein market creates a tremendous opportunity for BioExx. IsolexxTM compares very favourably against other plant-based proteins, such as soy and pea protein isolates, as well as higher priced animal-based protein isolates, such as whey and caseinates. Potential customers who have tested Isolexx™ have been impressed by its high nutritional value, low allergenicity, benign flavour, and excellent solubility and functionality. In addition, recent trials have indicated that Isolexx™ has very good digestibility and is well suited, as an example, for use in nutritional and protein bars, with lower water absorption than traditional isolates (leading to extended shelf life and low bar hardening), and being functionally superior to soy and comparable to whey proteins.

The production run consisted of 1.3 metric tonnes of meal that had been processed in the BioExx pilot plant and utilized all of the full scale equipment necessary to recover protein from the meal. The company has used this approach to minimize the operating variables while starting up the protein facility. It should be noted that it remains the intention of the Company to produce Isolexx™ at an industry-standard commercial purity closer to 90%. Now that the desired protein results have been proven, the Company will continue with its start-up and ramp-up of the remainder of the Saskatoon plant.

“Today is a day for which everyone involved with this company has waited. The level of commitment and effort we have received from the plant team, and our consultants and contractors, in the past few months has been extraordinary. To be able to prove the ability to operate the plant so successfully and so quickly after our first run is a testament to the quality of work contributed by the entire team,” said BioExx CEO, Chris Carl. “This has not been an easy road and we still have a great deal of work ahead of us to bring the plant to full continuous operation, and to complete the plant certifications and ancillary systems required for human food status, but these near-term milestones seem much more easily attainable now that we have so clearly proven the commercial viability of our protein purification process.”


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.


To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

das ist richtig miserabel von diesen Newstickern -meistens funktioniert es, aber manchmal werden Meldungen auf den meisten, oder allen, nicht veröffentlicht. :x Wie diese hier, noch nichtmal auf der Website. Dadurch bekommt man das dann wenn man Pech hat erst etliche Zeit später, wenn überhaupt, mit.

Die Finanzierung wird nicht die letzte gewesen sein, wobei aber langsam mal die Debt Finanzierungen(Banken, eventl. Förderprogramme, o.ä.) greifen sollten(da hätte ich mir mehr/zu einem früherem Zeitpunkt erhofft):

BioExx announces $30.0 million bought deal financing - Aug 9, 2010
http://finance.alphatrade.com/story/2010-08-09/CNW/201008091…

"TORONTO, Aug. 9 /CNW/ - BioExx Specialty Proteins Ltd. (TSX: BXI) ("BioExx" or the "Company") announced today that it has entered into an agreement to sell to a syndicate of underwriters led by Canaccord Genuity Corp., on a bought deal basis, 15,400,000 common shares ("Offered Shares") at a price of $1.95 per Offered Share for gross proceeds to BioExx of approximately $30.0 million (the "Offering"). BioExx has also granted the underwriters an over-allotment option to purchase up to an additional 15% of the Offered Shares on the same terms and conditions, exercisable any time, in whole or in part, up to 30 days after the closing of the Offering, for additional gross proceeds of up to approximately $4.5 million.


The net proceeds of the Offering are intended to be used as may be required to complete and ramp up the Saskatoon facility to 100% of protein capacity; for engineering, development, and initial construction work for the Company's second plant in Minot, North Dakota; for ongoing R&D related to continuous improvement of the Company's technologies as well as related but non-competing markets and technologies that BioExx is pursuing; and for general corporate purposes.

"This financing will allow us to continue along the curve of success marked most recently by first protein production in Saskatoon, while maintaining a strong balance sheet which is important for all shareholders. Commercial scale protein production was a seminal event in our development because it significantly de-risks the core technology thesis and provides a platform for growth and continued achievement of major milestones, both in Saskatoon and North Dakota. While we could not be more pleased with the way the plant has performed in its initial production runs, there is still work to be done in order that we may continue on our path as the world's first commercial producer of food-grade canola protein isolate," said BioExx CFO, Chris Schnarr.

The Offering is expected to close on or about August 24, 2010 and is subject to regulatory approval. The Offered Shares will be issued under a short form prospectus and as such will be freely tradable. The Offered Shares will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets.

BioExx uses patented technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Without the extraction of virtually all of the oil at low temperatures, and in the manner developed by BioExx, the protein separation methods would not work. It is the combination of these proprietary processes that has enabled BioExx to develop product profiles that do not infringe either on methods or product profiles developed by others. Through its extensive research and development work, together with an exhaustive review of published and prior art, BioExx is confident that all of its processes and resulting products are unique in the marketplace.

Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint.

BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis. To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

Notice of Q2 2010 Conference Call - Aug 12, 2010
www.marketwire.com/press-release/Notice-of-Q2-2010-Conferenc…

"TORONTO, ONTARIO--(Marketwire - Aug. 12, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) will release its Q2 2010 financial results following the close of markets on Monday, August 16, 2010. Management will host a conference call on Tuesday, August 17 at 10:00 a.m. (Eastern Time) to review the financial results.


Live Conference Call:
Dial-in Numbers: 416-340-8061 / 866-225-0198


Instant Replay:

Dial-in Numbers: 416-695-5800 / 800-408-3053
Pass code: 6000176
Available Until: August 31, 2010 11:59 PM


The call will also be audio-cast live and archived for 90 days at www.bioexx.com. "

[Popeye82]

BioExx Closes $30 Million Bought Deal Financing; Provides Saskatoon Plant Update - Aug 24, 2010
www.marketwire.com/press-release/BioExx-Closes-30-Million-Bo…

"BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx") is pleased to announce that it has closed its previously announced bought deal financing, sold by a syndicate of underwriters led by Canaccord Genuity Corp., and including Wellington West Capital Markets Inc., Cormark Securities Inc., Fraser Mackenzie Limited, GMP Securities L.P. and Stonecap Securities Inc. The financing consisted of 15,400,000 common shares sold at $1.95 per share for gross proceeds of $30,030,000. The underwriters have an over- allotment option to purchase up to an additional 2,310,000 common shares on the same terms and conditions, exercisable any time, in whole or in part, up to 30 days after the closing.


Saskatoon Plant Update

BioExx is also pleased to note that start-up activities towards food-grade protein production at the Saskatoon plant are proceeding as planned. The Company had elected to institute some additional leak monitoring and safety equipment in the extraction area, because it is more easily completed prior to solvent being loaded into the plant. The installation of this equipment is completely ancillary to the extraction process itself and has no impact on the overall design or operation of the facility. This peripheral work is nearing completion and the Company looks forward to its first full-plant operation, inclusive of full-size extraction, very soon and anticipates a continuation of the success demonstrated on its initial protein plant runs.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for oil extraction, to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Successfully Completes First End-To-End Production at Saskatoon Plant - Sep 07, 2010
www.marketwire.com/press-release/BioExx-Successfully-Complet…

"TORONTO, ONTARIO--(Marketwire - Sept. 7, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to announce that it has successfully produced commercial-scale canola protein isolate in its first complete end-to-end protein production run at its Saskatoon plant. The protein produced was tested in the BioExx lab for purity and was corroborated at the independent testing facilities of POS Pilot Plant Corp. These results are more desirable than the prior run as they are above 90% but more consistent with the Company's published commercial product specifications and operating targets. Protein yields were slightly lower than on the prior run due to some product losses resulting from a modification to equipment settings during the run, but yield is expected to fluctuate within a small range as adjustments are made leading to continuous operation, at which time yields are expected to meet or exceed targets.


The protein isolate was produced using each of the three full-scale commercial sections of the BioExx plant, including Pressing, Extraction, and Protein Processing. The run, which included both batch and for the first time, some continuous processing, was the largest so far using a seed input quantity of 2.5 metric tonnes. This is also the first production where all sections of the plant were utilized in the normal operating sequence and therefore provides the most compelling evidence to date of the efficacy of each of the processing sections working in concert.

This run was also significant because it utilized the full size commercial extraction system for the first time. The operating team was very pleased with how well the extraction plant performed, as oil content of extracted meal was below 2%, ahead of the commercial operating plan of 3% or lower.

BioExx will now continue its methodical ramp-up of the Saskatoon plant, focussed on activities leading to the production and shipment of food grade proteins from the plant on a continuous commercial basis. These activities include:

+ moving from batch to fully continuous production, albeit at low volumes initially

+ completing work on ancillary systems required for food grade production (such as packaging, pasteurization, and automated cleaning systems)

+ ramping continuous production volumes first to a 4/24 level and then, as staffing is increased and certification is completed, to 7/24

+ extending the existing plant HACCP/GMP/ISO certifications to include the extraction and protein sections of the plant.


"Meeting our targeted commercial purity specification on our first full-plant production run is yet another important milestone that again adds to our confidence that we have a plant that can meet all of its original objectives," said BioExx CEO Chris Carl. "We still have much work ahead of us to bring the plant to full continuous operation and food grade sales over the balance of the year, but the remaining steps are largely incremental and operational matters. Achieving these results on our first attempt is a testament to the quality and determination of our R&D, operations and engineering teams. We are excited and ready for the challenges that lie ahead and we look forward to the ongoing creation of additional value for our shareholders."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Updates Product Certification Status; And Provides Voluntary Disclosure for Share Sales by Founder - Sep 14, 2010
www.bioexx.com/index.php?option=com_content&view=article&id=…

[ValueFreak]

Antwort auf Beitrag Nr.: 40.111.800 von Popeye82 am 07.09.10 16:23:14

Glückwunsch, Popeye.

Die Aktie hat sich ja wirklich gut entwickelt.

Gruß
ValueFreak

[Popeye82]

Antwort auf Beitrag Nr.: 40.173.154 von ValueFreak am 18.09.10 13:55:37

Habe ich auch nicht sooo viele Zweifel dran gehabt. Und wenn es gut läuft sind die Möglichkeiten noch klar nicht ausgereizt.

Die Extraktion funktioniert, künftig dürften sich die Schwergewichte IMO eher in Richtung (Prozess)Optimierung, die Planung der neuen, weiteren, Anlagen, sowie, ganz wichtig, die weitere Entwicklung der Crush Margins &mögliche zusätzliche Anwendungsbereiche, wo man noch einige Eisen im Feuer hat, verschieben.


P.S.: Du versaust mir meine ganze Alleinunterhalterquote.

Gruß
P.

[CHingaCHcook]

Ich verstehe leider nicht, dass Herr Carl als "founder" in den naechsten 12 Monaten sein Aktienpaket verringern will. Persoenliche Entschuldung ist sicher eine sehr gute Sache, aber glaubt er nicht an einen weiteren Kursanstieg? Mir scheint jedenfalls, dass er seine Glaeubiger nicht davon zu ueberzeugen wusste, wie es scheint, weshalb fuer mich hier jetzt erstmal Schluss ist. Man kann ja immer mal wieder vorbeikommen, auch wenn's dann 20 cent teurer (bitte gerne) sein sollte...! ;-)

[Popeye82]

Antwort auf Beitrag Nr.: 40.300.475 von CHingaCHcook am 11.10.10 18:48:40

Hi,

"Persoenliche Entschuldung ist sicher eine sehr gute Sache, aber glaubt er nicht an einen weiteren Kursanstieg?"

Ist das für Dich eher eine Frage, oder Feststellung?



Das Thema wurde in den Stockboards schon auuuusgiebigst diskutiert -der letzte Stand, soweit ich weiss, war, dass er einige verkaufen wird, der Anteil am Total aber marginal ist. Ist glaube ich sogar in den CCs u.w. enthalten.

Das sind Diskussionen/Sachen, die kannst Du im Vorneherein eh´ nicht wirklich "definitiv" klären, von daher ist´s finde ich eher müssig. Muss sich jeder selber eine Meinung bilden. Man sollte m.A.n. aber aufpassen, sich auf bestimmte Ereignisse keine Automatismen, "Reflex"erklärungen/Ableitungen zu machen.


"Mir scheint jedenfalls, dass er seine Glaeubiger nicht davon zu ueberzeugen wusste, wie es scheint, weshalb fuer mich hier jetzt erstmal Schluss ist."

Verstehe ich das richtig, dass Du die ganze Zeit gehalten hast, und nun aussteigst? Btw. -das hätte man dann eigentlich schon lange früher machen müssen.


"Man kann ja immer mal wieder vorbeikommen, auch wenn's dann 20 cent teurer (bitte gerne) sein sollte...! ;-)"

Ist reine Spekulation, aber die Chancen stehen denke ich nicht schlecht, dass Du die -und einiges mehr- zu sehen bekommst.

Gruß
P.

[CHingaCHcook]

Ist das für Dich eher eine Frage, oder Feststellung?
Eine Frage.

Seit Mai halt ich diese, ja. Ich finde den Zeitpunkt dieser Entschuldungsaktion merkwuerdig, insbesondere nach den guten Nachrichten im September.
Ich warte diesen Monat noch, vielleicht sogar bis Mitte November...

Ist meine rein persoenliche Ansicht, auf jeden Fall.
Gruss zurueck!

[Popeye82]

BioExx Updates Product Certification Status; And Provides Voluntary Disclosure for Share Sales by Founder - Sep 14, 2010
www.bioexx.com/index.php?option=com.....tid=43:news&Itemid=8…

"TORONTO, ONTARIO – September 14, 2010 – BioExx Specialty Proteins Ltd. (TSX: BXI) is pleased to provide an update regarding its progress toward the various certifications required by the company prior to commencing sales of its food-grade protein isolates as expected later this year. The Company is currently engaged in testing and evaluation programs with more than 30 potential customers. Many of these have been engaged through the Company’s distribution partner Helm AG, and the majority are based in the United States with the balance primarily in Europe. These companies range in size from small niche producers to large multinational companies and all are in receipt of sample products that are subject to Material Transfer Agreements and/or Confidentiality Agreements.

Most of these potential customers are ready to engage in final trials leading to purchases once food-grade protein from the full scale facility is available on a continuous basis. Feedback has been consistently positive due to high functionality, high overall amino acid quality, high solubility, low anti-nutritional factors, and the generally positive attributes of canola protein isolates extracted at low temperatures, as compared to other plant sources.

To sell food-grade protein to these customers, BioExx requires certain certifications both for the protein products and for the Saskatoon production facility itself.

Regarding the facility, BioExx is in the process of extending its existing HACCP/ISO/GMP certification that was obtained last year (see October 26, 2009 news release) for the crush plant to the rest of the plant. This is expected to take approximately 60 days after continuous food-grade production is commenced. This certification is not a regulatory requirement but rather a general market requirement, and the process can only be completed after a production facility is in continuous operation. BioExx has already begun working with Silliker Inc., the leading internationally accredited provider of global food safety and quality consulting, to assist in systems design and preparation for the final audit and certification. The final certificate will, following a successful audit, be issued by NSF-ISR, which is a not-for-profit, non-governmental organization that is the world leader in standards development, product certification, education, and risk-management for public health and safety.

Regulatory product certifications vary by geographical jurisdiction. In the United States, which accounts for approximately 25% of global food ingredient protein demand (source: Global Industry Analysts Inc.), BioExx requires, and has obtained, Self-Affirmed GRAS (Generally Regarded as Safe) status in accordance with the regulations of the US Food and Drug Administration (see November 18, 2009 news release). The self-affirmed GRAS status was obtained as a result of a detailed process that required a thorough review of both the manufacturing process and the resulting chemical profile of each product by independent and qualified experts in the fields of toxicology and allergenicity. The GRAS review was completed by Keller and Heckman LLP based in Washington D.C., whose comprehensive food and drug practice is one of the largest in the world, having represented companies in front of the FDA in matters such as this for more than 40 years. Self-Affirmed GRAS is all that is required for BioExx to sell its protein products into most human food applications.

As BioExx has noted previously, in selected situations, such as infant formula and certain clinical nutrition products, some customers may request BioExx to also obtain GRAS Notification status directly from the FDA, and accordingly BioExx does intend to complete the GRAS Notification process in due course. In the interim, the current self-affirmed GRAS status is sufficient to facilitate the Company’s growth and execution of its business plan.

In Europe, BioExx requires a food safety registration issued by the European Food Safety Authority. BioExx has, in conjunction with Helm AG, commenced work on this registration process and expects a favourable outcome on a timeline consistent with plans for sale of proteins into Europe.

BioExx has a similar product certification process underway in Canada and will seek to extend certifications into other jurisdictions as and when required.


Voluntary Disclosure

The Company also announces that its founder and CEO, Chris Carl, is engaging a financial manager to dispose of up to 15% of his holdings in BioExx over a 12 month period, for personal financial planning and debt reduction reasons. This will be based on monthly targets to be set with the manager, after which the manager will have full discretion as to volume and timing, subject of course to scheduled and unscheduled insider trading blackout periods. All prescribed insider transactions, by Mr. Carl or others, will be subject to reporting requirements in accordance with applicable securities regulations.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.


To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Provides Confirmation of AGM Results - Oct 21, 2010
www.marketwire.com/press-release/BioExx-Provides-Confirmatio…

"TORONTO, ONTARIO--(Marketwire - Oct. 21, 2010) - Due to an inadvertent omission immediately following its AGM earlier in the year, BioExx Specialty Proteins Ltd. (TSX:BXI) ("BioExx") is today providing formal notice that it held its Annual and Special Meeting of Shareholders on June 17, 2010, where all of the resolutions that shareholders were asked to consider at the Meeting were approved by a majority of the votes cast at the Meeting. Shareholders accepted the Company's fiscal year 2009 financial statements and re-elected Chris Carl, Chris Schnarr, Paul McClory, Peter Lacey, John MacDonald and William Ollerhead to serve as directors on the Company's board of directors. Shareholders also approved certain amendments to the Company's incentive Stock Option Plan, intended to bring the Plan in line with Toronto Stock Exchange comparables after the migration of the Company from the Toronto Venture Exchange earlier in the year.


Operations Update

While there will be more details forthcoming after continuous operations have commenced, BioExx is pleased to report that it is nearing completion of the various adjustments and final ancillary system installation work required to allow the company to commence continuous food-grade production at its Saskatoon facility. During this final preparation period, the engineering and operations team has, as always, exercised tremendous diligence in an effort to smooth the transition to continuous operations. This period has also been used to complete various staffing and training requirements as well as to finalize HACCP operating procedures so that the certification audit can commence as soon as practical.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com "

[CHingaCHcook]

OK. Das klingt jetzt sehr gut. Gut dass wir noch drin sind:

In response to a large volume of questions in the past week, BioExx Specialty Proteins Ltd. (TSX:BXI) (“BioExx” or the “Company”) is pleased to provide this update and confirmation of the integrity of its intellectual property relating to protein and protein separation. The BioExx suite of Intellectual property is extensive, well protected, and has been intensively tested and analyzed by third-party experts.

Specifically, BioExx has now received, after an extremely thorough review, an additional, and very detailed “Opinion of No Infringement” (the “Opinion”) against any published patents or patents-pending in the United States owned or claimed by the only known alternative company reportedly developing technology to produce protein isolates from canola (the “Alternative Company”). The review work that resulted in the Opinion also carefully investigated all claims made to support the initial patents filed by the Alternative Company, as well as prior art that was published before those patents were filed. Based on the extensive review of those documents, it is concluded that the BioExx processes used to produce its commercial products, and the BioExx protein products which are produced by those processes and are to be offered for sale, do not constitute an infringement of any of the Alternative Company patent claims.

Of particular relevance, based on that analysis, it is specifically concluded that:

1. The methods to prepare the defatted meal for protein extraction are materially different.
2. The protein extraction solvents are materially different.
3. The protein separation processes are materially different.
4. The resulting protein products and profiles are materially different.

The review was completed by Dr. Michael Ram with the firm Koppel, Patrick, Heybl & Dawson based in Ventura County, California. KPH&D focus exclusively on intellectual property matters, including patent, trademark, copyright, and trade secret law and in 2008 was named a “Go-To Law Firm” for the nation’’s Leading Technology Companies in American Law Magazine’’s reference guide. Dr. Ram has more than 35 years experience rendering patentability, infringement and state of the art opinions and has prosecuted patent applications in biomedical, biochemical, pharmaceutical, natural substances, chemicals, advanced materials, mechanical, computer software and general arts before the USPTO. Prior to that he earned a B.S. degree in Chemical Engineering from Lafayette College, a M.S. and D.Sc. in Chemical Engineering from New Jersey Institute of Technology, with a particular emphasis on chemicals, chemical processing, extraction techniques and advanced materials production. He also obtained a Juris Doctorate from Seton Hall Law School. A more thorough biography is available at www.koppelpatent.com.

The massive global protein ingredient market presents a tremendous opportunity for any company that can successfully commercially produce a high quality plant-based protein that can be used in combination with, or as a substitute for, animal based protein ingredients in human food markets. BioExx notes that canola proteins produced from a different starting point and by way of a different process (as is the case with the technology developed by the Alternative Company) will necessarily have different characteristics. Given the application-specific nature of potential end-uses of protein products, it is likely that two such canola proteins may not be directly competitive. As the world’’s first commercial-scale producer of canola protein isolates, BioExx views the possible commercial production by other companies at some future date as a positive for the industry, as it helps build critical mass and much needed capacity to serve the growing global demand for plant-based proteins.

Patent Portfolio Update

As described in its November 11, 2009 press release, BioExx has ten multi-jurisdictional patents issued or pending that are directly related to the specialty proteins to be produced at BioExx facilities. This includes a patent application filed on a process to convert meal produced from conventional high temperature extraction processes to feed-grade Protein Concentrates at purity levels of approximately 65%.

The increasingly broad patent portfolio that BioExx has developed protects its very unique and proprietary processes and products. The scope of this portfolio covers:

* Protection of scalable, economic low temperature extraction methods
* Protection of unique solvent combinations to effect such extractions
* Protection of unique solvent separation and recovery methods
* Protection of unique methods of producing protein concentrates, protein isolates and hydrolyzed protein extracts from oilseeds and other feedstock
* Protection of the unique products resulting from the foregoing processes

The BioExx protein patent claims also cover rapeseed, mustard seed, soy, flax, and micro-algae and hence are not limited to canola protein.

The BioExx process that has been deployed for commercial protein isolate production does not use high temperatures or process additives that cannot be fully removed from the end products, and specifically does not use salt solutions, in any form, at any stage in the process. The processes and products that BioExx has developed have undergone a series of extensive scientific and legal reviews, including substantial product testing, to confirm their unique properties and assessment of freedom to operate in the marketplace.

Product Testing Update

BioExx has recently received excellent results from industry-standard rat digestibility studies that were conducted in Germany. These studies have demonstrated that BioExx protein isolate, Isolexx™has a true digestibility of approximately 95%, while the BioExx hydrolyzed protein extract, Vitalexx™has a true digestibility of over 98%. By comparison, milk proteins such as casein and whey are considered to have a standard digestibility of 95%.

Other recent testing has also confirmed that the amino acid profiles for both Isolexx™and Vitalexx™are particularly strong. When compared to the amino acid profile recommended by the FAO WHO (2007), both proteins are shown to be complete with more than 110% of each essential amino acid required for both children and adults. Combined with the new digestibility results, the PDCAAS (Protein Digestibility Corrected Amino Acid Score) of Isolexx™is 1.11, and Vitalexx™is 1.16, versus high-end and high-priced milk-based proteins, including whey at 1.12 and caseinates at 1.11. The most widely available plant-based protein, soy, has a score of 1.02.

Previous testing has also demonstrated that the BioExx protein products have functional properties (including solubility, foaming and emulsification) that are much closer related to the properties of milk based proteins than they are to most plant-based proteins.

These combined results are significant as they continue to affirm the Company’’s view that its proteins make an attractive ingredient for very high value applications such as Infant Nutrition, Child Nutrition, and Clinical and Therapeutic Nutrition. On-going engagements with potential customers are increasingly affirming this strong product positioning. The Company expects to provide additional and specific details of these engagements over the coming months.

Production Update

Finally, BioExx is pleased to confirm that it expects to commence continuous production of protein isolates at its Saskatoon facility the week of November 15th. During the period since the first end-to-end run, the extensive food-grade clean-in-place system has been completed, a number of other ancillary items required to be compliant with HACCP, ISO and GMP (collectively “HACCP”) have been installed, personnel training for HACCP has been completed, and new operating and maintenance staff have been hired and trained.

BioExx also decided to accept the recommendations of its engineers, based on knowledge gained from recent production test runs, and use the period after the end-to-end run to add a new buffer tank system to its extraction plant. This system has been added to optimize process efficiency and extraction cycle times, as well as afford an additional measure of redundancy within the process. While not a significant capital cost, the system will have taken approximately nine weeks to design and install which has added about two additional weeks before continuous operations could commence. It was optimal to install the additional systems presently, rather than after commencement of continuous production, to reduce future potential downtime and increase the probability of more immediate success as continuous operations commence. Generally, BioExx has been endeavouring to design and construct this facility to an enhanced quality specification level that will enable future production at standards required for very high value specialty nutrition protein products as those market opportunities unfold. As noted above, current market and customer engagements are confirming the strength of this thesis.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com

http://stockmarketsreview.com/pressrelease/2010/11/01/bioexx…

[Popeye82]

From Canaccord's Morning Coffee - BioBilly - Nov 2, 2010
www.stockhouse.com/bullboards/MessageDetail.aspx?p=0&m=28786…

" BioExx Specialty Proteins* (BXI : TSX : $2.76) Net Change: 0.21, % Change: 8.24%, Volume: 2,385,203

Looking to shutdown the rumour mill. Shares of BioExx leapt, offsetting most of last week's market weakness after the company released an update on the integrity of its intellectual property (IP) relating to protein and protein separation, noting it has received a detailed "opinion of no infringement" against any published patents or patents pending in the U.S.

There has been significant debate regarding intellectual property (IP) risk over the last two plus years, and this "noise" appeared to intensify over the last week or so. More specifically, investors have long contended with rumours and speculation that Burcon NutraScience (BU) may file a patent infringement claim immediately after BioExx ships its first canola protein isolates. Canaccord Genuity Sustainability Analyst Sara Elford does not purport to have any idea what Burcon may or may not do in this regard, or when for that matter, but she has never ruled out the potential for such a claim. She still does not. However, having visited the Saskatoon plant on several occasions and having read all of Burcon's U.S. patents, she remains satisfied to the best of her ability that the probability of a successful claim is extremely low. The review BioExx highlighted on Monday was completed by Dr. Michael Ram with the firm Koppel, Patrick, Heybl & Dawson.

Dr. Ram's key conclusions (as per BioExx's press release):

1) "The methods to prepare the defatted meal for protein extraction are materially different;

2) The protein extraction solvents are materially different;

3) The protein separation processes are materially different; and

4) The resulting protein products and profiles are materially different."


Given that they have not been denatured in any material way, Elford believes these products would also be superior.

She has talked with Dr. Ram and these four conclusions were confirmed to her directly. BioExx is one of Elford's top picks as she believes the stock offers risk-tolerant investors a unique opportunity to participate in the advanced commercialization of a disruptive, economically compelling technology within a large addressable market. She believes this market (protein) also enjoys very attractive long-term macro drivers. Against a low- or no-growth economic backdrop, Elford thinks such an opportunity stands to attract considerable investor attention in the quarters and years ahead. "

[Popeye82]

Notice of Q3 2010 Conference Call - Nov 05, 2010
www.marketwire.com/press-release/Notice-of-Q3-2010-Conferenc…

[Popeye82]

BioExx Enters Continuous Production Operations at Saskatoon Plant - Nov 22, 2010
www.marketwire.com/press-release/BioExx-Enters-Continuous-Pr…

"TORONTO, ONTARIO--(Marketwire - Nov. 22, 2010) - BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to announce that it has commenced the continuous operations process at is Saskatoon plant.


As expected, there were a number of challenges to overcome as the plant was restarted after its lengthy completion period. Each challenge requires adjustments of varying types and degrees, but each successful adjustment also represents a permanent correction to the process. By week's end, the team was pleased with the many successes that were achieved and what was learned in the process.

The plant will be restarted again today and will continue on a schedule designed to have the plant operating on a 7 day, 24 hour per day basis about the same time as the plant is certified for HACCP/ISO22000/GMP in Q1 2011.

At present, the plant is staffed with two complete operating shift crews which allow the plant to be operated up to 3.5 days per week on a 24 hour basis. During the certification period, a third shift crew will be added that will increase operability of the plant up to 5 days per week on a 24 hour basis, and the fourth crew will be added in time to be trained and ready to have the plant operated on a 7 day, 24 hour basis as plant certification is achieved.

Fluctuations in daily operating results are normal and expected during this period and unless there is a material departure from the schedule described, or other developments of a material nature, the company does not intend to report ordinary operating details of the ramp-up process through press releases.

"We have had a number of successes during our first week of renewed operations, and there were some important lessons learned through adjustments that were required to be made," said Chris Carl, BioExx CEO. "Internally, we have set our expectations and goals very high, and we look forward to continued progress and success through the initial ramp-up period up as we move towards food-grade protein sales in Saskatoon."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[CHingaCHcook]

Ich bin bei Can$ 2.43 komplett ausgestiegen.
Die Aktie befindet sich im Kursrahmen von
Can$ 1.90 bis 2,08 auf Einstiegsniveau.
Ich allerdings warte jetzt erstmal 2 bis
3 Monate, bis ich wieder einsteige.
Ich will zwei Dinge sehen:
1. Minot plant feasibility study accomplished
2. Food grade certification accomplished.
Alles Gute!

[Popeye82]

Antwort auf Beitrag Nr.: 40.733.985 von CHingaCHcook am 19.12.10 06:55:51

Tja, dann schauen wir mal, ob es die richtige Entscheidung war.

Gruß
P.

[Popeye82]

BioExx Confirms Planned Milestone Timing - Dec 13, 2010
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, ONTARIO – December 13, 2010 – BioExx Specialty Proteins Ltd. (TSX: BXI) is pleased to confirm that, following a recent external review meeting, it maintains its previous guidance with respect to the schedule for completion of HACCP/ISO/GMP certification and commencement of food-grade protein shipments from its Saskatoon plant. While a series of events must continue to occur to successfully meet this timetable, experience to date provides the Company with confidence that the scheduled certification audit date will be met. BioExx notes that achieving this milestone is the best and only measure of a successful ramp-up.


BioExx also confirms that the ramp-up in Saskatoon is proceeding as expected, with a combination of day-to-day challenges and successes. As previously communicated, the challenges are generally ordinary course for any plant start-up with each adjustment typically constituting a permanent fix and therefore allowing the plant team to move on to the next operating issue.

Among many other plant activities, the checklist of items required to complete the HACCP/ISO/GMP certification process continues to be completed, and the plant will maintain a schedule designed to have the plant operating on a 7 day, 24 hour per day basis about the same time as the plant is certified for HACCP/ISO22000/GMP in Q1 2011.

The Company would also like to reiterate comments made on its most recent conference call that its balance sheet remains strong and that no additional equity funding is expected to be required prior to the planned funding of the North Dakota plant in 2011.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.


To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

Orocobre Gets EIS Approval for Argentina Project - MT - Jan 6, 2010
www.mining-technology.com/news/news106230.html?WT.mc_id=DN_N…
www.stocknessmonster.com/news-item?S=ORE&E=ASX&N=228037

"Australia's Orocobre has obtained environmental impact statement approval from the Jujuy provincial government for the development &exploitation of its Salar de Olaroz lithium-potash project in Jujuy province, northern Argentina.


The approval follows a recommendation by the Unit of Mining Environmental Management, according to the company.

The company will provide additional information on its proposed construction works as the project design is finalised and will keep local communities informed about its activities.

Orocobre managing director Richard Seville said it is the first project to be assessed by the government under new provincial government legislation. "

[Popeye82]

noch recht schwammig formuliert:

BioExx Receives Positive Feasibility Report in Minot - Jan 6, 2010
www.bioexx.com/index.php?option=com_content&view=article&id=…

"TORONTO, ONTARIO – January 6, 2011 – BioExx Specialty Proteins Ltd. (TSX: BXI) is pleased to announce that it has received a thorough and positive feasibility report from N.C. Doty & Associates LLC, regarding the development of its planned 80,0000 Metric Tonne per year canola processing facility to be located in Minot, North Dakota. Receipt of this report assists BioExx in aggressively pursuing construction plans for the facility in 2011.


The feasibility report was commissioned by the Agriculture Products Utilization Commission (APUC), which is a division of the North Dakota Department of Commerce. The report, which is also a requirement of a potential project lender, included comprehensive investigations of the BioExx markets, products, technology, management team, and overall project economics. The report concluded that, “the BioExx canola protein isolate manufacturing facility would be commercially feasible, is well located and commercially supported in the Minot area, and would make a valuable addition to the business base for the Minot community.”


Overall, the development of the proposed facility was concluded as being feasible because:

+ There exists a rapidly expanding global market for protein ingredients from animal and vegetable sources. In addition to replacing soy protein isolates, canola protein isolates can also take the place of animal (dairy) protein isolates. The protein ingredients marketplace is projected to grow significantly in the near and extended future. The introduction of canola protein isolate products with high nutrition profiles and superior functional characteristics should be welcomed by manufacturers and marketers of protein fortified food and nutraceutical products.

+ Canola protein isolates from BioExx are expected to perform as well as dairy protein isolates and better than most soy protein isolates in selected applications in the food and beverage marketplace, based on a nutrition profile that match milk protein isolates and that exceeds soy protein isolates. The hydrolyzed protein product VitalexxTM is suitable as a good alternative for less tolerant children and adults. It has a great potential and is expected to perform well in the high value pediatric and therapeutic nutrition market.

+ BioExx has strong strategic partnerships in place, which may be leveraged for supply to and distribution from, its planned North Dakota facility.

+ BioExx has demonstrated its capacity to develop, build, and operate a canola protein isolate production facility.

+ BioExx has developed a patent and patent pending portfolio that protects its design and process technology regarding the production of canola oil, meal, and protein isolate products. BioExx’s processes and products have undergone a series of extensive scientific and legal reviews to confirm their unique properties and assessment of freedom to operate in the marketplace.

+ Each management team member has capabilities and experience to supply the leadership and direction required by their positions to execute BioExx’s business plan.

+ By entering the marketplace with canola protein isolate pricing on a par with other vegetable protein isolates, a proposed Minot facility could feasibly operate on a sound financial footing of profitability and positive cash flow.


Dr. Neil Doty, author of the study, has been comprehensively involved in the protein ingredient marketplace for 35 years. Neil earned a Ph.D. in Cereal Chemistry and Technology from North Dakota State University (NDSU). Part of Dr. Doty’s work at NDSU involved isolating and characterizing sunflower protein fractions from sunflower kernels.

His first professional position was as the Director of Product Development at General Nutrition Corporation (GNC), where he became involved in developing food and nutritional supplement manufacturing development for GNC over the next 12 years, with a focus on the introduction to the market of soy protein isolates to global markets. During this period, Dr. Doty was directly involved in formulating and developing protein-based product lines that included protein fortified breakfast cereals, baked goods, pasta, snack foods, nutritional supplements and cosmetics; yogurts; prepared dry dinners; and liquid dietary collagen protein. The protein beverage mix product line, which utilized the protein ingredients casein, whey protein isolate, egg white protein, and soy protein isolate, rapidly became supplements of choice for athletes and body builders.

Dr. Doty was also co-founder and President of Sonne Labs, which focused on producing sunflower and soybean-based food ingredients and snack foods, and whose high protein snack foods were sold to a majority of the USDA School Lunch participating schools in the U.S., as well as a line of soy protein isolate beverage mix products that were sold to Far East customers. The company was sold in 2004.

Dr. Doty started N.C. Doty & Associates, LLC in 1994 and has been involved in agricultural and food business development since that time. Projects include studies on soybean crushing, canola crushing, grain milling, dry edible bean processing, soybean snack, nutrition bar, and dairy products manufacturing. Several of these projects involved fortification with protein ingredients such as caseinates, whey protein isolates, and soy protein isolates.


European Study Suggests Canola Oil Adds Value For Infant Formula

As reported in Nutra-Ingredients on January 3, 2011, “a new study that re-examined data on the length and weight gain of infants indicates that infant formula containing canola oil supports normal growth. According to the authors of the new study from Germany, this nutritional profile facilitates the manufacture of infant formula with a fatty acid profile more similar to human milk.”

This study, while examining canola oil rather than protein, does add to a growing body of evidence with respect to the nutritional efficacy and food safety of adult, child, and infant nutrition products derived from canola.

The full article and the references to the authors of the report are posted on the BioExx website in the ‘Media Articles of Interest’ section of the ‘News and Events’ tab at: www.bioexx.com/index.php?option=com_content&view=article&id=…


Saskatoon Update

BioExx also reports that its Saskatoon protein facility is being ramped-up according to required food-grade procedures and remains on schedule toward its next major milestone of HACCP certification. Typical ramp-up challenges have been encountered with items such as ongoing control systems adjustments, conveying systems, pumps, and seals, but these issues have generally been addressed quickly and are non-recurring once corrected. As expected and previously communicated, these challenges have resulted in moderate production volumes, and fluctuating yields and purities. The Company remains quite comfortable with the timing of its next major milestone of food-grade certification, the ensuing commencement of commercial shipments, and the continued ramp-up of plant volumes.

BioExx is also pleased to report that, upon becoming HACCP certified, the food safety control procedures established in Saskatoon are expected to be in full compliance with all defined clauses of the new United States S. 510 Food Safety Modernization Act, passed into law on January 4, 2011.


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent-pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX: BXI), please visit www.bioexx.com "

[Popeye82]

Fraser Mackenzie’s top picks - BNN - Jan 6, 2010

- A. Bell -
www.bnn.ca/Blogs/2011/01/06/Fraser-Mackenzies-top-picks.aspx

[Popeye82]

um es kurz zu machen: Ja, es ist -Suuupermaaaaan :

BioExx Appoints New U.S. Based Director - Jan 10, 2011
www.marketwire.com/press-release/BioExx-Appoints-New-US-Base…

"TORONTO, ONTARIO--(Marketwire - Jan. 10, 2011) - BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to announce that Mr. Henry Linsert Jr. has been appointed to its Board of Directors to add additional, and direct, industry expertise and depth. The Company has also accepted the retirement of Mr. Paul McClory from the Board of Directors, following more than 13 years involvement with the genesis and evolution of BioExx. The Company further announces that it has selected KPMG LLP to serve as the Company's independent auditor commencing with fiscal year 2011.


Appointment of New Director

Mr. Linsert, who is based near Washington, D.C., founded Columbia Biosciences Corporation in 2007 to develop new uses for algal fluorescent proteins and new purification technology to improve the performance of proteins and antibodies for therapeutics, diagnostics and biochemical reagents.

Prior to Columbia, Mr. Linsert was Chairman of the Board and Chief Executive Officer of Martek Biosciences Corporation from 1989 to 2006. As CEO he led Martek from being a small private R&D company, to a profitable Nasdaq-listed company with a market capitalization of over $1 billion. In 2006 he also received the Ernst & Young Entrepreneur of the Year® Life Sciences Award for the Washington, DC area and was a national runner-up for the same category. His tenure included construction and operation of multiple new processing facilities for the world's first production of DHA from micro-algae and ARA from natural fungi , to provide essential Omega-3 and Omega-6 fatty acids, and introducing these products to global infant nutrition markets. Today, over 90% of all infant formula sold in the US includes Martek products , and the products are sold in more than 70 countries worldwide. Mr. Linsert retired in 2006 as CEO, remaining as Chairman until mid 2007.

Prior to Martek, Mr. Linsert was primarily engaged in the development and financing of early-stage companies in the Mid-Atlantic area in a variety of roles, including having been CEO of venture capital company Suburban Capital Corp, which was subsequently acquired by Bank of America , and as Vice President of First Virginia Bank. Mr. Linsert also served as a Captain in the U.S. Marine Corps.

Mr. Linsert received an M.A. in economics from George Washington University in 1970 and a B.A. in economics from Duke University in 1963. In 2009, he was one of the three inductees in the Space Technology Hall of Fame. He currently serves on the review committee of the US National Academies of Sciences for Technology, Innovation and Entrepreneurship.

Concurrently, the Company wishes to express its sincere gratitude to retiring Director, Paul McClory, for his long-time stewardship and service to the Company and its shareholders. Mr. McClory was the discoverer of the effectiveness of low temperature extraction in the recovery of protein isolates from oilseeds and the founder of Naturol Ltd. in 1998. Naturol was the original applicant and owner of the cold temperature extraction patents that are now wholly-owned by BioExx and that formed the original basis of the Company. While BioExx has developed its technology considerably beyond what was first patented by Naturol, and has developed several additional patent-pending technologies, Mr. McClory helped create the vision for what has become BioExx. Mr. McClory has agreed to maintain his involvement with BioExx by joining its Science Advisory Board, where his experience and vision will continue to add value for shareholders.


Selection of New Auditor

The Company also announces that it has selected KPMG LLP as the Company's independent auditor commencing with fiscal year 2011. The selection concludes a thorough evaluation that the Company conducted among several international audit firms. BioExx conducted this evaluation to assess its ongoing and growing need for audit, assurance, and tax services, and in particular as its business plan evolves into international markets. BioExx has been well served since its inception as a public company by its current independent auditor, McGovern Hurley Cunningham ("MHC"), and it extends its sincere thanks to MHC for its strong service to the Company and its shareholders. The intended change in independent auditors does not result from any disagreement or dissatisfaction between the Company and MHC. The appointment of KPMG LLP as independent auditor is subject to the approval of the Company's shareholders at its next shareholder meeting.

"We are extremely pleased with both of these new appointments," said BioExx CEO, Chris Carl. "In particular, Mr. Linsert brings a wealth of successful experience that is well aligned with the BioExx business plan, especially in terms of taking new technology from lab-scale through to multiple commercial plants, and developing high-end nutrition products for global markets. There is little doubt that Mr. Linsert can add tremendous value to BioExx as it continues on its path to becoming a larger scale operating company in similar markets over the coming years."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com "

[Popeye82]

BioExx Completes Internal HACCP Audit; Expands Executive Team - Jan 25, 2011
www.marketwire.com/press-release/BioExx-Completes-Internal-H…

"BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to announce that it has completed the internal audit of its Hazard Analysis and Critical Control Points ("HACCP") procedures at the Saskatoon plant. The audit was performed by Silliker, Inc. The purpose of the internal audit is not to determine a pass or fail but rather to prepare the facility for its first external audit which is presently scheduled for late February.


As expected, various observations were made resulting in suggestions for improvement, but a post-audit review has determined that all necessary recommended control procedure improvements should be completed in time for the external audit. The internal audit also noted that further production volume improvements would be required to satisfy the physical compliance requirements of the external audit and a plan has been established to allow the plant to achieve this volume prior to the external audit.

The Company continues to observe fluctuations in daily operating results, and while there has generally been a consistent pace of learning in the start-up of this pioneering facility, there have been several issues, primarily equipment-related and beyond the Company's control, that have prevented the company from reaching its desired levels of production thus far. Problem areas have included some on-going failures in critical components such as pumps, compressors, and seals, and have recently extended to power outages during production runs in the business park where the plant is situated. These issues are being resolved but have impeded progress to date. Most of the challenges have been encountered in the extraction area and the clean-in-place system, both of which limit protein production and meeting human food specifications. Despite these challenges, which will be overcome, the team has been generally pleased with the performance of the protein area and the balance of the plant.

To address these issues in an aggressive and complete manner, the extraction plant was shut down for one week to allow for a number of equipment adjustments and a thorough cleaning. During this period the crush plant and parts of the protein plant are continuing to operate, focusing on yield and equipment optimization. Full plant operations will resume in the next week, with an expectation that these on-going nuisance problems will have been largely addressed and the necessary volume gains can then be achieved.

The Company is pleased with the state of readiness of its required control systems, and remains confident in the efficacy of its technology. It is now looking forward to accelerated progress as it moves toward consistent, commercial food-grade protein production, and to successfully completing its external HACCP audit. As planned, the Company expects 7/24 operations and commercial food sales to commence shortly thereafter, in small but steadily increasing volumes.


New Executive Team Appointments

The Company is also pleased to announce the appointment of two new members to its executive team to continue to add depth and breadth for the next phase of its growth. Clinton Smith, who has been General Manager, Saskatoon since last January, has been appointed VP Operations, and Deane Pittman is joining the company as VP Engineering. Both Clinton and Deane will have direct and key roles related to the further ramp-up and capacity growth in Saskatoon as well as the development of the Minot facility.

Clinton Smith has more than 20 years in senior operations management positions in the food industry, playing key roles in all aspects of the business. Clinton spent 9 years with Canada Safeway Limited, one of Canada's largest grocery chains, managing food production operations for Lucerne Foods, with annual sales of over $500 million. In his last position as VP Canadian Operations, his team was responsible for all aspects of 12 Canadian food processing plants, improving sales and profitability by more than 100% over a 2 year period while increasing food safety controls and improving operations. Prior to that, he held three related positions at different companies including Director, International and Domestic Sales with XL Foods, where international sales were doubled during his tenure while simultaneously increasing productivity and reducing loss and waste. Clinton also has significant training in loss control management and lean manufacturing practices and holds a B.Sc. (Agriculture) from the University of Saskatchewan.

Deane Pittman has more than 30 years experience including holding successive positions as maintenance manager, controls specialist and plant engineer with Procter and Gamble in Canada; senior technical manager and director of quality at Molson Breweries; director of engineering and construction services at generic drug manufacturer Apotex Inc. with oversight and direct involvement in more than $700 million in capital projects and start-ups; and most recently as project director for the construction of a $100 million research and discovery facility with the pharmaceutical company Sanofi Pasteur. Deane also has extensive training and implementation experience in Total Quality Management and measurement systems and holds a Mechanical Engineering degree from McGill University.

"We are very pleased to welcome Clinton and Deane to the executive team, where they can utilize their significant skill and experience to help shape BioExx into a world-class operating company," said Chris Carl, BioExx CEO. "Getting through our internal audit definitely brings us one step closer to our goal of commencing human food sales. However, there is little doubt that bringing a first-of-its-kind technology to market is a challenging endeavour, and that BioExx is continuing to build a strong team of diverse and talented people to help ensure that these challenges are met successfully."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. Relative to other commercial processes, the low temperature BioExx process results in comparatively low energy requirements, environmentally sound extraction and protein separation processes, and very high human food yield that cumulatively have the potential to make a highly valuable contribution to global food and protein supply while maintaining an excellent environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[CHingaCHcook]

Ich habe dies im Mai2010 bei ca. 1.42Can$ gekauft und im Dezember bei 2.48 verkauft.
Ich bin dann bei 2.12 wieder eingestiegen und habe bei 2.61 verkauft. Ich bin dann wieder bei 2.25 eingestiegen und habe gestern bei 2.33 nachgekauft. So viel zu meinen trades mit bioexx.
Ich halte es fuer ein starkes Zeichen, dass man bereit ist so viele Spezialisten in dieser Phase anzuheuern und das diese die Herausforderung annehmen und BIOEXX helfen wollen, aus den Startloechern zu kommen. Have fun!

[Popeye82]

Antwort auf Beitrag Nr.: 40.948.494 von CHingaCHcook am 29.01.11 16:20:40

Na dann weiterhin so ein gutes "Händchen". Ich hab´ im April ´09 gekauft -&seitdem nie wieder verkauft.


Zu den "Spezialisten": Es ist ja nicht so, dass sie betteln gehen müssen, um Leute mit ausgezeichneter Reputation zu bekommen. Ist ´ne 2seitige Sache. Im Endeffekt sind sie auf dem Weg zu einem weltweitem Novum, in einem hochattraktiven Markt -mit potenziell, wenn die Anfangsprobleme überstanden werden, EXTREMMargen. Auf einem Niveau, wie man sie abseits der Emerging Markets kaum kennt.

Also wer/welche Seite nun "froh" darüber sein kann, dass es zu diesem Angestelltenverhältnis kommt, kann man durchaus verschieden sehen.

Gruß
P.

[Popeye82]

Antwort auf Beitrag Nr.: 40.944.479 von Popeye82 am 28.01.11 16:18:42

BioExx Successfully Completes ISO 22000 Audit - Feb 24, 2011
www.marketwire.com/press-release/BioExx-Successfully-Complet…

"TORONTO, ONTARIO--(Marketwire - Feb. 24, 2011) - BioExx Specialty Proteins Ltd. (TSX:BXI) is pleased to announce that, following on-site audit inspections over a two-week period, the company has been awarded certification for ISO 22000:2005, which incorporates the principles of both HACCP and GMP, by NSF International Inc. ("NSF"). This certification is required to allow BioExx to sell its conforming protein products into human food markets.


As described by NSF on its website, the "International Organization for Standardization (ISO) 22000:2005 Standard: Requirements for a Food Safety Management System", demonstrates an organization's commitment to food safety, and provides a means to demonstrate that an organization is taking the necessary steps to control food safety hazards. The standard has three parts including: Good Manufacturing Practices (GMP); Hazard Analysis Critical Control Points (HACCP) principles; and management system requirements. ISO 22000:2005 applies to all organizations, regardless of their size, that impact the food chain. This includes ingredient suppliers, equipment manufacturers, package suppliers, service providers, farmers, food processors, and catering and retailing organizations.

NSF Food Safety Auditors check conformance with internationally recognized Codex General Principles of Food Hygiene, and Codex Codes of Practice. NSF International Food Safety Auditors work with companies to ensure that there are effective systems in place for sanitary food processing. NSF International Food Safety Auditors are also qualified to verify compliance with U.S. FDA and USDA regulations for Good Manufacturing Practices (GMPs) and Sanitation Standard Operating Procedures (SSOPs).

While it was noted that production levels to date have not been as high as expected, the findings of the auditors resulted in citing only two minor non-conformances, dealing first with ensuring that all food safety management systems are subject to ongoing internal audits and second, that a complete Emergency Preparedness & Response plan be fully instituted. BioExx has already submitted the required corrective action plan and has made the changes to its systems effective immediately. Both the corrective actions and ongoing plant operations will be verified at the next regularly scheduled surveillance review that all certified companies undergo to ensure that the food safety system is monitored and maintained.

The Company is also pleased to confirm that it continues to make progress on production challenges. Most of the vendor-related equipment problems have been resolved either through replacement or on-site corrective actions, with only one piece of equipment remaining to be replaced. In this instance, a smaller volume substitute has been installed until the replacement is in place in approximately six weeks.[/b]

With the audit completed, and equipment issues largely resolved, the Company is now able to concentrate on growing its production volumes. The biggest challenge now being addressed results from two positive functional attributes of Isolexx™, foam and emulsion, being moderately formed at the extraction stage and negatively impacting downstream processes. Two sets of corrective measures are being installed; first in the next two weeks, followed by a more robust solution in approximately eight weeks. During this time the plant will be operated at modest volumes (likely below 10% capacity early in the period) and once fully addressed, maintain the goal to approach full Isolexx™ capacity toward mid-year, consistent with plans as previously disclosed.

"The BioExx team is thrilled to have achieved such a high quality result on its first external ISO audit. This is a huge milestone not only for a new food company but also for a company using first-of-a-kind technology," said BioExx CEO Chris Carl. "As we have discussed in the past, we expected to face some challenges as we bring this pioneering technology to full scale but we are pleased that nothing has emerged that suggests any unresolvable long term issues. Throughout this process, our Operating and Engineering teams, and now the separate Quality Assurance team, have demonstrated an incredible capacity for hard work, problem solving, and positive results and what remains now is to steadily build our production volumes."


About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial processing company focused on the extraction of oil and high-value proteins from oilseeds for the global food, beverage, and nutrition markets. BioExx uses patented and patent-pending technology that utilizes significantly lower temperatures than conventional methods for extracting the final quantities of oil necessary to enable its simplified and patent- pending methods for separating proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint. BioExx operates a commercial scale extraction facility in Saskatoon, Saskatchewan, is in development stages on it second plant in Minot, North Dakota and has a mission to construct additional and larger processing facilities on a global basis.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com. "

[CHingaCHcook]

Habe also in der Zwischenzeit wieder gekauft und zweimal verkauft und heute bei 2.01 fett zugeschlagen. Jetzt wird gehalten bis 3.20 :-)
Viel Glueck allerseits!

[CHingaCHcook]

'Trading range' und 'holding pattern' vor Donnerstags Ankuendigung.
Ich erwarte, dass eine time line gegeben wird bezueglich der
zu erwartenden Volumina und ebenso ein Zeitrahmen fuer die
Einrichtung der Fabrik in Minot/Dakota.
Die Machbarkeitsstudien dort sind offenbar positiv verlaufen.
Das Marketing ist ja schon seit letztem Herbst unter Dach und Fach mit den Hamburgern und den Kaliforniern. E/S wohl immer noch bei -0,1Can$ fuer 2010, alles andere waehre eine faustdicke Ueberraschung.

[CHingaCHcook]

Schoen. Das wars also fuer mindestens bis nach dem 15. (Fed meeting).
Jemand hatte eine 'Strassensperre' von rund 80000 Aktien bei 2.0 Can$ errichtet. Nach dem 'shaky' Dienstag - Gaddafi sei Dank - habe ich also meinen 'Stop' direkt dahinter bei 1.99 eingerichtet. Bei 1.96 war ich schliesslich wieder komplett raus. Puhh!
Schade, aber 1. hat der Markt immer Recht und 2. sind wir jetzt bald auf einem viel angenehmeren Einstiegsniveau. Warten, was TSX, der Dow und die S&P naechste Woche machen und dann klein wieder rein mit zunaechst extrem dichten Stop-loss (3 oder 4 cent). Die Ankuendigungen von BIOEXX waren insgesamt sehr positiv, aber so hochspekulative Werte werden halt bei 'Reversals' immer am haertesten getroffen. Selbst Viterra mit ihren super Quartalszahlen traded jetzt bei nur ca. 17.5 KGV.
Viel Glueck allerseits!

[CHingaCHcook]

OOps, bevor ichs vergess, jetzt erstmal sehen, was bei 1.60Can$ los ist und ob die Linie haelt. Wenn nicht ist der Weg zu ca. 1.28 meilenweit offen. ;-)

[CHingaCHcook]

An Japan denken. Ich wuensche den Menschen und aussergewoehnlichen Volk dort Kraft und das sie nach einer Zeit der Trauer wieder Zuversicht schoepfen koennen. Ich bete zu Gott, dass mehr Menschen dieses Disaster ueberlebt haben als die Bilder mir zu hoffen erlauben.

[CHingaCHcook]

Jemand hat gerade 240000 Aktien gekauft, bei Can$ 1.70 und etwas frueher hat Herr Schnarr 30000 ebenfalls bei 1.70$ ?
Zeit wieder zuzulegen?

[CHingaCHcook]

Am 18. Mai 2011 gibts den Q1 earnings report.
Sonst seh ich nichts auf dem Radarschirm.
Irgendetwas sagt mir ABWARTEN. ;-)
Ich kaufe lieber bei 2.20 und "weiss" was los ist,
als in dieser Situation.

[Popeye82]

Zitat von CHingaCHcook: aber so hochspekulative Werte werden halt bei 'Reversals' immer am haertesten getroffen.

Da stimme ich Dir vollkommen zu.

Zitat von CHingaCHcook: Selbst Viterra mit ihren super Quartalszahlen traded jetzt bei nur ca. 17.5 KGV.

Aber wenn Du sooolche Vergleiche ziehst, dann solltest Du Dir IMO andere Werte suchen. Dann frage ich mich auch, ob dann die "Geschichte" halfway verstanden wurde. Machen, in der Art, überhaupt keinen Sinn -dann hätte man, bisher, NOCH NIE etwas in BioExx reinstecken dürfen..


Trotzdem auch viel Glück.

Gruß
P.

[CHingaCHcook]

Hallo Popeye, ich handele diese Werte und 'halte' sie nicht.
Sektor-KGV sind fuer mich ein (unter vielen) Anzeichen, wie
der Sektor (in dem Fall Nahrungsmittel wie Viterra) insgesamt aussieht und ob er rauf oder runter geht. Ich habe bisher mit BXI gut abgeschnitten, weil ich knallharte Stops fahre, die mich aber nicht daran hindern nach 5 minuten wieder einzusteigen, wenn die Daten das unterstuetzen. Hier gehts nur um Geld und Wahrscheinlichkeiten, sonst um gar nichts.
Es geht nicht darum, Recht zu haben, jeder Trader weiss das... ;-), sondern darum, sein Kapital zu schuetzen und zu verzinsen. That's all.
Viterra hat mir schon gut Holz gebracht, Bioexx auch.

[Popeye82]

Antwort auf Beitrag Nr.: 41.409.665 von CHingaCHcook am 26.04.11 00:19:30

Finde Deine Logik schon relativ widersprüchlich -aber good Luck.

Gruß
P.

[CHingaCHcook]

Oh? Kannst du mir das mal erklaeren?
Was ist der Widerspruch?

Etwa, dass ich Wahrscheinlichkeiten wie long-term investments untersuche, und dann (im Schnitt) maximal 2 Wochen in einem trade bin?

Good luck to you too!

[CHingaCHcook]

AH, ich glaube ich habs: Der unterschiedliche Auffassung besteht
aus Deinem steuerfreien Investment und meinem trading for living...
Das sind in der Tat "zwei paar Schuh".

[CHingaCHcook]

Bin bei 1.73 und 1.99 wieder rein. Daumen druecken

[CHingaCHcook]

So, averaged runter zu einem guten Preisniveau. Ich freu mich auf den 18.5.

[Popeye82]

Antwort auf Beitrag Nr.: 41.495.144 von CHingaCHcook am 12.05.11 22:13:20

[CHingaCHcook]

Antwort auf Beitrag Nr.: 41.499.014 von Popeye82 am 13.05.11 14:42:19

Die Produkte sind so klasse, und ich finde auch modern, dass ich da mal demnaechst hinfahren will. Hast du mit denen geredet, in letzter Zeit? Die sind wohl manchmal bei Helm AG in HH.
Vielleicht werd ich hier doch noch zum 'Investor' ;-)

[Popeye82]

Zitat von CHingaCHcook: Die Produkte sind so klasse, und ich finde auch modern, dass ich da mal demnaechst hinfahren will.

Das sehe ich auch so. Aber nicht im Sinne von "modern", sondern eher "zeit(- und zukunfs-)gemäss".

Zitat von CHingaCHcook: Hast du mit denen geredet, in letzter Zeit? Die sind wohl manchmal bei Helm AG in HH.

Nein. Wo ist HH(Hamburg)? Wenn in der Nähe, würd ichs auch sehr gern mal machen, ansonsten momentan eher schwierig.

Letzteres ist 10.000%ig Deine Entscheidung. Ich "glaube", bis dato jedenfalls, weiterhin an das Unternehmen.

Gruß
P.

[CHingaCHcook]

Der Kurs ist runter wegen der Grosswetterlage und Herrn Gaddafi und der Tatsache, dass sie im letzten quarter Geld verloren haben. Wer das bei einem 'startup' von der Groesse nicht tolerieren kann, kann nicht investieren. Es gibt keine SOLIDE Firma, die es ohne Blut, Traene und Schweiss schafft. Keine.

Was fuer Bioexx spricht ist nicht nur das 'moderne' (per Definition "zeitgemaess") Produkt, sondern auch, dass sie die Expansion durch egenes Wachstum und ohne weitere Kapitalaufnahmen schwingen koennen. Die Margen sind erschreckend gut.

Das Managment-team ist erfahren und komplett. Umwelt- und Produktionsauflagen inc. Qualitaetssicherung und 'human-grade-food' Zertifikate sind unter Dach und Fach.
Wie sie bei der letzten Veroeffentlichung bereits sagten: "Alles was nun noch fehlt, ist Volumen".

Das Absatz-Marketing ist vollstaendig und auf 10 Jahre gesichert, Helm AG in Hamburg, Shafer in Kalifornien. Viterra liefert den Rohstoff.

Ich denke die 'Blut- und Traenenphase' ist vorueber, was bleibt ist die Schweissarbeit, das Volumen hochzufahren und die technischen Details dieser neuen Verfahren zu meistern.

Die Planungen zum naechsten Expansionsschritt in North Dakota sind fortgeschritten. Machbarkeitsstudien fuer Minot sind offenbar erfolgreich abgeschlossen. Die Finanzierung duerfte keine Kopfschmerzen machen, wenn das Produktionvolumen von Saskatoon ausgeschoepft werden kann.

Analysten verschiedener Banken und Investmentfonds geben dem Unternehmen ein "buy" bis (mehrheitlich) "strong-buy". Bei 1.70Can$ hat es Insideraktivitaet gegeben. In den letzten Monaten ist das Boersenvolumen bei etwa 300000 Aktien/Tag gelegen, das entspricht etwa 350 bis 450 Transaktionen.
Wir sind also nicht "allein" mit unserem Interesse

Ich denke, dass sie, bedingt durch Produktionsoptimierung und dem dadurch langsameren Hochfahren bis zur 'Vollast', ein Quarter hinter ihrer urspruenglich Planung vom Sommer 2010 liegen. Dafuer sind sie an der Boerse bestraft worden. Das Blatt koennte sich in diesem oder naechsten Quarter, wenn der Spatenstich in North Dakota erfolgt ist, radikal wenden.

[CHingaCHcook]

... Schweigen?
Habe versucht anzurufen, um herauszufinden, wann die Zahlen kommen, keiner ruft zurueck...
Bin mit minimalem 'loss' wieder komplett draussen und warte ab, hier stimmt was nicht!! Ich kann Probleme jedweder Art verdauen, aber nur, wenn sie offen zur Sprache kommen. Ich denke, die haben ihre Produktionsprobleme noch nicht im Griff und warten Tests mit neuen Maschinen ab, bevor sie die shareholder informieren. Mir zu neblig.

[Popeye82]

Zitat von CHingaCHcook: Was fuer Bioexx spricht ist nicht nur das 'moderne' (per Definition "zeitgemaess") Produkt, ...

Habe ich vielleicht nicht das Wort getroffen, was ich eigentlich wollte, aber für mich liegt da trotzdem ein großer Unterschied drin. Modern geht für mich eher in Richtung "Megatrend"(super trendig, angesagt -Hauptsache das Ding geht uuup (im Moment )). Zeit/Zukunftsgemäss hat das für mich grundsätzlich eine viel nachhaltigere, substantiellere, wie pragmatischere Bedeutung.


@187,

Wie es Dir beliebt.

Gruß
P.

[CHingaCHcook]

Ich hab das neue Datum fuer die naechsten offiziellen Nachrichten:
8. Juni - aber kein Wort, warum das fast 3 Wochen verschoben worden ist.
Ich vermute aus oben genannten Gruenden!

[CHingaCHcook]

BioExx Specialty Proteins Ltd (C:BXI)
Shares Issued 192,076,575
Last Close 6/3/2011 $1.49
Monday June 06 2011 - News Release

Mr. Scott Koyich reports

BIOEXX COMMENCES COMMERCIAL PROTEIN OPERATIONS

BioExx Specialty Proteins Ltd. has commenced commercial food-grade protein operations, comprising daily production and sales of canola protein isolates, making it the first and only such company in the world. Since its last update, BioExx has made progress in a number of critical production areas at its Saskatoon plant which have enabled the Company to move beyond the internal start-up phase and into commercial operations.

Product

The initial focus of short-term production and sales will be on canola protein produced to purity levels of 80% or above, for which there is an established, substantial, and robust market. The customers and applications at 80% and 90% purity are largely the same, with the main differentiator being protein pricing. The two are used somewhat interchangeably in many food and beverage products, such as protein shakes, bars, baked goods, confectionaries, meat analogues, and meal replacers. BioExx also notes that it has confirmed significant protein market sectors in high-value, non-food applications, including sustainable ingredients for cosmetic and industrial products.

The characteristics of the BioExx canola protein products are generally superior to typical soy products and in many cases competitive with whey proteins. The company is selling this product, Advantexx80?, as an isolate at 80% or greater purity while it continues to work toward ensuring that 100% of production meets 90% purity, at which point a 90% isolate will be offered to the market.

Pricing

In general, 80% purity proteins sell at about a 15-20% discount to 90% purity proteins. Recent channel checks with buyers suggest current indicative pricing for whey protein isolates with 90% purity (called "WPI-90") at approximately $13.00 per kg, and whey protein isolate at 80% purity (called "WPI-80") at approximately $11.00 per kg. Given strong pricing in broader protein markets, BioExx has posted pricing for its 80% canola protein isolates ("CPI-80") at $6.00 per kg, competitive with high quality and similar purity soy and whey products and consistent with the Company's earlier guidance on pricing of Isolexx? at 90% purity.

Shipments

First commercial shipments from the Saskatoon plant are being arranged presently for delivery to the Company's protein distribution partner, Helm AG, for re-sale to its customers. Sales are expected to grow steadily from here forward, both to Helm AG and to direct BioExx customers in North America, as production volumes at the Saskatoon plant continue to increase.

Plant Operations

The plant has progressed on both hourly throughput and on quality, with continued improvements still to come. The plant is running well mechanically, with good predictability. While all individual equipment has now proven operational at 100% run rate, the entire plant is now running at an average aggregate hourly throughput rate of approximately 35% of capacity with as high as 65% having been achieved so far. Further gains are now being made on a weekly basis and the Company believes that the key previous issues that represented significant impediments to productivity have been resolved.

With hourly throughput solidified and improving, great effort is now being placed on increasing weekly operating uptime by reducing clean-in-place cycle time, adding production staff to run additional shifts, and steadily diminishing the amount of unplanned process interruption. Because the plant is only now moving from start-up mode to full operating mode, weekly production has remained below 10% of installed capacity. Weekly production is expected to increase measurably now, with another production shift being added presently to enable operations on a 5 day per week schedule through the end of July, at which point the plant will take a standard annual two week summer plant maintenance and improvement shut down, bring on a final shift, and re- start in mid-August on a 7 day per week schedule. Production is expected to be at or above 50% of Phase 2 capacity soon after the August shutdown with a plan to drive toward 100% as quickly as possible.

Protein yield is now about 50% of target, as the focus has been on other operating parameters. The path to reaching near 100% yield targets is well understood, with all required equipment already installed. Higher yields are expected to unfold in step with production volumes throughout the continued ramp-up as this equipment is brought on line.

Perhaps the most significant recent achievement at the plant has been process modifications to widen the operating parameters in the extraction area, which has been the primary bottleneck and source of most of the challenges encountered in start-up to date. These modifications have successfully enabled improved operating consistency and provided a clear and confident path to higher capacities. This has been the Company's primary hurdle to date, and the key precondition to the commencement of regular commercial operations.

Beneficially, these process modifications also represent new and valuable intellectual property for BioExx, in the accumulation of valuable trade secrets and "know-how". Moreover, the knowledge gained and modifications made through the start-up phase may result in significantly lower capital and operating cost for future plants.

"There is little doubt that the start-up of this first-in-the-world facility has taken longer, and been far more difficult, than originally anticipated. Operations at scale have not always acted consistent with lab and pilot work, and each resulting modification has taken longer than desired due to normal design, ordering, installation, and break-in times, but we have always pressed on and have successfully worked through each challenge that has arisen," said BioExx CEO Chris Carl. "We are therefore particularly pleased to have succeeded in becoming the world's first commercially producing, food-grade canola protein company. We still have much to do, but given what has been accomplished as a team to date, we are confident we can overcome any remaining challenges, and look forward to continuing to create long-term value for our shareholders as we press forward."

Regulatory Developments

BioExx is also pleased to announce that it has completed its filing of a formal GRAS Notice in accordance with the U.S. Food & Drug Administration ("FDA") proposed regulation 62FR 18938. According to the GRAS Notice as filed, BioExx has determined after extensive external and independent scientific panel review that its high-purity canola protein products, Isolexx? and Vitalexx? are Generally Recognized As Safe (GRAS) for their intended use in a variety of food and beverage products. Once a GRAS Notice is received by FDA, FDA evaluates the submission and advises whether it believes the Notice provides a sufficient basis for an affirmative GRAS determination, generally within 180 days.

While BioExx already has self-affirmed GRAS status for Isolexx? and Vitalexx?, which fulfils the FDA regulatory requirement for sales in the U.S. and meets the needs of the vast majority of applications and customers for BioExx proteins, the GRAS Notice was filed in order to move towards an enhanced level of regulatory status to ensure the satisfaction of, and meet the purchase requirements of, even the most stringent applications and most demanding customers. The Company also notes that it has self-affirmed GRAS for its 80% protein isolate, Advantexx80?, and therefore meets the regulatory requirement for sales of that product into the US market.

Aha. 80% statt 90% Reinheit. Also immer noch ungeloeste Probleme, die den bei der Produktion auftretenden Schaum betreffen. 35% bis 65% Auslastung der Fabrik ist auch nicht gerade der grosse Bringer. Ich warte ab. Bei 1.60 sieht das gute Stueck zwar billig aus aber die Grosswetterlage ist im Moment doch etwas "birnenfoermig". Mitte August wollen die 100% und 7-Tage Produktion erreicht haben.
Ich seh mir die Sache dann wieder an. Vielleicht geh ich vorher mit kleinen Haeppchen wieder hinein. Allet Jute allerseits!

[CHingaCHcook]

BioExx arranges $20-million bought-deal financing

BioExx Specialty Proteins Ltd (C:BXI)
Shares Issued 192,076,575
Last Close 6/13/2011 $1.06
Tuesday June 14 2011 - News Release

Mr. Chris Schnarr reports

BIOEXX ANNOUNCES $20.0 MILLION BOUGHT DEAL FINANCING

BioExx Specialty Proteins Ltd. has entered into an agreement to sell to a syndicate of underwriters led by Canaccord Genuity Corp., on a bought-deal basis, 20 million units at a price of $1 per unit for gross proceeds to BioExx of $20.0-million. Each Unit will consist of one common share of the Company and one half of one share purchase warrant, each whole warrant (the "Warrants") entitling the holder to acquire one additional common share of the Company at an exercise price of $1.50 for a period of 36 months, subject to early exercise upon notice by the Company to holders that the 20 day volume weighted average trading price of the Company's common shares on the TSX (or such other stock exchange that the Company's shares may then be listed on) is greater than $2.25. BioExx has also granted the underwriters an over-allotment option to purchase up to an additional 15% of the Offered Shares on the same terms and conditions, exercisable any time, in whole or in part, up to 30 days after the closing of the Offering, for additional gross proceeds of up to approximately $3.0 million.

The net proceeds of the Offering are intended to be used for further capital and operating expenditures at the Company's Saskatoon plant, for additional engineering and project development expenditures on its proposed North Dakota plant, and for working capital, research and development, and general corporate purposes.

The Offering is expected to close on or about June 30, 2011 and is subject to regulatory approval. The Units will be issued under a short form prospectus. The Units will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

We seek Safe Harbor.

© 2011 Canjex Publishing Ltd.

Gut. Damit war zu rechnen und mein Riecher hatte Recht auszusteigen. Die Erloese aus Saskatoon koennen auf absehbare Zeit die Erweiterung in North-Dakota (Minot) nicht finanzieren. Der Zeithorizont ist jetzt auch etwas deutlicher (36 months). Der Laden ist fuer mich bei 0.75-0.80cent ein 'buy'. Nicht vorher, dann aber richtig. Allet jute allerseits!

[CHingaCHcook]

BioExx Specialty to list 30 million more shares June 30
Ticker Symbol: C:BXI

BioExx Specialty to list 30 million more shares June 30

BioExx Specialty Proteins Ltd (C:BXI)
Shares Issued 192,081,158
Last Close 6/28/2011 $0.95
Tuesday June 28 2011 - Prospectus Approved

BioExx Specialty Proteins Ltd. will list an additional 30 million common shares on the Toronto Stock Exchange at the open on Thursday, June 30, 2011, according to the TSX. As in a June 20, 2011, preliminary short form prospectus, BioExx plans to sell up to 20 million units at $1 each, raising $20-million. It has granted the underwriters an overallotment option to buy up to three million units at the same price. Each unit consists of one share and one-half of one share purchase warrant. Each whole warrant entitles the holder to buy one share at $1.50 for 36 months from the closing date of the offering. The TSX reports that the warrants will not be listed for trading.

The company plans to use the money to pay capital and operating expenses at its Saskatoon plant, for engineering and project development expenses at its proposed North Dakota plant, and for general working capital and corporate purposes.

© 2011 Canjex Publishing Ltd.

[MrRipley]

Unter Beobachtung. Preislich derzeti ziemlich günstig!

[MrRipley]

1,2 Tonnen / Woche schaffen sie momentan an den Spezialproteinen.
Erhofft waren erheblich mehr.
Wenigstens gabs die letzten Tage nicht unerhebliche Insiderkäufe.


Heute mal 65% Plus, das Downgap vom letzten Monat fast wieder geschlossen, welches daher rührte, dass ein Analystenhaus den Kurs um 90% runterstufte von 2,5 auf 0,25CAD - keine große Kunst...

hier die letzten News 15. Nov 2011
http://tmx.quotemedia.com/article.php?newsid=46116224&qm_sym…

[CHingaCHcook]

BioExx receives GRAF letter for Isolexx, Vitalexx

BioExx Specialty Proteins Ltd (C:BXI)
Shares Issued 227,180,158
Last Close 1/9/2012 $0.155
Tuesday January 10 2012 - News Release

Mr. Chris Schnarr reports

BIOEXX COMPLETES GRAS NOTIFICATION PROCESS FOR ISOLEXX(R) AND VITALEXX(TM)

BioExx Specialty Proteins Ltd. has received a letter from the U.S. Food & Drug Administration (FDA), wherein the FDA confirms that it has no questions regarding BioExx's conclusion that its canola protein products are generally recognized as safe (GRAS) for use in a variety of foods and beverages.

The FDA response was pursuant to a GRAS Notice submitted by BioExx to FDA documenting its conclusion that IsolexxAtrademark (canola protein isolate) and Vitalexx(TM) (hydrolyzed canola protein isolate) are GRAS for use in a variety of foods and beverages. The Notice also included a report with such a conclusion from a panel of qualified experts. The Notice informed FDA that IsolexxAtrademark and Vitalexx(TM) are GRAS, through scientific procedures, as ingredients in foods such as bakery products, snack foods, beverages, soups, dairy products, dry instant milkshake mixes and protein drinks, instant powdered nutritional beverages, processed meat and poultry products, vegetarian food products/meat analogues and meal replacement and nutritional bars.

While BioExx already has self-affirmed GRAS status for its protein products, the enhanced stature of being GRAS Notified is expected to assist in market recognition and market acceptance, particularly in specialty applications. The Company believes this enhancement to its product portfolio will also assist its current global strategic partnering initiative.

The Company also notes that its progress continues towards Novel Food Registration with the European Food Safety Authority, and it anticipates completion of the process in the coming months. EU market size and growth, and a strong orientation towards healthy living and sustainability, make this market a key long-term focus for BioExx.

IsolexxAtrademark is a protein isolate with at least 90% purity (protein content), comprised of un-denatured soluble proteins from non-GMO canola. This allows IsolexxAtrademark to have excellent solubility, strong foaming and emulsification characteristics, and an excellent nutritional profile. The protein delivers more than 109% of the recommended essential amino acids (WHO/FAO ref. 2007) and is well-digested with a true digestibility of 95%. Isolexx(TM) is well suited to a wide variety of applications where soy, whey, or milk proteins are traditionally used. BioExx has also established a self-affirmed GRAS position for Advantexx(TM), which is a canola protein currently being produced by the Company at approximately 86% purity (protein content).

Vitalexx(TM) is a hydrolyzed protein with at least 80% purity (peptides and amino acid content) and a very low average molecular weight. This characteristic allows excellent digestion and absorption. Vitalexx(TM) is 100% water soluble, forming a clear solution across a wide pH range. It has an excellent amino acid profile, with more than 117% of the recommended essential amino acids (WHO/FAO ref. 2007). The BioExx protein hydrolysis process also lowers the prospective risk of immunological response, making it appropriate for sensitive immune systems and lower tolerance applications. The true digestibility of Vitalexx(TM) is 98%, being easily metabolized and biologically available. Vitalexx(TM) is intended for use in human food products including nutritional beverages (protein drinks, fruit juices, infant formula, clinical nutrition), and a range of healthy food applications such as protein bars.

Im Prinzip ist es das, worauf ich gewartet habe: Voll zertifiziertes Produkt! Angesichts der Tatsache, dass sie eine strategische Beteiligung suchen, ist diese Zertifizierung ein Schritt zur rechten Zeit. Das Unternehmen ist ziemlich unter Liquiditaetsdruck aber das Produkt ist von Bedeutung. Meine Einschaetzung ist, dass sie zum Ende des Fruehjahrs/Fruehsommer einen Partner gefunden haben, wie z.B. Viterra oder Bunge...
In Erwartung dessen habe ich 400.000 Aktien zwischen 0.11 und 0.19CAD gekauft. Viel Glueck allerseits!

[CHingaCHcook]

Eine Uebersicht zu Insiderverhalten:
http://canadianinsider.com/node/7?menu_tickersearch=BXI+|+Bi…

[misterwrong]

Woraus resultieren eigentlch die Verluste die Bioexx macht?
Konzept natürlich prima, aber ist das auf Dauer wirtschaftlich?
Technisch auf jeden Fall eine Menge Luft.

[CHingaCHcook]

BioExx boosts volume at Saskatoon plant in January

2012-01-30 08:18 ET - News Release

Mr. Chris Schnarr reports

BIOEXX PROVIDES BUSINESS UPDATE

BioExx Specialty Proteins Ltd. is providing the following update on its business activities.

Plant update

Operational results have continued to improve at the Saskatoon plant. To encapsulate this in a simplified format for general and illustrative comparison purposes against prior updates as issued, results (adjusted for short weeks due to seasonal holidays) have been approximately as tabulated.

Weekly volume Protein purity

Pre-August shutdown 0.4 Mt 80%
Nov. 14 update 1.2 Mt 83%
Dec. 20 update 2.0 Mt 86%
Through Jan. 20 week 2.7 Mt 88%

The data do not reflect the Jan. 27 week, which was shortened for maintenance on the large spray dryer. The company has recently shipped approximately 2.5 million tonnes to a distributor for product application development, and is presently accumulating a further 10 million tonnes for shipment to another distributor in February.

Going forward, the key interim focus of operations will continue to be on quality, consistency and steady shipments, based on existing infrastructure. This is intended to ensure a stable and scalable platform, reduce uncertainty and variability, provide a strong foundation for future capacity expansion, and reduce interim capital expenditure requirements, while at the same time enabling the company to move forward with its strategic partner plans as the foundation for long-term growth.

GEA Process Engineering Inc. retained for engineering scale-up study

In support of its various key initiatives, the company has commissioned a study to confirm the scalability of its technology. The study will be conducted by GEA Process Engineering, which specializes in the design and development of process solutions for the dairy, brewery, food, pharmaceutical and chemical industries. GEA is recognized as a world leader in its field and is one of the largest and most experienced protein engineering firms in the world. The intention of the study is to provide detailed and actionable third party expert recommendations for the scale up of the Saskatoon plant, together with associated capital costs and key operating economics, and is also being extended to include a similar analysis of a new greenfield facility on a larger scale. Subject to requisite protection of sensitive items in respect of valuable and confidential intellectual property, the company looks forward to sharing summary results of the study with its shareholders and other key constituents on completion of the various phases under the work program, the first of which is expected within approximately 60 days.

We seek Safe Harbor.

[CHingaCHcook]

Antwort auf Beitrag Nr.: 42.690.678 von misterwrong am 02.02.12 21:53:48

Woraus resultieren eigentlich die Verluste die Bioexx macht?
Konzept natürlich prima, aber ist das auf Dauer wirtschaftlich?
Technisch auf jeden Fall eine Menge Luft.


Die Verluste stammen meines Wissens aus verfahrenstechnischen Aenderungen am Produktionsprozess, Verschiedenen technischen Aenderungen am Maschinenpark und natuerlich laufenden Kosten.

Die Kapitaldecke ist duenn, daher ist ein Einstieg riskant.
Andererseits ist man auf dem Weg.
Der Net loss fuer Q32011 war rd. 5,8 mio (0.3c/share)
Seit November 2011 hat sich aber der Output mehr als verdoppelt.
Wenn BIOEXX jetzt die Scalability fuer das Verfahren nachweisen kann, dann duerfte das fuer institutionelle Investoren oder auch eine Partnerschaft sehr interessant sein, hier einzusteigen.

Insiderkaeufe der letzten 2 Wochen belegen ein Vertrauen der Geschaeftsfuehrung in das Unternehmen.
Bioexx ist ein klassisches Beispiel fuer ein Venture Capital Investment. Das Risiko ist hoch, dass sie die "Kurve" nicht rechtzeitig kriegen, die Chancen fuer ziemliches Kurspotential bei gelingender Finanzierung/Partnersuche und Scalability duerften im Bereich von (vorsichtig geschaetzt) mehr als 500% innerhalb der naechsten 3 Jahre liegen.
Ich finde, dieser Ausblick und die Tatsache, dass es keinen Zweifel mehr an der Validitaet des Produktes gibt, sind ein gewisses Risiko wert, das natuerlich im Gesamtrahmen eines individuellen Portfolios eingeschaetzt werden muss.
Seit Januar halten wir Anteile zum Buchwert von 300k Can$. Das sind etwa 1% des von uns verwalteten Kapitals. Alles Gute.

[CHingaCHcook]

Gestern nochmal aufgestockt auf nunmehr 1.5 mio Aktien.

[CHingaCHcook]

BioExx Obtains Preliminary Third Party Technology Confirmation
Reaches 90% purity and rationalizes operations

TORONTO, ONTARIO--(Marketwire - Feb. 29, 2012) - BioExx Specialty Proteins Ltd. ("BioExx" or the "Company")(TSX:BXI), the first company to commercialize a new and complete food-grade protein from a major global crop in 50 years, today announced that it has received preliminary third party confirmation of the scalability of its unique canola protein production methods from GEA Process Engineering Inc. This confirmation, together with success in achieving the major milestone of 90% protein purity, strongly supports the Company's strategy to pursue qualified strategic partners.

The preliminary GEA report confirms the feasibility for plant sizes of 40,000 Mt and 80,000 Mt per year and also details the associated equipment and capital investment requirements. "Our progress and investment, together with successful innovation, over the last 6-12 months in particular, have been instrumental in stabilizing and proving the strength of our technology, as well as in providing a solid foundation for the work undertaken by GEA", said Chris Schnarr, CEO of BioExx. "It has been a long and challenging road to get here, but I think we can now safely say that the technology is strong, it is feasible, it is scalable, and it can drive compelling economic returns."

As the GEA report focused on the core protein processing area, it did not include ancillary costs for land, buildings, crush capacity and utilities infrastructure. The totals, including these ancillary costs, for the 40,000 Mt Saskatoon plant and an 80,000 Mt "greenfield" plant are estimated at approximately US$65 million and US$130 million respectively. Based on this preliminary report, the Company believes that its technology offers very attractive returns on investment to potential strategic partners in either scenario. GEA will now undertake the second phase of its mandate, over the next 10-12 weeks, to complete further engineering work and more detailed cost estimates. Subsequent implementation in accordance with final recommendations can be done on a turnkey basis, with performance guarantees based on final engineering and testing results as to protein purities, yields, production volumes, and key operating cost metrics.

In the interim, with this confirmation of its technology completed, the Company will proceed aggressively with its strategic partnering process. "We are moving towards being in a position to deliver to strategic partners an economically compelling and complete turnkey and performance-guaranteed package to produce high quality canola protein for delivery to a very large global market", Chris Schnarr continued. "Major industry players have already shown interest in accessing our process and expertise and this report should definitely serve to support further interest".

The Company is also pleased to announce its recent success in reaching a major milestone through the production of its Isolexx™ canola protein at greater than 90% purity. The Company notes that this success came without trade-offs in process yields or throughput - both of those metrics have in fact also improved, while still achieving these very high purities. This is another "first ever" accomplishment and further strengthens the technology foundation available to potential strategic partners.

Finally, in order to minimize interim operating losses which do not contribute to the fulfillment of the corporate strategy and also to preserve available capital, the Company is scaling back operations at the Saskatoon plant to two days a week, which is sufficient to demonstrate process efficacy to qualified strategic partners as they are identified.

Conference Call

BioExx will hold a conference call to further discuss this announcement, Thursday March 1, 2012 at 9:00 a.m. (ET).

Participant dial-in number(s): 416-340-2216 / 866-226-1792 / 800-9559-6849

Replay Dial-in number(s): 905-694-9451 / 800-408-3053 / 800-3366-3052 Pass code: 5518212

Available until: Midnight, March 15, 2012

The call will be audio-cast live and available for replay at www.bioexx.com.

About GEA

GEA Process Engineering is a group of more than 40 process engineering companies specialized in process technologies, and is one of the world's market and technology leaders in 90 percent of its businesses. GEA Process Engineering develops, designs and markets production plants, systems and processes for the food, beverage, pharmaceutical and chemical industries. With a turnover of approximately EUR 1.3 billion in 2010 and close to 4,600 employees working in 40 countries, GEA Process Engineering is recognized as a world leader in industrial drying, concentration, liquid processing, powder processing and handling, and aseptic packaging. GEA has specific and relevant industry experience with concentration and spray drying of both animal and plant-based proteins.

About BioExx Specialty Proteins Ltd.

Headquartered in Toronto, Canada, BioExx is focused on the separation of oil and high-value proteins from oilseeds for global food, beverage, nutrition, and other markets. BioExx employs trade secret, patented and patent-pending technologies that utilize significantly lower temperatures than conventional oilseed processing, in order to enable the improved separation of proteins from oilseeds. BioExx believes that these processes cumulatively have the potential to make a valuable contribution to global food and protein supply while maintaining an environmentally sustainable footprint.

To find out more about BioExx Specialty Proteins Ltd. (TSX:BXI), please visit www.bioexx.com

The statements made in this press release include forward-looking statements that involve a number of risks and uncertainties. These statements relate to future events or future performance and reflect management's current expectations and assumptions. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, such as the economy, generally, competition in its target markets, the demand for BioExx's products, the availability of funding, the efficacy of its technology, and the anticipated costs of BioExx's plant construction and operation. These forward-looking statements are made as of the date hereof and BioExx does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from BioExx's expectations and projections.

[CHingaCHcook]

Kinder, ich will nicht zuviel sagen, nur eines sei erlaubt:
So billig wie heute noch kommen wir in Zukunft nicht mehr zusammen.... :-)
Der Conference Call war super!

http://www.bioexx.com/page/news-and-events

[ElfenbeinelaufenschnellermitKo]

was gibts Neues?

[Popeye82]

Zitat von CHingaCHcook: Das sind etwa 1% des von uns verwalteten Kapitals.

Hallo CHingaCHcook,

Ich muss zugeben ich bin vor noch gar nicht so langer Zeit mit einem sehr großen Verlust ausgestiegen.

In Verbindung damit dass es eine meiner größten Positionen war und das zweite "geplatzte" von einigen wenigen Unternehmen ist, Denen ich das größte Potenzial/Möglichkeiten zugetraut habe, für mich sehr bitter.

Jetzt sehe ich gerade durch Zufall Deine Bemerkung -im Rahmen von/für was verwaltet Ihr denn Kapital??

Grüße
Popeye